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Abstract 
Biotin is a commercially important vitamin which is produced only 
in minute amounts from biological sources. Biotin functions in vivo as the 
carrier of carbon dioxide in enzymatic carboxylation and 
transcarboxylation ractions. This thesis describes the results of studies of 
biotin biosynthesis in Escherichia coli. 
Work is focused on aspects of the final step of the biotin 
biosynthetic pathway which involves the insertion of sulfur into the 
carbon skeleton of dethiobiotin to yield biotin. This reaction is apparently 
catalysed by biotin synthetase, which is encoded by the bioB gene of the 
biotin operon. The nature of the sulfur donor and of cofactors involved is 
unclear. 
Biotin synthetase was expressed in E.coli using the bioB gene 
cloned in a plasmid vector. Biotin production in these cells was 
determined using a Lactobacillus plantarum bioassay. It was found that 
overexpression of biotin synthetase led to an increase in both the rate and 
quantity of biotin produced compared to wild type bacteria. However the 
rate of biotin produced decreases sharply as the cells grow from 
logarithmic to stationary phase. An explanation for this phenomenon was 
sought by supplementing the growth medium with various additives and 
analysing their effect on biotin production. 
Biotin production in cell-free extracts was assayed using a 
radiometric, chromatographic assay technique. Various additives were 
assayed for their effect on dethiobiotin to biotin conversion in an attempt 
to define the exact nature of substrates and cofactors required for biotin 
production in vitro. 
Various chromatographic methods were performed on cell-free 
extracts of biotin synthetase overproducing cells in an attempt to purify 
the enzyme. Results from these experiments point toward the 
requirement of other hitherto unidentified proteins to produce biotin from 
dethiobiotin in vitro. 
The amino acids sequences of three known biotin synthetase 
enzymes were compared in order to define the contribution of specific 
amino acid residues to biotin synthetase structure and function. This led 
to the synthesis of bioB deletions mutants using recombinant DNA 
technology. 
The biotin synthetase amino acid sequence was used to probe 
avaliable protein databases to search for proteins with similar amino acid 
sequence motifs. Biotin synthetase shows strong homology to a number of 
proteins but in particular to enzymes involved in lipoic acid and thiamine 
biosynthesis. It is hypothesised that the mechanism of sulfur insertion 
could be similar in each of these products. A new sequence motif defined 
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GLOSSARY 
Open Reading Frame (ORF) A sequence of in-phase codons preceeded 
by a translational initiation codon and 
terminated by a chain termination triplet. 
Promoter The DNA sequence to which RNA 
polymerase binds in order to initiate 
transcription. 
Operator The DNA sequence to which a repressor 
protein reversibly binds so as to regulate 
the activity of one or more closely linked 
structural genes. 
Repressor The protein product of a regulator gene, 
when it binds to its own operator it 
prevents transcription. 
Operon A group of coordinately controlled 
structural genes together with the 
operator and promoter sequences that 
control them. 
Plasmid 	 An extrachromosomal, covalently closed, 
circular molecule of DNA carrying non-
essential genetic information and 
replicating independently of the bacterial 
chromosome. 
Induction 	 The switching on of transcription in an 
inducible system following interaction 
VIII 
between the inducer and the repressor 
protein. 
Consensus Sequence 	is an idealized sequence in which each 
position represents the base most often 
found when actual sequences are 
compared. 
Deletions 	 are generated by removal of a sequence of 
DNA, the regions on either side being 
joined together. 
Divergent transcription 	refers to the initiation of transcription at 
two promoters facing in the opposite 
direction, so that transcription proceeds 
away in both directions from a central 
region. 
Ribosome Binding Site 	A site on E. coli mRNA which begins 3 to 
11 nucleotides upstream from the AUG 
start codon; is complementary to the 3' 
end of 165 ribosomal RNA. Also known 






Tris TRIZMA - Tris[hydroxymethyl]amino-methane 
SDS Sodium dodecyl sulphate 
a.a. Amino acid 
h.p. Base pair 
0D280/0D600 Optical density at 280 or 600 nm. 
Amp Ampicillin 
Tet Tetracycline 
BSA Bovine serum albumin 
Cm Chloramphenicol 
kDa Molecular weight in kiloDaltons 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
EDTA Ethylenediamine tetraacetic acid 
IPTG Isopropyl f3-D-thiogalactopyranoside 
nt nucleotide 
PAGE Polyacrylamide gel electrophoresis 
APS Ammonium Persulphate (10% solution) 
TEMED N, N, N', N'-tetramethylethylene diamine 
U Unit, units 
X-gal 5-bromo-4-chloro-3-indoyl- J3-D-galactopyrano side 
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Sulfur containing natural products exhibit diverse structure and 
function, a few examples of which are given in Figure 1.1 below. The 
enzyme cofactors biotin (1), lipoic acid (2) and thiamine (3) and the amino 
acid cysteine (4) are examples of the so-called primary metabolites, those 
that are essential to life. Isopenicillin (5) and a-terthienyl (6) are 
examples of secondary metabolites, compounds believed to be non-
essential to the producing organism. By investigating the biosynthesis of 
such compounds one would hope to gain an insight into carbon-sulfur 
bond formation. 
This thesis explores the biosynthesis of the coenzyme biotin in the 
bacterium Escherichia coli. In particular, the work described in this 
thesis is focused on the final enzymatic step in the biosynthetic pathway 
wherein a sulfur atom is incorporated between two sp 3 carbon atoms of 
the dethiobiotin skeleton to form the tetrahydrothiophene ring of biotin. 
This final step is catalysed by the enzyme biotin synthetase. 
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Figure 1.1 Examples of sulfur-containing natural products. 
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1.2 Biological role of biotin 
Biotin is a commercially important vitamin first isolated in 1936 by 
Kogi and Tonnis. The compound is an essential cofactor for a small 
number of enzymes that have diverse metabolic functions. However more 
than fifty years since its initial isolation, the mechanistic role of biotin as 
a carbon dioxide carrier in enzymatic carboxylation and 
transcarboxylation reactions is still not completely understood and 
continues to be the subject of study. The early work on the role of biotin 
utilizing enzymes in Nature has been reviewed by Wood and Barden 
(1977). Wright and Skeggs (1944) isolated biocytin (7) from yeast and 
suggested that biotin existed covalently linked to a lysine residue of 
biotin-dependent enzymes. This was subsequently verified by Kasow and 
Lane (1962) who showed that biotin is linked to the E-amino group of a 
lysine residue in propionyl-CoA carboxylase. This linkage has been found 
in all biotin enzymes studied to date. The biotin dependant enzymes fall 
into three functional categories : CO2 fixation (carboxylase reactions), CO2 
transfer (transcarboxylase reactions) and CO 2 loss (decarboxylase 
reactions). Examples of each of the above classifications are given below. 
4 
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S-Methylmalonyl-CoA + pyruvate 	oxalacetate+propionyl-CoA 
3 Decarboxylase 
Methylmalonyl-CoA decarboxylase 
S-Methylmalonyl-CoA 	' propionyl-CoA + CO2 
The overall reaction catalysed by a biotin enzyme proceeds via two 
partial reactions as follows: 
E-biotin + ATP + HCO3- 	E-biotin-0O2 + ADP + P1 
E-biotin-0O2 + acceptor 	E-biotin + acceptor-0O2 
Or CO2 donor + biotin-E 	 carboxybiotin-E + products 
Carboxybiotin-E + acceptor 	carboxylated acceptor + biotin-E 
In the carboxylase reactions, HCO3 is the carboxyl group donor 
and is activated by ATP + Mg2 . In the transcarboxylase and 
decarboxylase reactions ATP is not required and the "active CO2 1 ' is 
transferred either from an acyl-CoA derivative or from an a- or 13-keto acid 
to the biotin enzyme. The most definitive evidence for the first reaction 
was obtained from the preparation of the carboxybiotin-enzyme complex 
by Kaziro and Ochoa (1961) after treating propionyl-CoA carboxylase with 
ATP, Mg2 and HCO3 . It was then possible to demonstrate the formation 
of ATP on the addition of ADP, Mg 2 and PPi to the isolated complex. 
Subsequently Lynen and co-workers (Lynen et al., 1959) showed that the 
N-1-atom was carboxylated in the E-biotin complex. Diazomethane 
treatment of the carboxybiotin-enzyme after labelling with H 14CO3- and 
proteolytic cleavage with pronase allowed the isolation of the N 1-
methy1carboxy derivative of biocytin. Treatment of this with biotinadese, 
an enzyme which cleaves biotin from the enzyme complex, gave N 1-
carboxybiotin. 
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1.3 Biotin-Holoenzyme formation. 
The biotin prosthetic group is covalently linked to the e- amino 
group of a lysine residue of biotin dependent enzymes. Kasow and Lane 
(1962) identified an enzymic activity in bacterial cell extracts which 
catalysed biotin-enzyme formation. The enzyme, biotin holoenzyme 
synthetase was purified to homogeneity by Eisenberg et al., (1982) and 
recently a three-dimensional crystal structure has been obtained by 
Wilson et al., (1992). See also Chapter 1.10. The holoenzyme synthetase 
reaction has been shown to require ATP and Mg2+ and to occur via the 
following mechanism :- 
Biotin + ATP + Mg2 	 biotin-AMP + PP1 
Biotin-AMP + N112-apoenzyme 	biotin-CO-NH-apoenzyme + AMP 
In support of the above mechanism, biotin adenylate was found to 
replace biotin and ATP in the formation of propionyl-CoA carboxylase and 
transcarboxylase holoenzymes (Kasow and Lane, 1961). The enzyme has 
a molecular weight of 35.3 kDaltons and appears to be active as a 
monomer. However, the enzyme may be active in several oligomeric forms 
as suggested by the occasional appearance of a Mr = 90,000 component on 
gel filtration and the appearance on native gel electrophoresis of multiple 
protein bands which also proved to be biologically active. The structure 
and mechanism of holoenzyme synthetase has recently been reviewed by 
Goss and Wood (1984) and by Cronan (1989). 
The amino acid sequence motif of the biotin binding site of pyruvate 
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carboxylase from sheep, chicken, and turkey livers, the transcarboxylase 
of Propionibacterium shermanii, and the acetyl-CoA carboxylase of E.coli 
show a great deal of homology. In all cases, an Ala-Met-Bct-Met 
(Bct=biocytin) sequence occurs, and in the pyruvate carboxylase and 
transcarboxylase the homology extends to Ala-Met-Bct-Met-Glu-Thr. This 
sequence homology has been suggested as evidence for the diverse 
bacterial and mammalian biotin enzymes having a common ancestry and 
may be important in designating the specific lysine of the protein that is 
to be biotinylated by the holoenzyme synthetase (Wood and Kumar, 1985). 
1.4 Mechanism of ATP-Dependent Carboxylations 
The formation of N 1-carboxybiotin presents an interesting 
mechanistic. problem central to which is whether an activated 
intermediate is formed between ATP and CO2, or whether the reaction 
proceeds by a concerted reaction without intermediate formation. The 
overall reaction can be envisaged as follows (see Scheme 1.1):- 
IScheme 1.1 
0 	 0 
HN NH 	 JANCO2 
+ ATP + H00O2 	 H Enz ""'b Enz 
P+ Pi 	 S 
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One pivotal piece of experimental evidence which effectively limits 
the plethora of possible mechanisms was the observation by Kaziro et al., 
(1962) that while two 180 atoms from [18031-bicarbonate are retained in 
the carboxylate group of the product the third was transferred to the 
inorganic phosphate produced in the reaction. Determining whether the 
above reaction occurs via a stepwise or concerted pathway has proven 
difficult because biotin enzymes do not catalyse partial exchange 
reactions; i.e. incubation of labelled ADP and unlabelled ATP in the 
absence of other substrates does not lead to their interconversion. 
Three pathways outlined below in Scheme 1.2 have been proposed 
which accomodate the experimental evidence and which to various extents 
circumvent the problems that biotin is a poor nucleophile and bicarbonate 
in contrast to CO2 is a poor electrophile. 
In mechanism (1.2(a)) (stepwise), proposed by Sauers et al., (1975) 
bicarbonate is phosphorylated by ATP to form the highly reactive mixed 
anhydride carboxyphosphate, which is then attacked by the N-i nitrogen 
of enzyme-bound biotin ( either directly or after collapse to enzyme-bound 
CO2) to yield carboxybiotin. This mechanism is attractive as 
carboxyphosphate is a known species (Powers and Meister, 1976 and 
Wimmer et al., 1979). This mechanism suffers the criticism however that 
the ureido nitrogen of biotin is not a strong nucleophile. 
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The concerted mechanism shown in scheme (1.2(b)) involves the 
formation of 0-phosphobiotin. A 6-electron pericydic process is then 
proposed to occur to give carboxybiotin and phosphate. Finally, 
mechanism (1.2(c)) again proceeds with the formation of 0-phosphobiotin. 
Bicarbonate attacks the phosphorus atom to give carboxyphosphate and 
the isourea form of biotin. These two species then react together to give 
the products. 
The results of Hansen and Knowles (1985) have removed 
mechanism (1.2(c)) from contention. In mechanism (1.2(c)) each of the 
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enzyme-catalyzed phospho group transfer reactions would presumably 
involve inversion of configuration at phosphorus resulting in an overall 
retention of configuration at the y-phosphorus. However, when the 
stereochemical fate of the y-phosphorus group of adenosine [y-Sp]-5'-O-
([i3 y-170 , y-170,180]-3-thiotriphosphate) was followed in the reaction 
catalyzed by pyruvate carboxylase, inversion of the configuration at 
phosphorus was observed. While Kiuger et al., (1979) have argued that 
formation of 0-phosphobiotin might proceed by a pseudorotatory route 
with retention of configuration for this step, it should be noted that 
pseudorotation mechanisms have not been observed for any enzymatic 
reaction studied to date. 
Evidence in favour of mechanism (1.2(a)) has recently been 
presented by both Ogita and Knowles and Tipton and Cleland (Ogita and 
Knowles, 1988, and Tipton and Cleland, 1988). Tipton and Cleland 
carried out a kinetic investigation on the biotin carboxylase from E.coli. 
They found that the enzyme contains an active site sulthydryl group and a 
catalytic base. They suggest that it is unlikely that biotin could attack 
carboxyphosphate when the carboxyl group is ionized, because a dianionic 
tetrahedral intermediate would result. If the carboxy group remains 
protonated then the dianion of phosphate, the product of the reaction, 
would not be formed. On these grounds they propose that the 
carboxyphosphate intermediate breaks down to the dianion of phosphate 
and carbon dioxide which subsequently reacts with the ureido form of 
biotin to give carboxybiotin. 
Ogita and Knowles have used a number of methods to try to 
confirm the presence of carboxyphosphate. They could not detect 
positional isotope exchange in adenosine 5'-([a,3- 18O,j343.. 18O21 
triphosphate) during the reaction, nor could they trap the putative 
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carboxyphosphate intermediate as its trimethyl ester, under conditions of 
incubation and analysis where the authentic triester was shown to be 
stable. However they were able to show that the ATP'ase activity of biotin 
carboxylase that is observed in the absence of biotin, an activity that is 
known to parallel the normal carboxylase reaction when biotin is present, 
occurs with the transfer of an 180  label directly from 180  bicarbonate into 
the product Pi. This result suggests that the bicarbonate-dependent 
biotin-independent ATP'ase reaction catalyzed by biotin carboxylase 
proceeds via carboxyphosphate and that the carboxylation of biotin itself 
may proceed analogously. The inability of Ogita and Knowles to detect 
the carboxyphosphate intermediate could be due to its high reactivity in 
the active site of the enzyme or alternatively to the breakdown of the 
intermediate to carbon dioxide and phosphate as suggested by Tipton and 
Cleland. 
Recently the gene encoding the biotin carboxylase subunit and the 
BCCP of E.coli Acetyl-CoA carboxylase was cloned and sequenced 
enabling the overproduction of the enzymes (Li and Cronan, 1992). This 
knowledge provides the opportunity to carry out further analysis of the 
mechanism of the carboxylase reaction and a full characterization of the 
protein structural elements involved. 
1.5 Carboxyl Transfer from biotin. 
CO2 transfer from N-carboxybiotin involves a formal electrophilic 
substitution of a proton of the substrate carbon by a carboxyl group. 
Retey and Lynen (1965) have shown this occurs with retention of relative 
configuration. Again mechanisms outlined below in Scheme 1.3 can be 
envisaged which involve either stepwise or concerted mechanisms. 
12 
The use of double isotope fractionation has ruled out the concerted 
mechanism (O'Keefe and Knowles, 1986 and Attwood et al., 1986). [ 13C] 
and [2H3] labelled pyruvates were used in the reaction of CO2 with 
pyruvate catalyzed by transcarboxylase from Propionibacterium 
shermanii. Both labelled substrates gave primary isotope effects which 
does not rule out either of the two mechanisms. 
R CH2O 
L~ 
















However by comparing the 'C effect with both 1113  and 2H3-
pyruvate it was possible to show that deuteration lowered the 'C isotope 
effect. In effect the removal of the proton by base is slowed by replacing 
this with a deuterium atom and so the carboxylation step becomes less 
rate limiting. A concerted mechanism would mean that both the H-loss 
13 
and the carboxylation steps occur simultaneously, so the overall rate 
would be slowed but the 13C  isotope effect would remain unchanged. 
1.6 Biotin biosynthesis. 
The biotin biosynthetic pathway in bacteria has been studied using 
a variety of approaches including radiotracer methods, substrate 
analogues and genetic mutants. On the basis of his results and those of 
other workers, Eisenberg (1973) proposed the pathway for biotin 
biosynthesis given in Scheme 1.4 below. The first biotin precursor to be 
identified was pimelic acid (8). The mechanism of formation and the 
enzyme involved in pimeloyl-CoA (9) synthesis from pimelic acid is still 
unclear. The route proceeds with the condensation of L-alanine with 
pimeloyl CoA to give 7-keto-8-aminopelargonic acid (7-KAPA) (10). 
Transamination then leads to 7,8-diaminopelargonic acid (DAPA) (11). 
DAPA subsequently reacts with CO2 inserting a carbon monoxide moiety 
to generate dethiobiotin (12). Finally, sulfur is inserted into dethiobiotin 
to yield biotin (1). 
Both Eisenberg (1962) and Elford and Wright (1963) showed that 
biotin was labelled by [1,7 14C] pimelic acid. 14C  Pimelic acid was also 
shown to label other metabolites in the pathway. Lezius et al. (1963) 
proposed, based on labelling studies with CO2 in Achromobacter that the 
biosynthetically unusual C-7 dicarboxylic acid derived pimelate group of 
biotin was constructed from 3 malonate units, the starter unit retaining 
the CO2 derived carboxylate which became the C-9 of biotin. Malonyl 
units have been shown to act as starter groups in other pathways, such as 
the biosynthesis of tetracycline (McCormick et al., 1968, Thomas and 
Williams, 1983). In his experiment, Lynen did not locate 40% of the 
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Scheme 1.4 Biotin biosynthetic pathway. 
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label incorporated and consequently the data does not exclude other 
biosynthetic routes; for example C2 degradation of a higher homologue or 
C2 addition to a lower homologue. Higher homologues of pimelic acid 
have been shown to stimulate biotin production, but this has been 
attributed to n-oxidation. Ogata et al. (1973) found that of several odd 
numbered chain dicarboxylic acids, only glutaric acid appeared to be 
essential for biotin biosynthesis in strains of Agrobacterium, whilst 
pimelic acid was inactive. Although the investigators mooted the 
possibility of a new biosynthetic pathway to biotin, it cannot be ruled out 
that the organism could activate glutaric acid and subsequently add a C2 
unit but is unable to convert pimelic acid to its CoA derivative. 
Eisenberg and his coworkers subsequently isolated and identified 7-
keto-8-amino pelargonic acid, the product of condensation of L-alanine 
with pimelic acid. It had been shown previously that 7,8-
diaminopelargonic acid and dethiobiotin could support the growth of yeast 
and Aspergillus nidulans. del Campillo-Campbell et al., (1967) provided 
direct evidence of the role of these vitamers by using mutants blocked in 
various enzymes of the pathway. Using these mutants it was possible to 
isolate and identify the excretion products from the culture broth of E. 
coli. 
The next two intermediates in the pathway, DAPA and 
dethiobiotin, were infered from the fact that both support the growth of 
mutants which were unable to synthesise DTB. Pai (1971) and Eisenberg 
and Stoner (1971) both used resting E.coli cells to demonstrate the 
synthesis of DAPA from KAPA. Pai showed methionine to be the most 
effective amino donor and Eisenberg determined that ATP, Mg 2 and 
pyridoxal phosphate are also required. The inability of methionine to 
function in the absence of ATP and Mg2 suggested possible S- 
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adenosylmethionine (SAM) formation. Indeed SAM proved to be 10 times 
more effective than ATP and methionine in DAPA synthesis. Studies by 
with resting cells of a mutant unable to grow on DTB provided first 
evidence for the conversion of DAPA to DTB (Krell and Eisenberg, 1969 
and Cheeseman and Pai, (1970)). The formation of the ureido ring was 
shown to involve the incorporation of CO 2 and to require ATP and Mg 2 . 
Initial experiments by Lezius et al., (1963) in Achromobacter had 
postulated that L-cysteine condensed with pimeloyl CoA to give a 9-
mercapto-7-KAPA derivative (13) according to scheme (1.5) given below :- 
H 	










A subsequent reinvestigation by Frappier and Marquet (1981) 
showed that the above route did not occur in Achromobacter and that the 
pathway was identical to that found in E. coli. In this study [3- 14C, 
L-cysteine was fed to Achromobacter cells but the isolated biotin was not 
labelled. On the other hand, Achromobacter WSW converts [3H, 14C]-DTB 
into biotin. 
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1.7 The origin of sulfur in biotin. 
The most unusual step in the biosynthesis of biotin is undoubtedly 
the conversion of dethiobiotin into biotin. The precise nature of the sulfur 
donor and the mechanism of the reaction continue to puzzle investigators. 
Niimura (1964) used sulfur-starved cells of S. cerevisiae to judge the 
effectiveness of various sulfur compounds to act as sources of the sulfur in 
biotin biosynthesis, and found the order of effectiveness to be as follows 
methionine sulfoxide, methionine, Na 2S, NaHSO4, homocysteine, S-
adenosylmethionine, and methyl mercaptan. They found that cystine, 
cysteine, methionine sulfone, S-methylthioadenosine, choline sulfate, 
and glutathione were inactive as sulfur donors. Niimura et al., (1964) 
found that addition of 35S-methionine to cells gave radiolabelled biotin. 
Shimada and Zaoshi (1967) also found that addition of 35S-methionine to 
Aspergillus niger gave labelled biotin. 
Various other sulfur compounds have been fed to various cell types 
to ascertain whether they labelled biotin. Although lipoic acid stimulates 
biotin production in A. niger, feeding 35S  lipoic acid results in low levels of 
incorporation into biotin (Elford and Wright, 1968). 
Co2 	 Co2H 
(14) 
Thiocystine (14) [bis (2-amino-2-carboxyethyl) trisulfide ] offers a 
unique biological source of sulfur in that it can simultaneously supply 
organic reduced sulfur, i.e cysteine, and inorganic sulfane sulfur to a cell. 
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The compound, appropriately labelled, can thus specifically label each of 
the different sulfur pools available to a cell although both types of sulfur 
from thiocystine are eventually cycled through cysteine. White (1982) has 
investigated the metabolism of L-thiocystine by E.coli using L-[ 35 
sulfane] thiocystine. The compound was found to serve as a sulfur source 
for E.coli grown on a defined medium, free of other sulfur sources and to 
incorporate its labelled sulfur into cysteine and other sulfur-containing 
cellular components, including biotin. It was determined that all of the 
sulfur atoms of thiocystine contribute approximately equally toward biotin 
biosynthesis. 
In marked contrast Frappier and Marquet (1981) were unable to 
observe significant incorporation of 35S  from L-35S-cysteine into biotin. 
More recently DeMoll and Shive (1983) reinvestigated the contribution to 
sulfur metabolism in E.coli from cystine, methionine and thiocystine. 
They found that E.coli grown in the presence of L- 35S methionine gave no 
labelled biotin. However when L-35S cystine was used, approximately 
80% of isolated biotin was labelled with 3 S. When E.coli was grown, in 
the presence of L-[ 35S-sulfane ] thiocystine, 28.7% of the label was found 
to be transferred to biotin. Since cystine and thiocystine appeared to be 
equally effective in serving as a sulfur source in biotin biosynthesis 
DeMoll and Shive investigated whether the two compounds would 
complement or compete with each other as sulfur donors. When E. coli 
was grown in the presence of 50pM L-thiocystine and 75p.M L-[ 35S] 
cystine, approximately 44% of the biotin was determined to have 
incorporated 35S. The maximum possible was 50% if all sulfur was 
utilised equally. In accordance with this result, when the sulfane sulfur of 
thiocystine was labelled and unlabelled cystine was added, the 
incorporation of 3 S into biotin was significantly lower. 
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The reason for the inability of Achromobacter to incorporate 35 
from cysteine might be due to the inability of the organism to use 
exogeneous cysteine. Indeed Roberts et al., (1955) have shown that this is 
the case for E. coli. Exogeniously supplied cysteine must first be oxidised 
to cystine before it will be transported and utilized by E.coli. 
DeMoll et al., (1984) demonstrated the close relationship of the 
precursorial sulfur pool of cysteine with that of biotin. They fed 34S SO4 
and L- [sulfane-34S I thiocystine to E.coli and showed by GC-MS that 
internal cysteine and excreted biotin were labelled to the same extent. 
The second major problem associated with the conversion of 
dethiobiotin to biotin concerns the mechanism of sulfur introduction. 
Early work by Li et al., (1968) tackled the problem of H loss from 
dethiobiotin to accomodate the S-atom of biotin. They administered a 
mixture of either [9-I or [10-]- 14C dethiobiotin and randomly tritiated 
dethiobiotin to cultures of A. niger and isolated radioactive biotin sulfone. 
Their results suggested that 4 hydrogen atoms were lost during the sulfur 
introduction process, and they postulated the possibility of two 
desaturation steps being involved. 
Parry removed the uncertainties resulting from the use of randomly 
tritiated dethiobiotins by synthesising dethiobiotin specifically tritiated at 
the C-i, C-2, C-3, C-4 and C-5 positions (Parry et al., 1975, Parry and 
Kunitani 1976 and Parry and Naidu 1980). The samples of tritiated (±)-
DTB were each mixed with [10- 14C]-(±)-DTB and the doubly labelled 
precursors were then administered to cultures of A.niger. The precursors 
were not resolved since only (+)-DTB appears to serve as a biotin 
precursor (Ogata 1970). Biotin was isolated as the biotin sulfone methyl 
ester. The methyl ester was purified by chromatography and by 
recrystallization to constant activity. 
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The results clearly demonstrated a number of points:- [3- 3H] and 
[5-3H] labelled (±)-dethiobiotins were incorporated with 105% and 93% 
retention of the tritium label respectively. Also, [2,3- 3H]-(±)-DTB was 
incorporated with 95% retention of label. It was found that incorporation 
of [1-3H]-(±)-DTB into biotin proceeds with about 30% tritium loss. This 
would mean that the oxidation of the methyl group of (+)-DTB involves 
the loss of one hydrogen atom, by a process that exhibits little or no 
isotope effect. The introduction of sulfur at C-i and C-4 of (+)-dethiobiotin 
takes place without the loss of hydrogen from C-2, C-3 or C-5. It would, 
therefore, appear unlikely that unsaturated species such as (15,16) are 
involved in the biosynthesis of (+) biotin from (+) dethiobiotin. 
1JNH 




However the possibility of enzymatic removal of hydrogen from C-2, 
C-3 or C-S followed by replacement of the hydrogen without exchange 
cannot be completely ruled out. The incorporation of [4-(R,S)- 3H2]-(±)-
DTB into biotin proceeds with 47% tritium loss. This result is indicative 
of the stereospecific removal of one hydrogen atom from the C-4 of DTB. 
Thus, it appears that two hydrogen atoms are removed from (+)-DTB as 
the result of its conversion to (+) biotin. 
Parry's work with the eukaryotic organism Aspergillus niger was 
subsequently complemented by work from Marquet's group in E.coli 
(Guillerm et al., 1977 and Frappier et al., 1982). Marquet synthesized 
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[2 ,3-2H2]-(±)-DTB, 	[2,3-3H2]-(±)-DTB 	and 	[5-2H2]-(±)-DTB. 
Administration of [2,3- 3H2]-(±)-DTB in conjunction with [9- 14C]-(±)-DTB 
gave biotin which retained all of the tritium label. The possibility of 
hydrogen migration was ruled out by administration of [2,3- 2H2]-(±)-DTB 
followed by mass spectral analysis of the isolated biotin which showed 
that no loss of deuterium had occurred from either position. In a similar 
experiment [5- 2H2]-(±)-DTB afforded biotin with retention of both 
deuterium atoms. 
Finally, administration of [1- 2H3]-(±)-DTB to E.coli C124 gave 
biotin labelled with two deuterium atoms at C-i. This observation agrees 
with Parry's interpretation of the change in 3H to 14C  ratio accompanying 
the incorporation of [1- 3H, 10- 14C]-(±)-DTB into biotin by A.niger. Parry 
probed the mechanism of sulfur insertion further by synthesizing chirally 
tritiated dethiobiotins. [4-(R)- 3H]-DTB (17) and [4-(S)- 3H]-DTB (18) were 
each mixed with [10- 14C]-(±)-DTB and the doubly labelled precursors 
administered to A.niger. 
W)--M, 	 M)--NH 
H---,~ COH H_, __4 	CH 
HS 
(17) 	 (18) 
The (+)-biotin sulfone isolated in these experiments was purified as 
its methyl ester to constant specific activity. The results showed 91.1% 
retention of the 3H label from the 4R isomer and 93% loss of the label from 
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the 4S isomer, clearly indicating that sulfur is introduced at the C-4 
position with the loss of the 4 pro S hydrogen atom. Since the absolute 
configuration of (+)-biotin at C-4 is known to be S, (Trotter and Hamilton, 
1966) it follows that sulfur is introduced at C-4 of dethiobiotin with 
retention of configuration at that pro-chiral centre. The results of Parry's 
experiments are summarised in Table (1.1) below. 
Marti from Arigoni's group (Marti, 1983) has probed the mechanism 
of H-loss from the C-i carbon of DTB in A. niger. Labelling the methyl 
group with hydrogen, deuterium and tritium resulted in DTB containing a 
chiral methyl group. The stereodistribution of the isotopes at C-i of the 
isolated biotin showed that there had been a scrambling of the isotopes. 
This is summarised in figure 1.2. Arigoni suggests that this scrambling 
is due to the production of an intermediate between DTB and biotin 
containing a conformationally labile methylene radical at C-i. 
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0 0 
HN)1~0 NH 	 HN NH 
H/CDTB H/cBIoT % Ret 
293-3H  6.05  5.74  95.0 
39-3H  2989  3904  105.0 
5-3H  5.72  5.33  93.2 
1-311  6.88  4.81  69.9 
4(R,S)-3H  5.88  3.10  52.7 
4-R-3H  3.37  3.07  9101 
4-S-3H_______ 1 6.00 1 0o42 -  7.0 
TABLE 1.1 Parry 14C 13H labelled DTB feeding study. 
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The results of the above experiments can be compared with the two 
other examples of sulfur introduction whose stereochemistry has been 
elucidated. Parry and Trainor (1980) have shown that sulfur is 
introduced at C-6 of octanoic acid (19) during lipoic acid biosynthesis with 
inversion of configuration, whilst Nevs et al., (1973) and Baxter et al., 
(1982) had shown that introduction of sulfur at C-3 of valine during 
penicillin biosynthesis occurs with retention of configuration at the C-3 
position of the D-valine residue. See Scheme 1.6 below. 
Scheme 1.6 
The stereochemistry observed in the introduction of sulfur at C-4 of 
dethiobiotin suggests that the functionalisation mechanism may be a 
single step process. Alternatively, one could envisage a derivative of 
dethiobiotin hydroxylated at the C-i or C-4 position. This intermediate 
could be activated and displaced by a sulfur nucleophile. This would 
presumably result in overall inversion of configuration since biological 
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hydroxylations at saturated carbon atoms are thought to generally 
proceed with retention of configuration (Parry, 1983). However sulfur 
displacement of a hydroxy intermediate has no precedent in the literature. 
Marquet and her co-workers provided evidence against the 
possibility of hydroxylated forms of dethiobiotin being intermediates 
between dethiobiotin and biotin (Frappier et al., 1979). They synthesized 
1-hydroxy (22) and the two epimers of 4-hydroxy dethiobiotin (20,21) and 
tested them as precursors of biotin in E.coli mutant C124. Ohrui et al., 
(1978) synthesized and tested 1,4-dihydroxy dethiobiotin (23). None of 
the compounds supported the growth of the organism. Transport studies 
have shown that all three compounds can enter the cells and so the 
absence of growth could not be attributed to permeability problems. It 
therefore seems unlikely that hydroxylation takes place at C-i or C-4 of 
dethiobiotin during the formation of biotin. However, one cannot rule out 
the involvement of hydroxylated intermediates that are tightly bound to 
the enzyme(s) catalysing the introduction of sulfur. 
IM1  M)~NH 



















Various thiol intermediates have been proposed to lie on the 
pathway between dethiobiotin and biotin, examples of which are given 
below. 
Marquet et al., (1993) have recently published a synthesis of the 
primary thiol (24) and its [1- 2H21 and [35S] labelled derivatives. They also 
synthesised both enantiomers of the secondary thiol (26,27). Both (24) 
and (26) supported the growth of the biotin requiring strain E.coli C124 
(bioAi, although (24) was required at very high concentrations. (27) was 
found to be inactive in the identical experiment. They administered [35S]-
labelled (24) to growing cells of E.coli and growing and resting cells of 
Bacillus sphaericus (Even et al., 1990). They found that the sulfur label 
was lost from the thiol (24) in growing cells of both species. However the 
label was retained when resting cells of B.sphaericus were used in similar 
experiments. The argument for the direct conversion of the primary thiol 
to biotin was affirmed using the dimeric derivative of (+)1[ 2H2](24). 
This compound was converted to biotin without degradation of the label. 
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Marquet et al. conclude that there are complicated desulfurating 
pathways in both species in growing cells which compete with the clean 
cycization to biotin. They assume that the true biosynthetic route from 
the DTB to biotin occurs in resting cells. 
Both enantiomers of the postulated disulfide intermediates (25) 
were synthesised and tested for growth promoting activity of E.coli C124. 
Both compounds were inactive, however this result should be interpreted 
with caution since the radioactive material was not prepared and the 
permeability of the cells to both compounds could not be checked. 
The intermediacy of the thiol derivatives is attractive on 
mechanistic grounds since insertion of sulfur in a single step would 
involve activation at two separated, saturated sites in a single reaction. 
Whilst the latter reaction has no known biosynthetic analogy, the closure 
of a thiol intermediate to afford a ring structure is precedented by the ring 
closure of LLD-2-aminadipoyl-cysteinyl-valine (28) to isopenicillin N 
shown in Scheme 1.6 (Hatfield et al., 1970). 
1.8 Genetic and Biochemical aspects of biotin biosynthesis. 
In parallel with the investigations into the nature of the chemical 
intermediates of the biotin pathway a great deal of effort has been 
expended in identifying the genes of the biotin (bio) operon which mediate 
the chemical reactions of biotin biosynthesis. Early work led by Campbell 
and Eisenberg identified the bio operon of E. coli and the genes contained 
therein (del-Campiilo-Campbell et al., 1967, Rolfe and Eisenberg, 1968, 
Cleary et al., 1972). The operon is located at 17 mm. on the genetic map 
(Taylor 1970) between the attachment site of the lambda prophage (att ) 
and the uvrB gene of E.coli. Initially, four nutritionally defined groups 
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were obtained and cross-feeding experiments permitted a tentative 
arrangement of the reaction sequence. (del-Campillo-Campbell et al., 
1967) - 
Rolfe and Eisenberg isolated some 60 biotin auxotrophs of E. coli K-
12 and classified these into four groups according to their cross-feeding 
patterns, excretion products and their ability to show a growth response to 
various biotin vitamers. Since all the mutants could be transduced with X 
bio phages known to carry the entire bio locus, it was concluded that all of 
the mutation sites were located in this locus. Eisenberg derived a gene 
order for the different mutant groups on the basis of transduction studies 
with various X bio phages that carried only portions of the bio locus. 
A more definitive arrangement of the reaction sequence was made 
from the excretion patterns of the biotin intermediates isolated and 
identified from these mutants. Complementation analysis by Rolfe (1969) 
and Cleary and Campbell (1972) indicated that the operon contained five 
complementation groups, namely bioA, bioB, bioC, bioD and bioF. Also, 
Schwartz discovered an unlinked gene, bioH, when a deletion of the malA 
region of the genome resulted in a biotin requirement (Schwartz 1966). 
Eisenberg (1975) also isolated two other genes bioP, a permeability gene 
and bioR, a regulatory gene. Pai (1972) had previously isolated mutants 
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Figure 1.3 Chromosomal locations of the 
E.coli bio genes (Nos in minutes). 
Cleary et al. (1972) and Adhya et al. (1968) described the gene order 
of the operon using deletion analysis. The gene activity of deletion 
mutants was studied by complementation tests and enzyme assays. 
Deletion of the left end of the bioA gene did not impair expression of the 
remaining genes, but deletions from the left extending into bioB abolished 
all gene expression. Nonsense mutations in bioB reduced expression of 
bioC, F and D. Therefore, they concluded that four genes bioB, F, C and D 
were transcribed as a unit from left to right and bioA from right to left, 
from a promoter located between bioA and bioB. See Figure 1.4 below :- 
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A-bioA- DAPA aminotransferase - 430 a.a. 47,403Da (PLP, SAM) 
B-bioB- Biotin synthetase-346 a.a. 38,665Da 
F-bioF- 7-KAPA synthetase - 384 a.a. 41,599Da (PLP) 
C-bioC- Unknown- prior to pimelic-CoA- 251a.a. 28,322Da 
D-bioD- Dethiobiotin synthetase- 218 a.a. 23,917Da (MgATP,CO2) 
ORF1- Open reading frame - 158 a.a. 17,10lDa 
1.4 E. coli bio 
1.9 Biotin Biosynthetic Enzymes. 
The bioC gene product. 
The bioC gene product is thought to be involved in an early, but 
chemically unexplored, step in the conversion of pimelic acid to biotin. In 
the bioC region there is an ORF containing an excellent RBS upstream 
and methionine start codon which Otsuka et al., (1988) have postulated 
would encode a protein of 251 a.a. (28,322 Da). Recent evidence suggests 
that this gene encodes the pimeloyl-CoA synthetase in E. coli, catalysing 
the condensation of pimelic acid with coenzyme A (Ploux, unpublished 
results). Ploux et al., (1992) have recently investigated this reaction in 
Bacillus sphaericus. The pimeloyl-CoA synthetase in this species is 
encoded by the bioW gene. The bioC and bioW gene products show very 
little sequence identity. This would suggest that there are differences 
involved in the synthesis of pimeloyl-CoA between the two organisms, the 
exact details of which remain unclear at present. 
7-KAPA Synthetase (bioF gene product). 
The condensation of alanine and pimeloyl-CoA to form 7-KAPA is 
catalyzed by 7-KAPA synthetase. The predicted size of the bioF from E. 
coli product (41,599 Da) approximates well with the biochemical estimate 
of 45,000 Daltons (Eisenberg, 1973). The enzyme has an absolute 
requirement for the PLP cofactor. The bioF reading frame was verified by 
comparison with the S. typhimurium sequence (Rolfe and Eisenberg, 
1968). The bioB stop codon and the bioF initiator overlap. At the 3' end of 
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bioF there is an 11-base pair overlap between the start of bioC and the 
bioF stop codon. Recently the bioF gene from Bacillus sphaericus was 
cloned and the 7-KAPA synthetase overexpressed in E.coli (Ploux and 
Marquet, 1992). The enzyme was purified to homogeneity and found to be 
a monomer of 41kDa. The enzyme showed a characteristic PLP 
absorption at 425nm and substrate Km's for L-alanine and pimeloyl-CoA 
are 3mM and 1pM respectively. 
7-KAPA synthetase shares high sequence homology with the 5-
aminolevulinic acid synthetases of Bradyrhizobium japonicum, mouse, 
and chicken. The enzyme 5-aminolevulinate synthase (EC 2.3.1.37), 
mediates the first step in the porphyrin synthesis pathway. 5-
Aininolevulinic acid synthetase catalyzes the reaction of succinyl-CoA and 
glycine to produce 5-aminolevulinic acid with the release of CO2. See 
Scheme 1.7 below. 
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Scheme 1.7 
Both enzymes utilize PLP as a cofactor and catalyze the 
condensation of an amino acid and an organic CoA ester. In higher 
organisms, the nuclear-encoded enzyme is transported into the 
mitochondria where it is used in the production of heme for electron 
transfer (Schoenhaut and Curtis, 1986). 5-Aminolevulinic acid synthetase 
activity is also found in differentiating erythroid cells where heme is 
required for hemoglobin synthesis. There are 2 lysine residues conserved 
in all four proteins at 7-KAPA synthetase a.a. positions 122 and 236. The 
PLP attachment site was assigned on the basis of sequence similarity 
surrounding lysine 236 in 7-KAPA synthetase and lysine 275 in DAPA 
aminotransferase. 
Eisenberg (1973) has suggested that the bioA and bioF products are 
derived from a common ancestral gene. Indeed, Otsuka found that the 
predicted protein sequences of the bioA and bioF products are weakly 
homologous (Otsuka et al., 1988). With a large number of gaps allowed, 
only 77 identical a.a. (20%) were present in the comparison of bioA and 
bioF products although the PLP and AdoMet binding site homologies are 
found in similar positions in the bioA and bioF products. Even with only a 
few gaps allowed, 115 a.a. matches (27%) were found in the bioA product - 
ornithine amino transferase comparison, and 158 a.a. identities (41%) 
were found in the bioF product - 5-aminolevulinic acid synthetase 
comparison. So although bioA and bioF may share common ancestry, they 
have now diverged to join two separate enzymic families. 
DAPA amino transferase (bioA gene product). 
The product of the bioA gene is the enzyme S-adenosyl-L-
methionine: 7-keto-8-aminopelargonic acid amino transferase (DAPA 
amino transferase). DAPA aminotransferase has been purified to 86% 
homogeneity and has been shown to be a dimer with an estimated 
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molecular weight of 47,000 ± 3,000 Daltons per subunit and an isoelectric 
point of 4.7. The cofactor of the reaction is pyridoxal phosphate (PLP). In 
the reaction mechanism, 7-KAP is transaminated to form DAPA. The 
source of the amine for the transamination is the 2-amino group of S-
adenosyl-L-methionine (AdoMet). The amino group is transferred by a 
ping-pong mechanism to the PLP cofactor on the enzyme and then onto 7-
KAPA (Stoner and Eisenberg, 1975). 
The bioA gene is predicted to encode a protein of 430 a.a., weighing 
47,403 daltons which agrees with Eisenberg's biochemical estimates. The 
bioA reading frame from E.coli was verified by comparing the codon 
differences from E.coli, Citrobacter freundii and Salmonella typhimurium 
(Shivan and Campbell, 1988). A potential AdoMet binding site from a.a. 
251 to 256 ( GFGRTG ) resembles an ATP binding site ( GXGXXG ) 
(Wierenga and Hol, 1983). Otsuka also found sequence homology between 
the bioA gene and the rat and human ornithine aminotransferases 
(Meuckler and Pitot, 1985 and Inana et al., 1986), whilst other 
aminotransferases or deaminases were not among the 20 best matches. 
On closer inspection, it is perhaps not surprising to find such a homology 
between the two enzymes. Ornithine-oxo-acid aminotransferase ( 
EC.2.6.1.13 ) catalyzes the transfer of an amino group from ormthine to a-
ketoglutarate yielding glutamic-y-semialdehyde and glutamic acid (see 
scheme (8). In common with most aminotransferases, ornithine 
aminotransferase is a PLP-containing enzyme. The attachment of PLP to 
DAPA aminotranferase at lysine 275 is inferred by the strong homology to 
the proposed PLP binding site in ormthine aminotransferase. Both 
enzymes have a weak homology to chicken aspartate aminotransferase. 
tro 
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Scheme 1.8 
Dethiobiotin synthetase (bioD gene product). 
Dethiobiotin synthetase catalyzes the addition of the biotin ureido 
carbonyl group. There is a 220 a.a. ORF in the bioD region. The protein 
of 218 a.a. has a molecular weight of 23,917 Da, which agrees well with 
the biochemical estimate of 23 kDa. The native enzyme has been purified 
and found to be a dimer of molecular weight 47 kDa with two identical 
subunits (Krell and Eisenberg, 1970). The stoichiometry of the reaction as 
determined with the aid of H 14CO3 and [8- 14C] ATP indicated the 
formation of one mole of dethiobiotin for each mole of ATP and HCO3 
utilized. ADP, the end product of the reaction, is a competitive inhibitor of 
ATP. CO2, rather than HCO3, was shown to be the true substrate. 
Diaminobiotin (29) could partially replace DAPA, with the formation of 
biotin which could account for the ability of this abnormal product to 




A mechanism has been proposed for DTB synthesis which envisages 
a nonenzymatic reaction of DAPA with CO2 to form a DAPA 
monocarbamate. Activation of the monocarbamate by ATP would give rise 
to a substituted carbamyl phosphate. This could cydize as a result of a 
nucleophilic attack by the amino group with phosphate as the leaving 
group. See Scheme 1.9 below. This mechanism explains the formation of 
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Scheme 1.9 
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Biotin Synthetase (bioB gene product). 
Biotin synthetase catalyzes the insertion of sulfur into dethiobiotin. 
The bioB gene has been cloned from Bacillus sphaericus and expressed in 
E.coli and Bacilli (Ohsawa et al., 1989). The bioB gene from E.coli has 
also been cloned and expressed in E.coli by Hirono et al., (1986). The 346 
a.a. protein from E.coli has a predicted size of 38,665 Daltons (Otsuka et 
al., 1988). The Bacillus enzyme has a predicted size of 332 a.a. of 
molecular weight 37 kDa. The reading frame of bioB was verified by 
comparison with the C. freundii and S.typhimurium DNA sequence 
(Adhya et al., 1968 and Rolfe and Eisenberg, 1968). To date, the enzyme 
has not been purified and the nature of the sulfur donor, the cofactors 
involved and the mechanism of the reaction have yet to be solved. The 
overall sequence homology between the E.coli and Bacillus genes is 32.5%, 
increasing to 55% when conservative replacements are considered. The 
position of the Cys residues is well-conserved in the N-terminal and 
central parts of both polypeptides. Within these regions, two distinct 
sequences sharing more than 50% homology were identified. See 
Chapters 4 and 5. 
The bioH gene product. 
The bioH gene product is thought to be involved in an early step 
leading to the synthesis of pimeloyl-CoA due to the fact that bioH mutants 
cannot grow on pimelate. The gene has been cloned and sequenced. The 
derived amino acid sequence shows no significant similarity to any 
proteins in the sequence databases (O'Regan et al., 1989). 
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1.10 Regulation of the bio operon 
The earliest evidence for the control of biotin biosynthesis came 
from the observations of Pai and Lichstein (1962) that the total biotin ( all 
compounds having biotin-like activity in supporting yeast growth ) 
decreased with increasing biotin concentrations in the growth medium. 
The nature of this inhibition was shown to be repression rather than 
feedback inhibition. Direct evidence for repression of the biosynthetic 
enzymes came from a study of the levels of 7-KAP synthetase in crude 
extracts from cells grown in various concentrations of biotin (Eisenberg 
and Star 1968). Maximum enzyme activity was attained at 0.2 ng/ml 
biotin and this was decreased to 0 as biotin concentration was increased to 
5ng/ml. 
Thus the classical model of Jacob and Monod (1961) for the 
regulation of an operon by repression can be applied to the biotin operon. 
The positions of the operator and promoter were determined by Guha et 
al., (1971). They discovered that transcription was divergent by 
hybridising bio-specific 3H-mRNA with the complimentary strands of 
DNA from bio transducing phages carrying various deletions of the bio 
operon. They concluded that bioA was transcribed to the left and that 
bioBFCD to the right. Cleary et al. (1972) positioned the promoters 
between cistrons A and B using complementation analysis. The number 
and positioning of the promoters and operator(s) relative to each other was 
unclear until Otsuka and Abelson (1978) sequenced the regulatory region. 
They showed that the bioA and bioB promoters overlap, and are situated 
face-to-face. An unusually large imperfect palindrome was identified as 
the single operator site and it was found to overlap with the two 
promoters. The promoters have the typical Pribnow box and -35 region 
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identified in other bacterial promoters. Shivan and Campbell (1988) 
compared the transcriptional regulation and gene arrangement of the 
E.coli, Citrobacter freundii and Salmonella typhimurium biotin operons. 
They found that the gene order in all species was the same. Comparing 
the nucleotide sequences of the 40 b.p. bio operator, only two b.p. changes 
were found between the three species. 
Prakash and Eisenberg (1979) developed an assay to study the 
interaction of the bio repressor with the operator site. For this they 
partially purified the bio repressor and found that biotin was capable of 
acting as a corepressor. Further studies revealed that biotin had been 
converted to a more active form, biotinyl-5' adenylic acid (biotinyl-AMP). 
Purification of the repressor to homogeneity provided evidence that the 
repressor protein was bifunctional and possessed enzymatic activity 
(Eisenberg et al., 1982). The repressor protein can activate biotin in the 
presence of ATP to form biotinyl-AMP, the co-repressor, which remains 
tightly bound to the repressor protein. This complex can either bind to the 
operator site and inhibit transcription or transfer the biotinyl moiety to a 
lysine residue of the apoenzyme of the biotin carboxyl carrier protein 
(BCCP) subunit of acetyl-CoA carboxylase ( see Chapter 1.3) (Prakash 
and Eisenberg, 1979). 
In summary the repressor protein can carry out each of the three 
reactions outlined below. 
Biotin + ATP +R (repressor) 	 biotinyl-5'.AMP.R + PPi 
Biotinyl-5'.AMP.R + apoenzyme 	holoenzyme + AMP + R 
Biotinyl-5'.AMP.R + operator (0) 	biotinyl-5'-AMP.R.0 
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This can be outlined in Figures 1.5a and b (Cronan 1989). 
Thus the level of expression of the biosynthetic enzymes and the amount 
of biotin synthesised de novo is dependant on the intracellular biotin 
concentration and on the supply of the protein to which the biotin must be 
attached in order to fulfil its essential metabolic role. 
It is clear that Eisenberg's bioR gene and Campbell's regulatory 
gene, birA, are identical and code for the biotin repressor. The gene 
encodes a protein of 321 a.a. with a molecular weight of 35.3 kDa. Both 
Campbell and Eisenberg suggested that the enzyme could be multimeric 
due to the appearance of bands at 80-100 kDa in disc gel electrophores. 
Reaction (1) indicates that exchange should occur between [32p] 
phosphate and ATP at equilibrium and this has been verified by the 
synthesis of 32ATP from biotinyl-AMP and 32p-pi.  
Howard et al., (1985) sequenced the bio repressor gene and 
predicted various DNA-binding and enzymatic domains of the enzyme. 
The predicted helix-turn-helix secondary structure of the protein is 
similar to those found for other DNA-binding proteins including the lad, 
gaiR, trpR, ci and cro proteins. Buoncristiani et al., (1986) isolated some 
18 birA mutations and found that they split into two functional categories: 
1) those lacking repressor function, but with marginally altered enzyme 
activity, and 2) those affected for both repressor and enzyme function. It 
has been shown that mutations in category one are mutations in the DNA 
binding site and the latter category had mutations in biotin binding, 
conversion of biotin to biotinyl-5'-adenylate or the corepressor-binding 
sites. 
Recently the three dimensional crystal structure of the repressor 
protein was determined (Wilson et al., 1992). Three domains can be 
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helix-turn-helix DNA-binding motif; a central domain containing a seven-
stranded mixed 13-sheet with a-helices covering one face, the other side of 
which is solvent-exposed and contains the active site; and a C-terminal 
domain which contains a six-stranded, antiparallel 13-sheet sandwich. The 
authors note that the structure/function information predicted by protein 
mutagenesis studies correlates well with the structural domains found, in 
the crystal structure. Current studies are concerned with obtaining a 
crystal structure of the BirA-corepressor-DNA complex. This, in turn, will 
aid in the elucidation of the exact nature of the interaction between the 
repressor and its operator site in order to obtain a full understanding of 
the regulation of the biotin operon. 
1.11 Biotin-Avidin Biotechnology. 
While biotin is available from natural sources in minute amounts, 
chemical synthesis has allowed the production of tonnes of biotin per 
annum. However, the recent publication of several patents suggests 
industry has turned its attention to producing biotin through a 
fermentation process using elevated levels of the genes and precursors of 
biotin biosynthesis (Komatsubara et al., 1990, Yamada et al., 1986, Fisher, 
1987, Haze et al., 1989, McKenzie Pearson and McKee, 1989 and Hirono et 
al., 1986). The drive to produce more, cheaper biotin has come from its 
increasing use not only as a dietary supplement but also its use in many 
biochemical processes. These stem from the highly specific non-covalent 
binding of biotin to the egg white protein avidin or the bacterial protein 
streptavidin (from Streptomyces avidinii). 
Avidin is a tetramer containing four identical subunits of molecular 
weight 15,000 Da. Each subunit contains a high affinity binding site for 
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biotin with a dissociation constant for the complex of approximately 10-15 
M. The binding is undisturbed by extremes of pH, buffer salts, or even 
chaotropic agents, such as guanidine hydrochloride (up to 3M). The 
strength of the avidin-biotin interaction has provided researchers with a 
unique tool for use in receptor studies, immunocytochemical staining, and 
protein isolation. 
The avidin-biotin system is particularly well suited for use as a 
bridging or sandwich system, in association with antibody-antigen 
interactions. The biotin moleule can easily be activated and coupled to 
either antigens or antibodies, usually with complete retention of avidin 
binding activity. Subsequently, avidin can be conjugated with enzymes, 
fluorochromes, ferritin, or colloidal markers and used as a sensitive, high 
affinity secondary reagent. A recent review of avidin-biotin biotechnology 
cited approximately 450 papers where the technique was used although 
the authors conceded that the actual number of relevant papers far 
exceeds their bibliography (Wilchek and Bayer, 1988). 
Two independant groups have recently published the crystal 
structure of the avidin-biotin complex at 2.6A and 2.7A respectively 
(Livnah et al., 1993 and Pugliese et al., 1993). Both groups agree on the 
overall structure of the monomer and tetramer. Each monomer is an 
eight-stranded antiparallel 13-barrel, similar to that of the bacterial analog 
streptavidin. The avidin binding site is located in a deep pocket at the 
centre of the barrel, displaying both hydrophobic and polar residues 
required for the recognition of the vitamin. Once bound biotin is almost 
completely buried within the protein core. These results go some way to 
explaining both the high affinity that avidin has for biotin and the 
stability of the protein-ligand complex. 
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CHAPTER TWO 
MATERIALS AND METHODS 
"Once upon a time in a lab far, far away." 
2.1 Materials. 
Sigma 
ATP, BSA (V), DTB, biotin, ferrozine, amino acids, Tris.HC1, HIEPES, 
SDS, DTT, beta-mercaptopyruvate, beta-mercaptoetanol, IAA, DTNB, 
DTNP, MMTS, iodoacetamide, iron (II) gluconate, Fe(II) chloride, 
Acrylamide, N, N'-methylene, bis-acrylamide, TEMED, ampicillin and 
other antibiotics, and most other standard chemicals, reagents and 
solvents. 
BDH 
Ethanol (100% pure) 
Gibco BRL 
Restriction enzymes, DNA ligase, Kienow fragment, Agarose, IPTG. 
Pharinacia 
Column chromatography resins (Sephacryl S200 HR, Q-sepharose) and 
columns (Fast Desalt G-25 10/10, Mono Q 5/5), restriction enzymes, T4 
polymerase, T7 double-stranded DNA sequencing kit. 
Difco Corporation 
Agar, bacto-tryptone, yeast extract, casamino acids. 
Amershani 
[35S]-cystine, a-[35S]-dATP. 
[14C]-DTB was a kind gift from LONZA AG. 
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2.2 General 
Some of the following techniques follow guidelines set out according 
to Maniatis et al., 1982. 
2.2.1 Bacterial strains and plasmids. 
The bacterial strains used for the expression of biotin synthetase 
and as recipients for recombinant plasmids were as follows. 
JM83 ( ara, (lac-proAB), rpsL(=strA),480, lacZiM15) 
DH1i (bio+, recA, hsclR, thi 1, placi) 
pCOi (bio-, A (att ? bio uvrB), thr, leu, thi, placi) 
Plasmid pIMSB (a pKK223-3 derivative, (Brosius and Holy, 1984)) 
was the vector used for the expression of biotin synthetase. This vector 
was constructed by S. Little at Ceiltech Limited. Plasmid pIMSB confers 
ampicillin resistance. Plasmid placi is a low copy number plasmid with 
the laci gene cloned into plasmid pSC101. placi confers tetracycline 
resistance. Plasmid pUC18 (Yanisch-Perron et al., 1985) was used for the 
subcloning of the bioB gene. pB030 AbioC (a bioC 
vector) and pB030A-
15/9iORF1 (a bio ORF vector ) were used in the cell-free biotin 
production assays and were kind gifts from M. Fuhrmann, Lonza AG. 
2.2.2 Maintenance of bacterial strains. 
All strains were stored at -70°C in 15% (v/v) glycerol. A single 
colony, selected for the correct phenotype was grown overnight at 37°C in 
5m1 L-B supplemented with the appropriate antibiotics. To 850p.l of this 
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culture was added 150jil glycerol and the culture stored at -70°C. Strains 
which were used regularly were also maintained on agar plates and were 
subcultured every 2 months. - 
2.3 Growth Medium and supplements. 
Luria Bertani medium ( L-broth) 
Bacterial cells were grown and maintained on L-broth ( lOg bacto-
tryptone, 5g bacto-yeast extract, lOg NaCl per litre, pH 7.5 ) 
supplemented with the appropriate antibiotics. 15g Bacto-agar per litre 
was added for plates. 
M9 Minimal Medium Casamino acids (M9CA) 
Minimal medium contained 6g Na2HPO4, 3g 1,CH2PO4, 0.5g NaCl, 
ig NH4C1 per litre. The media was adjusted to pH 7.4, autoclaved and 
allowed to cool before the addition of 2m1 1M MgSO4, 0.1ml 1M CaC12, 10 
ml 20% glucose and ig ± casamino acids per litre, which had all been 
sterilised separately. 
MRS modified medium 
MRS modified medium was used in the in vivo biotin assay. The 
medium contained 15g proteose peptone, 5g yeast extract, 5g sodium 
acetate, 2g ammonium citrate, 2.4g K2HPO4, imi Tween 80, 50mg 
MnSO4.4H20, 200mg MgSO4.7H20, 20g glucose per litre. The pH was 
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adjusted to 6.4 with acetic acid. For the preparation of assay agar plates, 
15g Bacto agar per litre was added before autoclaving. 
Thiamine 10% (w/v) filter sterile. 
Ainpidillin 100mg/mi filter sterile, store at 4°C. 
Tetracycline 12.5mg/mi in ethanol, filter sterile, store at -20°C. 
IPTG 	20mg/mi filter sterile, store at 200C. 
X-gal 	24mg/mi in dimethylformamide, store at -20°C. 
DTB 	10mg/mi in 100mM NaOH, store at 4°C. 
Biotin 	10mg/mi in 100mM NaOH, store at 4°C. 
2.4 Biotin assay (Disc plate method) 
The biotin concentration of liquid media was determined using the 
paper disc plate method with Lactobacillus plantarum. (Wright and 
Skeggs, 1944) 
Stock culture. 
Lactobacillus plantarum stock was prepared and stored as follows. 
2m1 of MRS modified medium was inoculated with a loop of L. plantarum 
and incubated at 37 °C for 10 hours. The culture was then centrifuged at 
4000Xg for 5 mins. and the supernatant discarded. The cell pellet was 
resuspended in fresh MRS medium. 
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Preparation of agar plates. 
100 p.1 of stock L. plantarum culture was added to lOmi MRS 
modified medium and grown overnight at 37 °C. The culture was 
centrifuged at 4000Xg for 5 mins. and the supernatant discarded. The cell 
pellet was resuspended in sufficient sterile water to give an 0D600 of 2.0 
(approx. 10 ml water). 
9.4g biotin assay medium was dissolved in 250ml of water and the 
pH was adjusted to 6.4 with acetic acid. 3.75g Bacto agar was added and 
the solution was boiled with constant stirring. The solution was 
autoclaved for 20mins and allowed to cool to 45-50 °C before 2.5ml of the 
plate culture was added. The solution was then poured into a UV-
sterilised plate taking care to remove any air bubbles. Once the agar had 
set the plate was inverted and allowed to dry in a cool stream of air for 1 
hr. 
Biotin assay. 
5mm diameter sterile filters were placed onto the plates just before 
use. 5p.l of a set of biotin standards (0.1, 0.2, 0.5, 1.0, 5.0, 10.0 p.g/ml 
biotin) and unknown samples were pipetted onto the filters. The plates 
were incubated overnight at 370C.  The diameter of growth area was 
measured and biotin concentrations were obtained by comparison with a 
plot of standard concentrations vs. log10 diameter of growth. 
NB When supernatants from medium containing ampicillin were 
assayed, penicillinase (20m11 6.06 units) was added to lOOmi of the 
supernatant and incubated at RT on a gyrotary shaker at 150 r.p.m. for 30 
mins. prior to assay. The standards were treated in the same manner. 
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2.5 Small scale preparation of DNA (Miniprep). 
DNA was isolated from bacterial cultures by a modification of the 
alkaline lysis method of Birnboim and Doly (1979). 
The following stock solutions were autoclaved for 20mins. and 
stored at room temperature. 
Solution 1) 50mM glucose, 10mM EDTA, 25mM tris pH 8.0 
Solution 2) 0.2M NaOH, 1% SDS - prepared as a fresh solution 
when required. 
Solution 3) 3M NaAc, pH 4.8 
Solution 4) 0.3M NaAc, soln 3 diluted ten fold. 
1.5 ml of a 10 ml 0/N culture was transferred to a 1.5 ml Eppendorf 
tube and centrifuged for 30 sec. at 13.000 r.p.m. The supernatant was 
discarded and the cell pellet was resuspended in lOOpi soln 1, incubated 
at RT for 15mm, then chilled on ice for 2-3mm. 200pi of soln 2 was added 
and the solution was mixed by gentle inversion of the tube. The tube was 
placed on ice for 5 mm., after which 150jil of soln 3 was added to 
precipitate chromosomal DNA. The solution was mixed by gentle 
inversion and placed on ice for 30 mm. The tube was centrifuged for 15 
min at 13,000 r.p.m. and the supernatant transferred to a fresh tube. The 
tube was centrifuged for 10 min at 13,000 r.p.m and the supernatant 
transferred to a fresh tube. The tube was filled with absolute ethanol at 
-70°C and placed at -700C for 30 mm. to allow precipitation of plasmid 
DNA. The tube was then centrifuged for 5 mm. and the supernatant was 
discarded. The pellet was resuspended in lOOpi of soln 4 using a Gilson 
tip, 250p.l absolute ethanol at -70 °C was added and the tube placed at 
-70°C for 30 mm. After centrifugation for 5 mm. at 13,000 r.p.m., the 
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DNA pellet was washed twice with 70% ethanol at -70 0C. The pellet was 
dried under vacuum and resuspended in 50p.l of distilled H20. The 
typical yield from one 1.5m1 culture was 2-3 jig DNA. 
2.6 Preparation of Competent Cells. 
E. coli cells were made competent for transformation by plasmid 
DNA or by the products of a plasmid ligation reaction using the CaCl2 
method. Competent cells were prepared as follows. 
50m1 broth + imi 1M MgCl2 was inoculated with imi of fresh E. 
coli from lOmi of a culture grown for 10-12 hrs. The cells were grown at 
370C and 250 r.p.m. to an 0D600 = 0.2. The cells were chilled on ice for 
5 mm, then centrifuged at 2,000 r.p.m. for 15 min at 4 0C. The 
supernatant was decanted and discarded and the cell pellet was gently 
resuspended in 20m1 fresh transformation buffer (50mM CaC12, 10mM 
tris pH 8). The cells were held on ice for 30mm, having been gently 
agitated every 10mm. The cells were centrifuged at 3,000 r.p.m. for 
15min at 40C. The supernatant was gently decanted and discarded and 
the cell pellet was gently resuspended in 2m1 chilled transformation 
buffer. The cells were held on ice for 12-16 hrs before being transformed 
with DNA. 
2.7 Transformation of Competent Cells. 
Competent cells prepared using the CaCl2 procedure were 
transformed with plasmid DNA or with the products of a ligation reaction 
as follows. 
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Competent cells which had been held on ice for 12-16 his were 
gently resuspended and 100p.1 aliquots were added to 2 sterile lOml tubes 
and left on ice for 5mm. A maximum of 10.tl of DNA solution was added 
to the cells and the tube was agitated gently and held on ice for 30mm. 
The cells were then heated for 5min at 37°C. 2m1 of warm (37 0C) broth 
was then added and the cells incubated at 37°C for lhr. The cells were 
then centrifuged at 2,000 r.p.m. for 10min at 4°C. The supernatant was 
removed and discarded. The cell pellet was resuspended in 250pi warm 
broth and 50i.d was spread to dryness on agar plates. 
2.8 Preparation of Agarose gels for DNA analysis. 
Restriction enzyme digests of plasmid DNA were routinely analysed 
by electrophoresis of restriction fragments in 1% agarose gels stained with 
ethidium bromide. Gels were prepared by boiling ig agarose in lOOmi 
TAE buffer. The solution was allowed to cool to 45°C before the addition 
of 5d of ethidiuin bromide (lOp.gIml). The gel was poured and allowed to 
set at room temperature. The DNA was electrophoresed at 80V, 43 mA for 
3-4 his before the DNA was visualized by UV light. 
Low melting point (LMP) agarose was used for the preparation of 
restriction fragments that were used in ligation reactions. LMP agarose 
was used to prepare the 1% gels which were set at 4°C. 
Samples to be loaded in gels were mixed with an appropriate 
amount of loading buffer (6X Loading buffer 11 0.25% bromophenol blue, 
0.25% xylene cyanol FF, 15% Ficoll (Type 400) in water) and heated at 
90°C for 5min before loading. 
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2.9 Isolation of DNA from LMP Agarose gels. 
DNA was recovered from LMP agarose gels using the Geneclean Kit 
(Geneclean Kit, BlO 101 Inc. ). The Geneclean procedure involves the 
following steps. 
LMP gels were visualized using long wave UV light (264 nm) to 
avoid damaging the DNA. The DNA band of interest was excised from the 
gel and dissolved in 2.5-3 volumes of 6M Nal solution at 45 0C. A 
Glassmilk suspension was added to the solution and the DNA was allowed 
to bind by incubating the solution on ice for 5mm. The solution was 
centrifuged briefly at 13,000 r.p.m. and the supernatant was discarded. 
The Glassmilk/ DNA pellet was washed 3 times with a high salt! ethanol/ 
H20 wash. The DNA was then eluted from the Glassmilk matrix into 
30p.l 1120 by incubating the Glassmilk pellet with lOj.tl H20 at 55°C, then 
centrifuging the tube at 13,000 r.p.m. for 30 seconds. The DNA-
containing supernatant was transferred to a fresh tube. This was 
repeated twice. 
2.10 Polyacrylamide gel electrophoresis (PAGE). 
Polyacrylamide gel electrophoresis (PAGE) was carried out using 
the discontinuous buffer system of Laemmli (1970). 
2.10.1 Solutions for PAGE. 
Acrylamide/bisacrylamide (30:0.8) 
30g acrylamide and 0.8g N,N methylenebisacrylamide was 
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dissolved in a total volume of lOOml water. The solution was filtered and 
stored at 4°C in the dark. 
Separating gels (12% acrylamide, 0.375M TrisHcl, pH8.8). 
Vol (ml) 
acrylamide:bisacrylamide 	 40 
1.5M Tris.HC1 (pH 8.8) 	 25 
water 	 33.5 
10%(w/v)SDS 	 1 
10% (w/v) APS 	 0.5 
TEMED 	 0.05 
Stacking gel (4% acrylamide, 0.125M Tris pH 6.8). 
Vol (ml) 
acrylamide:bisacrylamide 	1.30 
0.5M Tris.HC1 (pH 6.8) 	2.50 
water 	 6.10 




Sample buffer (SDS reducing buffer). 
Vol (ml) 
0.5M Tris.HC1 pH 6.8 	2.0 
Glycerol 	 1.6 
10% SDS 	 3.2 
2-mercaptoethanol 	 0.8 
0.05% bromophenol blue 	0.4 
lox running buffer 
Tris.base 30g 	SDS lOg 
Glycine 	144g made to 1 litre with distilled water and stored at 
room temp. 
Gel stain 
0.1% Coomassie Blue R-250 
40% (v/v) methanol 
10% (v/v)acetic acid 
Gel destain 
40% (v/v) methanol 
10% (v/v) acetic acid 
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2.10.2 SDS-PAGE. 
Gel pouring (approx. 40m1 per plate). 
Ethanol washed glass plates were clamped together, separated by 
1mm thick spacers. The acrylamide/Tris/water part of the mixture was 
degassed for 5mm. After addition of SDS, APS and TEMED the solution 
was loaded between the plates using a syringe and needle to within 2-3cm 
of the top of the plates, taking care to remove any air bubbles. The gel 
was carefully overlaid with water or isopropanol and allowed to set. Once 
the gel was set (approx. lhr.) the stacking gel was prepared as above, the 
water was removed from the top of the gel and the stacking gel carefully 
poured using a syringe and needle. A comb was then inserted taking care 
to remove all air bubbles and the gel allowed to set. 
Sample preparation 
Protein samples were diluted 1:4 with the sample buffer and heated 
at 95°C for 5min before loading onto gels. 
Running SDS polyacrylamide gels. 
The comb was removed and the gel assembly clipped into the 
vertical gel holder and the top and bottom electrodes submerged in IX 
running buffer. The wells were flushed with buffer and freshly boiled 
samples were loaded. Cold tap water was circulated through the 
apparatus throughout the run. Gels were run at 16mA per gel through 
the stacking gel, then 24mA per gel through the separating gel. Gels were 
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run for approx. 3hrs until the bromophenol blue marker dye reached the 
bottom of the gel. The gel assembly was removed from the tank, the 
plates were carefully prised apart and the gel transferred to a tank 
containing gel stain. After 30 mins the gel was transferred to a tank of 
destain and left overnight with shaking. The gels could then be laid onto 
filter paper and dried in a vacuum dryer. 
2.10.3 Native PAGE. 
Non-denaturing gels were prepared as described for SDS gels 
except that SDS and 2-mercaptoethanol were replaced by water in all the 
mixes. Samples were added directly onto the gel without boiling. 
2.11 DNA Ligation reaction. 
Ligation of plasmid DNA restriction fragments was carried out 
using the following procedure. 
lox ligation buffer-(200mM tris, pH 7.5, 1.2mM EDTA, pH 8, 
76mM MgC12, 5mM ATP, 0.2 mg/ml BSA). 
Ligation reaction :- Linear plasmid 	3j.tl ( 200ng) 
DNA fragment 	6p.tl (0.6-1jig) 
lox buffer 	2p1 
T4 DNA ligase 	2j.tl (2 units) 
H20 	 6p.l 
The reaction was incubated for 8-14 hr at 13 °C. 
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2.12 Conversion of DNA fragments with recessed 3' ends to 
blunt ends (Kienow reaction). 
DNA fragments containing recessed 3' ends were converted to blunt 
ends using the polymerase activity of the Kienow fragment of E.coli DNA 
poll. The reaction was carried using the following procedure. 
lox Nick translation buffer-(500mM Tris, pH 7.2, 100mM MgSO4, 
1mM DTT, 500pg/m1 BSA). 
dNTP's - ( 2mM solution of the four bases dATP, dCTP, dGTP, 
dTTP). 
}Uenow reaction:- DNA 	 lg 
lOX NT buffer 	2.t1 
dNTP's 	2j.tl 
Kienow enzyme lp.l (1 unit) 
H20 	to 	25il 
The reaction was incubated at RT, for 45min and stopped by the 
addition of ijil 0.5M EDTA. 
2.13 Induction of the tac promoter of plasmid pIMSB. 
The following procedure was used to 35S  label proteins using 
bacterial strains carrying the ptac promoter (pIMSB) in a laci cell line 
(DH1i or pCOi). 
lOml broth was inoculated with a loop of cells and allowed to grow 
12-16 hrs. lml of this cell culture was added to 10 fresh broth and 
grown until 0D600=0.4. 5m1 of the cell culture was centrifuged at 3,000 
r.p.m. for 10min and the supernatant was discarded. The cell pellet was 
resuspended in 5m1 fresh broth and IPTG was added to a concentration of 
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10 5M. The cells were grown at 37°C for 3 hrs. The cells were collected by 
centrifugation and the proteins analysed by SDS 12% polyacrylamide 
electrophoresis (SDS-PAGE). 
The proteins were radioactively labelled with 35S methionine using 
the above procedure. 25.tCi 35S Methionine was added to the cell culture 
at the same time as the IPTG. 
2.14 Spheroplast Preparation. 
Bacterial spheroplasts were prepared by a modification of the 
lysozyme-EDTA method of Kaback, (1971). 5m1 L-broth supplemented 
with ampicillin (50p.g/ml) was inoculated with a loop of pIMSB pCOi and 
the culture was grown at 37 °C for 12 hrs. The culture was then diluted 
1:10 with 45ml fresh medium and the culture was grown at 37 °C for 1.5 
hrs until it had an 0D600=0.4. The cells were harvested by centrifuging 
the culture at 5,000 r.p.m. for 15 min at 0 °C and the pellet was 
resuspended in 50m1 fresh L-amp medium. IPTG was added to a final 
concentration of 10 5 M and the culture was grown for 3hrs at 37 °C. The 
cells were harvested by centrifuging the culture at 5,000 r.p.m. for 15 mm 
at 0°C. The cell pellet was resuspended in 20m1 ( 30 mM Tris.HC1, pH 
8.0 3,  20% sucrose) and the suspension was swirled by means of a magnetic 
stirrer. 400j.tl EDTA, pH 7.0 and 10mg lysozyme were added and the 
suspension was incubated for 30 min at room temperature. The 
spheroplast suspension was centrifuged at 13,000 r.p.m. for 20 min at 0 °C 
and the spheroplast pellet was resuspended in 5m1 of the assay buffer 
(10mM Tris.HC1, pH 8.0, 1mM cysteine, 2mM Fe2 ). The suspension was 
left on ice for 20 min to lyse the spheroplasts. lml of the suspension was 
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removed and 20pi (0.2j.tCi) DTB was added and the extract incubated at 
37°C for 30 mm. 
2.15 Cell-free extract preparation. 
Cell-free extracts used in biotin synthetase and rhodanese assays 
were prepared as follows:- 
Four different types of extracts were prepared according to the cell 
type, growth time and volume of the cell culture used. Cell-free extracts 
were prepared and designated (CF I-M. 
2.15.1 Cell-free extract I (CF-I) 
(51itre pIMSB DH1i log phase extract). 
To prepare a cell-free extract from 5 litres of cells lOmi pIMSB 
DH1i cells . grown overnight at 37°C in L-broth supplemented with the 
appropriate antibiotics was used to innoculate 500nil of identical broth. 
The cells were grown at 37°C until the 0D6 00=0.4 (-3hrs). 50m1 of this 
culture was then used to innoculate 9 x 500ml flasks of the same broth. 
These cultures were grown until their 0D600=0.4 then IPTG was then 
added at a final concentration of 0.1mM and the cells were grown for a 
further 3hrs (final 0D 600-1.8). The cells were collected by centrifugation 
at 5,000 r.p.m. for 15 minutes at 4°C. The cell pellet was washed with ice-
cold HEPES buffer (50mM, pH 7.5). The cells were then resuspended in 
buffer to give ig wet weight cells/mi. The cell extract was sonicated for 
10X30 second bursts with 30 seconds in between bursts on ice. The cell 
debris was removed by centrifugation at 15,000 r.p.m. for 15 minutes at 
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4°C. The volume of the extract was made to 50m1 with buffer and 500p.l 
aliquots were stored at -20°C. 
2.15.2 Cell-free extract II (CF-H) 
ilitre pIMSB/DH1i - Early log phase. 
This extract was prepared in an identical manner as the 5 litre prep 
however only 2 X 500m1 flasks were innoculated. The cell-free extract was 
made up to a final volume of lOmi and stored as above. 
2.15.3 Cell-free extract III (CF-M) 
pIMSBfDH1i - Stationary phase. 
A cell-free extract of 1 litre of stationary phase pIMSB DH1i cells 
was prepared in a similar manner to CFI however the cells were 
harvested 24hrs after the addition of IPTG. 
2.15.4 Cell-free extract IV (CF-IV) 
pCOi extract. 
A cell-free extract of 1 litre of pCOi cells was prepared in a similar 
way to CFH. 
Cell-free extracts were prepared from the biotin synthetase mutant 
constructs pIMSB/Tthffll pCOi, pIMSB/AIuI pCOi, pIMSB/RsaIfNruI 
pCOi, pIMSB/SspI pCOi and from pB030/iORF1 pCOi, pB030/iThioC 
pCOi in an identical way to to CFII. 
2.16 E. coli Rhodanese assay. 
E.coli bacterial rhodanese was assayed according to the method of 
Alexander and Volini, (1987). 
2.16.1 Activity measurements 
For the standard assay of enzyme activity, the reaction mixture 
contained 50mM NaS203, 50mM NaCN, 250p.l pIMSB DH1i cell free 
extract (CF I) in HEPES buffer (100mM, pH 7.5 ) in a final volume of 1.0 
ml. The reaction was incubated at 37°C. The reaction was initiated by 
the addition of cyanide and stopped by the addition of 0.5m1 15% 
formaldehyde. 1.5 ml Ferric nitrate was added (lOOg Fe(NO3)3.9H20, 
200m1 65% HNO3 per 1500 ml), yielding the characteristic red-brown 
colour of the acidic iron thiocyanate complex. The reaction mixture was 
cleared of turbidity by centrifugation at 5,000 r.p.m. for 5mm. before 
measurement of the colour intensity at 460 nm. Values (0D460) were 
compared to a standard thiocyanate curve. 
2.16.2 Kinetic Measurements 
Rate measurements of thiocyanate formation were carried out 
under conditions similar to those used for the standard asssay. To obtain 
kinetic data the concentrations of thiosuiphate and cyanide were varied 
(4, 6.25, 25 and 50mM) and the initial rate was measured. The reciprocal 
substrate concentration was plotted against reciprocal rate values. K m 
values for each substrate were calculated from the ratio of the slope to 
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intercept values of the secondary plots. i.e. KmCN was evaluated from a 
secondary plot of ( VappSS03)4 versus [CN1 -1. Km S2032 was evaluated 
from a secondary plot of(Vapp CN)-1 versus [S20 3 2]. 
2.17 Phenol extraction of nucleic acid solutions. 
Protein was removed from solutions of nucleic acids by extraction 
with phenollchioroformlisoamylalcohol (25:24:1) saturated in Tris.HC1 
(10mM, pH 7.5). Phenol solution (0.5m1) was added to 0.5m1 nucleic acid 
solution in a 1.5ml Eppendorf tube, the solutions mixed by vortexing for 
30 seconds and the phases separated by centrifugation at 12,000 r.p.m. for 
5 minutes. The upper aqueous layer (450j.tl) was collected , care being 
taken not to disturb the layer of denatured protein at the phase interface, 
and an equal volume of chloroformlisoamylalcohol (24:1) added. After 
vortexing for 30 seconds the phases were separated by centrifugation and 
the aqueous phase collected. 
2.18 Ethanol precipitation of nucleic acids. 
Nucleic acids were precipitated from aqueous solution by addition 
of sterile sodium acetate to a final concentration of 0.3M and two volumes 
of ethanol at -70°C. After incubation at -70°C for 30 minutes precipitated 
nucleic acid was pelleted by centrifugation at 12,000 r.p.m. and the pellet 
carefully washed with 70% ethanol (-70 0C), followed by further 
centrifugation. The supernatant was removed with a pipette tip and the 
pellet dried under vacuum before being resuspended in an appropriate 
volume of sterile dcIH20 and stored at -20°C. 
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2.19 Construction of plasmids. 
Restriction digests. 
Typically 1-2p.g plasmid DNA was prepared by the Mini-prep. 
procedure from 1.5m1 0/N culture and diluted to 100jd with sterile water 
(1-2pg/100p.l). A 40-50j.tl (0.5-1j.tg ) aliquot of this was digested in 
restriction digests with 2-5U of the restriction enzyme in the appropriate 
restriction buffer supplied by the manufacturer. Digests were incubated 
at the appropriate reaction temperature for 2-3hrs. At the end of the 
incubation, loading buffer was added and the samples were boiled at 90°C 
to terminate the reaction. Samples were then loaded onto agarose gels as 
described below. 
2.19.1 Construction of pIMSB/Tth3I (see Figure 4.4). 
Vector pIMSB was digested with Tth3I to give two fragments 2129 
and 3504 b.p. in length. The fragments were separated by gel 
electrophoresis and the 3504 b.p. fragment was isolated using Geneclean. 
The 5' Tth3I overhang was filled in with DNA polymerase Kienow 
fragment. The bioB-gene fragment was digested with XbaI to give 2 
fragments which were separated by gel electophoresis. The fragment 
containing the B-gene was isolated using Geneclean to give a B-gene 
fragment with a blunt 5'end and a XbaI Tend. pIMSB was digested with 
NcoI and the 5' overhang was filled in using DNA polymerase Kienow 
fragment. The plasmid was then digested with XbaI to give 2 fragments. 
The fragments were separated by gel electrophoresis and the pIMS vector 
was isolated using Geneclean. The B-gene fragment was then ligated to 
67 
the pIMS vector and the recombinant plasmid pIMSB/Tth3I was selected 
for by digestion with Tth3I and XbaI. 
2.19.2 Construction of pIMSB/XhoH (See Figure 4.5). 
pIMSB was digested with Xholl to give 6 fragments of 1449, 1291, 
1000, 768, 682, 280 b.p. The fragments were separated by gel 
electrophoresis and the 1000 b.p. bioB-gene fragment was removed using 
Geneclean. This fragment was treated with DNA polymerase Kienow 
fragment to fill in the 5' overhangs then digested with XbaI and isolated 
with Geneclean. The pIMS vector was prepared by digesting pIMSB with 
NcoI and then filling in the 5' overhang with DNA polymerase Kienow 
fragment. This was then digested with XbaI and the two fragments 
separated by gel electrophoresis and isolated using Geneclean. The B-
gene blunt/ XbaJ sticky fragment was ligated to the pIMS bluntiXbal 
fragment and recombinants detected using Tth3I. Another attempt 
involved ligating the B-gene cut with Xholl and filled to the pIMS 
fragment blunt at both ends in a blunt ended ligation. However both 
attempts failed to yield the recombinant deletion vector. 
2.19.3 Construction of pIMSB/SspI (See Figure 4.6). 
pIMSB was digested with SspI to give three fragments 560, 1108, 
and 3965 b.p. in size. The fragments were separated on an agarose gel 
and the 1108 b.p. B-gene containing fragment removed using Geneclean. 
This fragment was then digested with EcoRI, separated by gel 
electrophoresis and purified with Geneclean to yield a B-gene fragment 
with an EcoRI 5'-end and SspI blunt 3'-end. pIMSB was digested with 
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Hindlil. The 5' overhang was filled in using DNA polymerase Kienow 
fragment. The linearised vector was then digested with EcoRI. The two 
fragments were separated by gel electrophoresis and isolated using 
Geneclean to give the pIMS vector with aa EcoRI end and a blunt end. 
The deletion vector was formed by ligation of the B-fragment to the pIMS 
vector using DNA ligase. The pIMSB/SspI deletion vector was selected by 
SspI digestion. 
2.19.4 Construction of pIMSBIBgII (See Figure 4.7). 
pIMSB was digested with BglI to give four fragments 240, 1222, 
1762 and 2320 b.p. The fragments were separated by gel electrophoresis 
and the 1762 bioB gene fragment was isolated using Geneclean. The 3' 
end of this fragment was removed using T4 DNA polymerase 3'-5' 
exonuclease. This was ligated to XbaI linker TCTAGA. The fragment was 
then digested with EcoRI and XbaI and isolated using Geneclean. The 
pIMS vector was prepared by digesting pIMSB with EcoRI and XbaI to 
give two fragments. The fragments were separated by gel electrophoresis 
and the pIMS fragment was isolated using Geneclean. The bio-B 
fragment was ligated to the pIMS vector. The recombinant deletion 
plasmid was selected for by digestion with BglI. However no recombinant 
plasmid was isolated. 
2.19.5 Construction of pIMSB/AIuI (See Figure 4.8). 
The bioB gene was removed from pIMSB by digestion with EcoRI 
and PstI. The two fragments 4592 and 1041 b.p. were separated by gel 
electrophoresis and both fragments were isolated from the gel using 
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Geneclean. The 1041 b.p. B-gene fragment was digested with AluT to give 
3 fragments 38, 154, and 853 b.p. This mixture was then ligated to the 
pIMS vector cut with EcoRI and PstI. The pIMSB/AluI deletion vector 
was selected using SstI digestion. 
2.19.6 Construction of pIMSB/NruIfRsaI (See Figure 4.9). 
pIMSB was digested with NruI to give two fragments 1284 and 
4349 b.p. The fragments were separated by gel electrophoresis and the 
4349 b.p. fragment was isolated using Geneclean. The 4349 h.p. fragment 
was digested with PstI to give two fragments 621 b.p. and 3728 h.p. 
fragments which were separated by gel electrophoresis and the two 
fragments isolated using Geneclean. The 621 b.p. fragment contained the 
3' end of the bioB gene. pIMSB was digested with PstI and SalI to give 
two fragments which were separated by gel electrophoresis and isolated 
using Geneclean. The bioB gene fragment was digested with RsaI and the 
867 b.p. fragment which contained the 5' end of the bioB gene was isolated 
using Geneclean. The 867 b.p. and 621 b.p. bioB gene fragments were 
ligated to the pIMS vector cut with SalI and PstI to give 
pIMSBINruLIRsaI. The recombinant deletion vector was selected by 
digestion with NruI, RsaI and PstI. 
2.19.7 Construction of pLJC18.bioB. 
The bioB gene was removed from from pIMSB by digestion with 
EcoRI and Hindu. The two fragments were separated by gel 
electrophoresis and isolated using Geneclean. pUC18 was digested with 
EcoRI and Hindifi and the vector isolated as above. The bioB fragment 
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was ligated to the pUC fragment and the recombinant vector was isolated 
by IPTGIX-gal blue/white screening and by digestion with EcoRI and 
Hindill. 
2.20 Chromatography. 
2.20.1 HPLC Separation of Dethiobiotin and Biotin. 
Dethiobiotin and biotin were separated by a modification of the 
procedure given by Bowers-Komro et al., (1986). The chromatographic 
conditions giving the best separation were provided by using a 10jim-p.-
Bondapak C-iS reverse phase column (5j.tm x 250nm) with a 35 mm. 
gradient elution from aqueous TFA (0.05%, adjusted to pH 2.5 with KOH) 
to aqueous TFA (0.05%): acetonitrile (70:30, v/v) at a flow rate of imi/min. 
The eluate was monitored at 214 nm. Biotin and DTB elute at 26 and 30 
mins respectively. 
2.20.2FPLC Gel Filtration Chromatography. 
Preparation of a Protein fraction and a Low 
Molecular Weight (LMWt) extract from pIMSB DH1i (CFI). 
Gel-filtration of cell-free extracts and desalting of ammonium 
sulphate fractions was performed on a G-25 F.P.L.C. Fast Desalt column 
(Pharmacia). Samples (imi) were loaded and eluted at a flow rate of 
6mllmin. in 50mM HEPES buffer, pH 7.5. Fractions were collected and 
assayed as follows:- 
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The gel-filtration column was used to split pIMSB DH1i cell-free 
extracts into protein and low molecular weight components and to desalt 
ammonium sulphate fractions. lml of cell-free extract or ammonium 
sulphate fraction was loaded onto the column and the protein fraction 
eluted in a sharp peak after 2m1 in one 2m1 fraction. This fraction was 
denoted as the protein fraction. Three other peaks were collected over a 
further 16ml in eight 2ml fractions which were assumed to be low 
molecular weight components. The 8 fractions were pooled and freeze-
dried under vacuum to give a white foam. The white foam was dissolved 
in lml buffer. This fraction was denoted as the low molecular weight 
fraction (LMWt). 
The protein and LMWt fractions were assayed for biotin synthetase 
activity by the [14C]-DTB SEP-PAK method. Protein fractions (400jil) 
were assayed in the presence of 1mM Fe 2 , 1mM MgATP, [14C]-DTB 
(0.75p.g, 0.2j.i.Ci) with or without a lOOp.l aliquot of the LMWt fraction in a 
total volume of 650p1 for lhr at 37°C. The LMWt fraction was assayed for 
activity in the absence of the protein fraction. 
pH Stability of the LMWt extract. 
The pH stability of the LMWt extract was determined as follows:- 
Acid stablity. 
A lml aliquot of the extract prepared as above was brought to pH 1 
using O.1M formic acid. The sample was incubated on ice for 1 hr. The 
complete extract was freeze-dried under vacuum to give a white foam. 
The foam was dissolved in 50mM HEPES buffer, pH 7.5. The pH of 
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extract was 7.5 at the end of this procedure. lOOpi of this extract was 
assayed for its ability to reconstitute the biotin synthetase activity of the 
protein fraction as described above. 
Base stability. 
The base stability of the LMWt extract was determined in a similar 
way to the acidic procedure. The pH of the extract was brought to pH 11 
using O.1M ammonium hydroxide and the sample incubated on ice for lhr. 
The ammonia was removed by freeze-drying under vacuum and the white 
foam obtained was dissolved in buffer to give a pH of 7.5. An aliquot of 
this extract was assayed in an identical fashion to the acidic extract. 
2.20.3 FPLC Mono-Q Anion Exchange Chromotagraphy. 
Fractions were loaded onto Mono-Q 5/5 and eluted using a salt 
gradient from 0-1M NaCl in 50mM HEPES buffer, pH7.5. The salt 
gradient was usually developed over 10-20 column volumes. 
2.20.4 Low Pressure Gel Filtration Chromatography. 
Gel filtration chromatography using Pharmacia Sephacryl S-200 
HR resin was carried out as follows. A slurry of gel resin in 50mM 
HEPES pH 7.5 buffer was prepared and poured into a glass column. The 
resin was allowed to settle and then washed with 200m1 buffer at 
imi/min. The eluate was monitored at 280nm. Typically 5m1 cell-free 
pIMSB DHLi extract was loaded onto the column and the cohirnri was 
eluted with HEPES buffer at lm]/min. 7ml fractions were collected. The 
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column was eluted until no further proteins eluted from the gel. imi 
aliquots were assayed. 
2.20.5 Low Pressure Ion-Exchange chromatography. 
Anion exchange chromatography was carried out using Q-
Sepharose anion exchange resin. The column resin was slurried in 
HEPES buffer and poured into a glass column. The gel was allowed to 
settle to give a 250mm x 20mm column. The column was washed with 
200m1 buffer at lmllmin. Either fractions from the Sephacryl S-200 HR 
gel filtration column were pooled and loaded onto the column or fractions 
from the FPLC Fast Desalt column were used. After loading fractions 
onto the column, unbound proteins were eluted using HEPES buffer. A 
salt gradient of 0-1M NaCl in 50mM HEPES buffer, pH 7.5 was developed 
over 600m1 at imi/min. lOmi fractions were collected and imi aliquots 
were assayed for biotin synthetase activity. 
2.21 Ammonium Sulphate fractionation. 
Ammonium sulphate fractionation was carried out on cell-free 
extracts as follows:- Cell-free extracts were brought to the desired 
ammonium sulphate concentration by the slow addition of solid 
ammonium sulphate with stiring on ice. After the addition of the 
ammonium sulphate, the solution was allowed to stand on ice for 30 mins, 
then centrifuged at 15,000 r.p.m. for 15 mins at 4°C. The supernatant 
was gently decanted and more solid ammonium sulphate was added if 
required and the sample treated in the same manner as before. Protein 
pellets were dissolved in cold HEPES buffer by gentle pipetting. 
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2.22 14C-DTB, SEP-PAK cell-free biotin assay. 
This assay was developed at Lonza AG by N. Shaw and 0. Birch. 
Typically 0. 75p.gI(0.2p.Ci) 14C-DTB (specific activity=57.2mCilmmol -1) 
labelled at the ureido carboxyl position was added to reaction mixtures. 
The experiment was incubated at 37°C for ihour. The reaction was 
terminated by the addition of 10% trichioroacetic acid (TCA) to 2% (v/v) 
and lOj.tg of DTB and biotin were added as carriers. Precipitated protein 
was removed by centrifugation at 12,000 r.p.m. for 5mins. The extract 
was then loaded onto a pre-washed C-18 SEP-PAK column. The column 
was washed with imi water then imi 1% acetic acid. DTB and biotin 
were eluted from the column using lml MeOH. The eluate was then dried 
down under a flow of nitrogen or in vacuo. The dried sample was 
dissolved in lOOp.l MeOHJO.1M NaOH (50/50 v/v). A portion of this 
sample was loaded onto silica t.l.c. plates. The t.l.c. was developed in a 
chloroformlMe0Hlformic acid (17/3/0.2 v/v) mixture. X-ray film was then 
placed over the t.l.c. plate for 16hrs. The developed X-ray film was then 
used as a template to cut out the radioactive portions of the t.l.c. plate. 
The amount of radioactivity on the pieces of t.l.c. plate was measured by 
scintillation counting. The amount of biotin produced was calculated as a 
percentage of the DTB added. 
2.23 DNA sequencing. 
Sequencing of double-stranded DNA was carried out according to 
the method of Sanger et al. (1977) using [a-35-S] dATP given in the TI 
Sequencing kit from Pharmacia LKB. 
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2.23.1 Reagents for DNA sequencing. 
'A' mix-Short & -Long: 15j.tM ddATP. 
'C' mix-Short & -Long: 15pM dCICTP. 
'G' mix-Short & -Long: 15tM dCIGTP. 
'T' mix-Short & -Long: 15p.M ddTTP. 
Each of the adove mixes also includes: 
150jiM dGTP, 1501iM dATP, 150j.tM dCTP, 150iM dTTP, 10mM MgC12, 
40mM Tris-HC1 (pH7.5) and 50mM NaCl. 
T7 DNA polymerase: 	In buffered glycerol solution. 
Enzyme dilution buffer: A buffered solution containig glycerol, BSA and 
Annealing buffer: 	.280mM Tris-HC1 (pH 7.5). 100mM MgCl2, 
350mM NaCl. 
Labelling mix: 	2.0j.tM dCTP, 2.01iM dGTP,and 2.Oj.tM dTTP. 
Stop solution: 	95% deionised formamide solution containing 
20mM EDTA (pH 7.5), 0.05% (w/v) xylene 
cyanol FF and 0.05% (w/v) bromophenol blue. 
2.23.2 Annealing of Primer to double-stranded template. 
The concentration of the template was adjusted so that 8g.tl 
contained 1.5-2jtg. The double-stranded template was denatured by 
mixing the folowing:- 
76 
Template 841 
2M NaOH 2p1 
Total lOp.! 
The reaction was incubated at room temperature for 10 minutes. 
3p.l of 3M NaAc (pH 4.8), 7p1 of distilled water and 60p1 of 100% ethanol 
were added, mixed, and placed -70°C for 15 minutes. The precipitated 
DNA was collected by centrifuging for 10 minutes and the supernatant 
was discarded. The pellet was washed with ice-cold 70% ethanol. The 
DNA was recovered by centrifugation for 10 minutes and the supernatant 
was discarded. The pellet was dried briefly under vacuum, and dissolved 
in 10p.1 of distilled water. 
The concentration of the primer solution was adjusted so that 2p.l 
contained the mass of primer needed to achieve the desired 
primer:template ratio (usually between 5:1 and 50:1). To 10p.l of 
denatured DNA 2jil of annealing buffer was added and 2j.d of primer 
solution. The reaction was incubated at 37°C for 20 minutes to anneal 
the primer then placed at room temperature for 10 minutes. This reaction 
was then used in the perform the sequence reactions. 
2.23.3 Sequencing reactions. 
Essential preliminaries. 
Four tubes were labelled 'A', 'C', 'G' and 'T'. 2.5p.l of each the mixes were 
dispensed into their respective tubes. Ice-cold enzyme dilution buffer was 
used to dilute the T7 DNA polymerase to 1.5 units/p.l. 2p.l  of this stock 
was used in each set of four reactions. 
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2.23.4 Labelling reaction. 
The radiolabelled nucleotide used was [a- 35S]dATPaS: lOmCiJml, 
>1000Ci/mmol. To the tube containing the annealed template and primer 
the following was added:- 
Tube 1 2 3 	4 
Template/primer 2 2 2 	2 
'A'mix 2 - - 	 - 
'C' mix - 2 - 	 - 
'G' mix - - 2 	- 
'T' mix - - - 	 2 
Labelling mix 2 2 2 	2 
0.3MDTT 1 1 1 	1 
[cc-35S]dATPaS (=10itCi) 1 1 1 	1 
T7 polymerase 2 2 2 	2 
The components were mixed by gentle agitation and collected at the 
bottom of the tube by a brief centrifugation. The reaction was incubated 
at room temperature for 5 minutes. Whilst the labelling reaction was in 
progress the four termination mixes which had been previously dipensed 
were warmed by placing them at 37°C for at least 1 minute. 
2.23.5 Termination reactions. 
After the 5 minute incubation the labelling reactions were 
terminated as follows:- 
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4.5jxl of the labelling reaction was transferred into each of the four 
pre-warmed termination mixes; using a fresh tip for each transfer. The 
components were mixed by gentle agitation then incubated at 37°C for 5 
minutes. 5jil of stop solution was added to each tube, and mixed by gentle 
agitation. The contents of the tube were collected by centrifugation. 3j.l 
of each reaction was transferred to a separate tube, and heated at 75-80°C 
for 2 minutes. 1.5-2tl of each reaction was immediately loaded into an 
appropriate well of a sequencing gel. The remaining material was stored 
at -20°C for subsequent loadings. 
2.24 Attachment of Synthetic Linkers. 
Oligonucleotide linkers were phosphorylated and attached to DNA 
substrates according to the methods described in Mariiatis et al., 1982. 
Oligo's were phosphorylated by T4 kinase. 
lox Kinase buffer. 
(660mM Tris, pH7, 10mM ATP, 10mM spermidine, 100mM MgC12, 
150mM DTI', 2mg1m1 BSA). 
Reaction:- iox buffer 	lixl 
Linkers 10mg 	1ji.1 
Sterile water 	6p.l 
T4 Kinase 	2U/2p.l 




IN VIVO AND CELL FREE ASSAYS 
PROTEIN PURIFICATION 
3.1 In Vivo Biotin Assays 
The starting point for the overproduction of biotin synthetase 
was the cloning of the E.coli bioB gene into a high level expression 
vector. The plasmid pKK223-3 (Pharmacia) was chosen because of 
its relatively high copy number and its strong, efficient and tightly 
controlled trp-lac (tac) promoter (Brosius, 1984). This promoter is 
under control of the lac operator and is induced by the presence of 
the synthetic inducer; isopropyl-thio-galactoside (IPTG). The bioB 
gene was cloned into pKK223-3 by S. Little at Celitech Limited to 
produce pIMSB and used to transform E.coli strains Dlii (bio) 
and pCOi (biol. See Figure 3.1. 
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Figure 3.1 Structures of the plasmids pKK223-3, pIMSB, and 
pUC derivatives. 

















1T2 5633 bp 





XamI(1912) p8R322 Pfl(t947) 
I 	PUC 19 __________ 
2"S OP I I 	J JJJ_J 
E6oI 	SW I 	Kpnl 	Sm. I 	I 	I 	Sm I 	PSI. 	Sm I 	Im 91 I )(Mal A.. - 
I 	pUC Is uGcrrGcATGccTccAoGTcGcrcmAGGArccccoaoT.cJGcycØ.Arrc 
268490 
I 1919191 	son 	Psi 	Sal ' I 	8919111 Sm. I 	190.1 	SmI 	8Rl 
I AmI 	 501.1 
I 1911.9 
I 	pUC '3 
I 	26O 90 L..._L_J L____.t....J.___J 	L...J 
I EmAI 	SW II 	A. I 	8911,111 	58. I 	Am I 	P1.1 1919191 
I SmI S.yml 
- 591*1 Sol 
I PW i5 
268090 L_J  
191919 	P911 	Am I 	594' 	9*11,111 	Mu 	Sm P 	6g.R I 
I I91m II Sm.l 	Sad 
SAl 	 Xm.I 
I pUC 0 GUTTCCCGGGGATCCGTCGACCTCCAGCCGCTT 
2665 øp 	 LJ 
I Em
LJ._J 
Al 	 I 	Sm I 	Pm I 	91 











' V Iadr 	- 	- 	Kualt 












Our initial investigations involved inducing bioB expression 
from pIMSB DH1i with IPTG and monitoring the production of 
biotin synthetase by incubating the growing cells with 
[35S]-
methionine. The profile of biotin synthetase production under 
these conditions is clearly shown by SDS-PAGE analysis of total 
cellular protein from pIMSB DH1i (Figure 3.2). A band between 
43 and 31kDa at approx. 38kDa (cf, biotin synthetase predicted 
mol. wt. 38,665 Da) indicated production of biotin synthetase. 
Biotin synthetase accumulates to approximately 5% of the total 
cellular protein under these conditions based on the intensity of the 
protein band on SDS gels. 
Production of biotin by induced pJMSB DH1i cells was 
monitored by the Lactobacillus plantarum disc assay. The 
production of biotin when excess DTB is present by these cells is 
approx. 100 times that of wild type E. coli K-12. Figure 3.3 shows 
the variation of biotin production with cell growth in a LB-based 
DTB enriched medium (50p.g/ml). It can be seen that the cells grow 
exponentially during the initial 10hrs of growth. During this time 
biotin production occurs at a fast rate (greater than lOpgllitre/hr). 
However, after 15-20 hrs growth the cells reach stationary phase. 
Thereafter the rate of biotin production decreases and the amount 
of biotin in the medium remains constant. Transfer of stationary 
phase cells to fresh culture medium resulted in a stimulation both 
of cell growth and biotin production ( See Figure 3.4) 
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Figure 3.2 35S-Met labelling of pIMSB DH1i. Cells grown in 
M9CA medium in the presence of 35S Methionine analysed by SDS-
PAGE and autoradiography. Overexpression of biotin synthetase 
was induced by the addition of 0.1mM IPTG at 0D 600=0.4 as 
described in Materials and methods. Molecular weight markers (in 
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Figure 3.3 Medium biotin concentration and cell growth of 
pIMSB/DH1i cells induced with IPTG (0.1mM). 
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Figure 3.4 Effect of medium replacement on biotin production 
and cell growth of pIMSB DH1i cells induced with IPTG (0.1mM). 
Cells were removed by centrifugation and resuspended in fresh 
















There are several possible explanations for this effect: 
DTB is not efficiently transported into stationary 
phase cells- thus biotin production is dependent on intracellular 
DTB production; 
that biotin production is dependent on availability of 
sulfur source in the medium, exhaustion of which results in 
lowered DTB to biotin conversion; 
feedback inhibition of biotin concentration in the 
medium (product inhibition) results in depression of the DTB to 
biotin conversion rate; 
biotin synthetase activity is lowered by degradation, or 
by decrease in expression with time; 
biotin synthetase expression decreases with time; 
another protein is required. This could be involved in 
sulfur source metabolism and present at wild-type concentrations 
in the cell. The protein could be degraded and no longer 
synthesised during the stationary phase. 
Definition of which of the above possibilities contributed to 
the decrease in biotin production with time required further 
experimentation. Accordingly the following experiments were 
carried out:- 
(a) Precursor availability: This was tested by 
examining the biotin production dependance on DTB levels in the 
medium. No significant differences to the results shown in Figure 
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3.3 were observed when the DTB concentration was varied between 
50 jig/ml and 500jig/ml. It is thus apparent that DTB is not a 
limiting factor. 
Sulfur source availability: To examine the effect of 
various sulfur sources, biotin production was measured in cells 
grown in media supplemented with the following:- L-methionine, 
L-cystine, sodium mercaptopyruvate, sodium thiosuiphate, sodium 
sulphate, sodium sulphide and elemental sulfur (S8) at levels 
concentrations between lOjig/mi- 1mg/mi. 
Although some variation was observed between different 
experiments no significantly higher level of biotin synthesis activity 
was apparent in any set of experiments over that observed in 
unsupplemented medium. One interpretation of this result is that 
none of the sulfur sources tested is taken up by the cells. However 
growth of cells in [35S]-L-methionine and [ 35S]-L-cystine enriched 
media resulted in high levels of labelling of biotin indicating that 
neither transport into the cell nor metabolism to the intracellular 
sulfur-donor were rate determining (Baxter, Ramsay and Baxter, 
private communication). Previous work by both DeMoll and Shive, 
1983, Niimura et al., 1964 and Izumi et al., 1973 had also shown 
that the above sulfur sources were incorporated into biotin. 
Feedback inhibition: Cells grown in LB medium 
containing up to lp.g/ml biotin gave similar biotin production levels 
(over background medium levels) indicating that biotin production 
in the medium was not a significant factor affecting the drop in rate 
as cells grew from log to stationary phase. 
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(d) and (e) Biotin 	synthetase 	synthesis 	and 
degradation variation with time: Biotin synthetase expression 
was monitored by adding [ 35S]-L-methionine to induced pIMSB 
DH1i cells during various stages of growth. Whole cell extracts 
were analysed by SDS-PAGE and autoradiography. It was noted 
that biotin synthetase was labelled as strongly during growth 
between log and stationary phase growth indicating that the 
protein was continually being expressed over this period of time (N. 
Shaw and 0. Birch, priv. commun., using cell line BM4062 
pB030A-15/9). 
3.2 Biotin production in supplemented media. 
One explanation for the rapid decrease in rate of biotin 
synthesis during cell growth is that the actual sulfur source 
employed in the synthesis of biotin is present only in minute 
concentrations and is rapidly exhausted when biotin synthetase is 
present in larger than wild-type concentrations (as is the case in 
IPTG-induced pIMSB DH1i cells). In an attempt to overcome this, 
various other active sulfur sources were added to the growth 
medium. By analogy with other sulfur donation reactions e.g. 
rhodanese, cystathionase and -mercaptopyruvate sulfur 
transferase it could be postulated that the sulfur donor is some 
activated persuiphide or sulfane sulfur such as thiocystine (14) 
(Alexander and Volini, 1986, Yamanishi and Tuboi, 1981 and 
Vachek and Wood, 1972). White had earlier demonstrated that 
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both sulfur atoms of thiocystine were incorporated into biotin 
(White, 1982). 
Toohey has used various methods to produce persuiphide 
sulfur at a low rate in vivo (Toohey 1986, 1989). Methods for the 
production of persuiphide sulfur in vivo include growing the cells in 
media supplemented with cystine and pyridoxal and in medium 
supplemented with sulphide-treated proteins, e.g. bovine serum 
albumin. 
pIMSB DH1i was grown in M9CA minima' medium 
supplemented with cystine (1mM), pyridoxal (50jiM) and cystine 
and pyridoxal together (1mM and 50p.M respectively). DTB was 
added to all experiments at a concentration of 50pg/ml. Biotin 
synthetase expression was induced with IPTG and aliquots of 
medium were removed at various time intervals and the biotin 
concentration measured using the Lactobacillus bioassay. The 
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Figure 3.5a Biotin production in supplemented media. 
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The experiment was repeated with pyridoxal phosphate (at 50p.M) 
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Figure 3.5b Biotin production in supplemented media. 
The graph of biotin production shows that pyridoxal at 50j.iM 
concentration slightly increases biotin production but both cystine, 
pyridoxal phosphate, cystine with pyridoxal and with pyridoxal 
phosphate lowered the amount of biotin synthesised to variuos 
degrees. Cells overproducing biotin synthetase were grown in 
sulphonated BSA and glutathione as a source of sulfane sulfur. It 
was found that the presence of these additives had little effect on 
biotin 	production. 	It is possible that the pyridoxal 	(Pyr) 
concentration is lowered by chemical reaction between pyridoxal 
and cystine. 
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In conclusion, additives that are known to produce 
persuiphide sulfur in growth medium have little or no effect on 
biotin production and do not stop the rate of biotin production 
decreasing as the cell growth proceeds from log to stationary phase. 
One reason for this could be that persuiphide sulfur is not 
incorporated into biotin or that the persuiphide species formed is 
not usable directly as a substrate by biotin synthetase. Pyridoxal 
addition does however increase biotin production. This may be due 
to an increase in the metabolism of other enzymes in the biotin 
pathway, noteably the 7-KA.PA and DAPA synthetases which 
require pyridoxal phosphate as a co-factor, and thus an increase in 
pyridoxal concentration increases the intracellular concentration of 
DTB. 
On the basis that biotin synthetase was likely to be a Fe 2 
containing enzyme by analogy with other sulfur utilising enzymes 
(e.g. isopenicillin N synthetase) and that the Fe 2 concentration 
might be a controlling factor in the activity of the enzyme in vivo, 
the concentration of Fe2+  in the medium was varied and the biotin 
concentration monitored. Addition of Fe 2 (0.1-10mM) to the 
growth medium did not increase the amount of biotin produced, 
therefore the addition of excess ferrous iron to the growth medium 
appears to have no effect on biotin production in vivo. 
Conclusions of in vivo experiments 
The main aim of overexpressing the genes of the biotin 
operon is to produce biotin in a large scale fermentation broth. 
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Wild-type biotin concentrations in bacterial cells are in the 
nanomolar range. By cloning and overexpressing the bioB gene we 
have tested the effect that the sulfur insertion reaction has on 
biotin production. 
Wild-type biotin production was compared with cells 
overexpressing bioB (pIMSB DH1i) and non-expressed bioB cells 
using the Lactobacillus plantarum bioassay. In the cells 
overexpressing bioB initial rates of biotin biosynthesis were very 
high. However, this overproduction phase is short and the rate of 
biotin production declines in the stationary phase cells. This 
indicates that there is a tight coupling of biotin biosynthesis with 
the growth phase. While there are many possible reasons for the 
decrease in the rate of synthesis a number of these have been 
eliminated from consideration by the experiments described above. 
It has been shown in these studies that neither feedback 
inhibition by biotin, repression of biotin synthesis by biotin or 
biotin degradation are responsible for the drop in rate of biotin 
biosynthesis. DTB continues to be synthesised during the 
stationary phase (Shaw and Brass, personal commun.). In vivo 
assays show that biotin synthetase is active in stationary phase 
cells. While it is possible that the sulfur donor supply is exhausted 
or the sulfur donor enzyme inhibited or rapidly broken down in the 
stationary phase attempts to overcome the sulfur donor problem by 
addition of possible sulfur donor candidates had no significant 
effect on biotin production. Growth of cells in additives which are 
thought to produce increased intracellular pools of sulfane sulfur 
also had no effect on amount of biotin synthesised by cells and the 
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stalling of the rate of biotin synthesis, indeed cystine and 
pryridoxal phosphate reduce the amount of biotin synthesised. 
Subculturing cells in stationary phase to fresh media did 
stimulate both cell division and biotin production. This suggests 
two possibilities:- that either newly synthesised protein (perhaps 
loaded with sulfur?) is required for catalytic activity or that the 
biological sulfur source is only present in log phase cells. A related 
and highly attractive possibility, in view of the inability of added 
sulfur compounds to increase production, is that sulfur donation to 
biotin synthetase requires the action of an additional enzymatic 
activity which is only expressed in growing cells or which is 
inactive or degraded in stationary phase cells. It is also possible 
that overproducing the bioB protein to 5% soluble protein may have 
detrimental effects on the expression of other enzymes in wild-type 
cells. 
The exact nature of the sulfur donor is unclear although it 
can be derived from a number of sulfur-containing compounds 
including cystine and methionine (DeMoll and Shive, 1983 and 
DeMoll et al., 1984, Parry, 1983). More recently Ifuku et al., (1992) 
have shown that S-adenosyl-methionine (SAM) increases the 
production of biotin from DTB in cell-free extracts of E.coli 
overproducing biotin synthetase. 
If the sulfur-donor species is only required in wild-type cells 
in minute quantities then during the initial hours of bioB 
overproduction the pool of this compound will be quickly exhausted. 
Clearly the enzymes required to synthesise such a compound via 
the available sulfur pool will not be able to keep up with the bioB 
enzyme as the boosting of intracellular sulfur pools by the addition 
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of cystine and methionine to the growth medium did not alleviate 
the problem of the decrease in rate of biotin synthesis. 
It seems that the possible way of overcoming this problem is 
to increase the enzyme(s) required to produce the unknown sulfur-
donor protein which may be required in tandem with biotin 
synthetase (e.g. rhodanese, cystathionase). This could be achieved 
by the cloning and overexpression of the gene(s) required. Another 
way of overcoming the problem is to add the sulfur donor to 
growing cells throughout the growth phase. A possible caveat 
which could become a problem in the future is that overexpression 
of any of the genes involved in generating the bacterial sulfur pool 
or addition of the sulfur donor might upset the delicate balance of 
sulfur metabolism and may be detrimental to the overall cellular 
metabolism and growth. 
Another reason for the relatively low level of biotin 
biosynthesis which has been proposed is that there is another 
protein required for the conversion of DTB to biotin. The early 
mutagenesis work by Eisenberg and coworkers and Campbell and 
colleagues suggested that it is only the product of the bioB gene 
that is required to synthesise biotin from DTB. These mutagenesis 
studies may not have picked up another protein required for biotin 
synthesis if mutagenesis of the gene caused cell death. The exact 
role of the bioC and bioH genes is unknown and these could have a 
part to play in DTB to biotin conversion. If another protein is 
involved in the conversion of DTB to biotin then it too will have to 
be over expressed to a level at least equal to that of biotin 
synthetase before a high rate of biotin synthesis can be sustained. 
Results gained from cell-free biotin assays point to the requirement 
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for another hitherto unidentified protein in DTB to biotin 
conversion (Ifuku et al., 1992 and Chapter 3.3). 
3.3 In vitro Biotin production. 
Other aims of this project were to identify and purify the 
components of the biotin synthetase reaction and reconstitute the 
reaction in vitro. With this in hand a clear mechanistic and kinetic 
investigation of the reaction could take place. This required an in 
vitro biotin assay. Although the Lactobacillus plantarum bioassay 
is useful it has many limitations including its unreliability at low 
biotin concentrations, its long set-up and run time and its accuracy. 
However by utilising radiolabelled DTB it was possible to monitor 
the direct conversion of DTB to biotin in in vitro reactions. 
Previous in vitro assays had been handicapped by the lack of a 
quick and rigorous purification method for biotin. The purification 
of radiochemically labelled biotin has typically involved the use of a 
preliminary chromatographic step coupled with methylation using 
e.g. diazomethane, and crystallisation of the methyl ester of biotin. 
This process is both labour and time demanding. Other methods of 
quantifying the amount of labelled biotin produced in an in vitro 
assay were investigated. 
3.3.1 Development of the Assay System. 
In view of the low levels of conversion in in vivo assays and 
our inability to detect DTB to biotin conversion in vitro in 
preliminary studies (Baxter and Ramsey, private communication) 
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attention was focused on radiochemical methodology. 
Conceptually; incubation of [14C1-DTB with the enzyme and 
cofactors would, if conversion was achieved, give radiolabelled 
biotin detectable even in small quantities. Development of an 
assay therefore depended upon the ability to separate biotin from 
DTB in a reproducable manner. The following separation 
techniques were analysed for effectiveness in determining DTB to 
biotin conversion in cell-free extracts. 
3.3.2 Reverse Phase HPLC 
Reverse phase HPLC on C18 silica using 
phosphate/methanol elution buffer systems gives good separation of 
biotin from DTB. However in radiochemical experiments using 
substrates the purified biotin contains radiochemical impurities 
presumably because of its relatively rapid elution from the column. 
The chromatographic conditions giving the best separation were 
provided by using a modification of the procedure given by Bowers-
Komro et al., (1986). This was carried out with a 0-18 5pm ODS 
column with an isocratic elution over 20min with 0. 1M phosphate 
(pH2.15) / MeOH (70:30, v/v) at a flow rate of imi/min. Biotin 
elutes at 3.75 min and DTB at 7.6 mm. See Figure 3.6. 
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Figure 3.6: HPLC of Biotin and DTB 
[5ji ODS, eluted with 0.1M 
phosphate (pH 2.15)- MeOH (7/3)] 
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3.3.3 Avidin-Biotin binding assay 
An avidin-biotin binding assay was developed by Dr. N. 
Shaw et al. at Lonza (personal commun.). The concept behind this 
assay was that radiolabelled biotin produced in an in vivo reaction 
could be extracted by mixing with avidin. The bound biotin was 
then separated from the supernatant by passing the suspension 
through a small Sephadex G-25 gel filtration column to separate 
protein and low molecular weight components. This assay worked 
well, however the [14C]-DTB substrate that was used for the assay 
also bound to the avidin resin. This gave very high background 
levels which complicated the calculation of the amount of biotin 
actually produced and this methodology was not developed further. 
3.3.4 C-18 SEP-PAR / TLC assay 
The assay which was used throughout the in vitro 
experiments described in the remainder of this thesis utilised [14C] 
DTB, disposable one-use C-18 silica columns and resolution of the 
resultant labelled DTB and biotin using appropriate t.l.c. 
conditions on silica gel (CHC1 3fMeOHJformic acid (17/3/0.2 v/v)) and 
autoradiography. 
[14C]-DTB labelled (specific activity=57.2mCiJmmol 4) at the 
ureido carboxyl position was added to reaction mixtures. When the 
incubation was complete lOp.g of cold DTB and biotin were added as 
carriers and the reaction was stopped and protein precipitated. 
The DTB and biotin in the extract were then isolated by reverse 
phase chromatography on disposable C-18 columns. The DTB and 
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biotin were eluted with MeOH, concentrated and resolved by t.l.c. 
Radioactive spots were visualised by autoradiography. The amount 
of biotin synthesised was calculated by scintillation counting of the 
radioactive zones cut from the t.l.c. plates. The recovery of this 
method was -95% of the radioactivity added to the reaction. The 
loss of material is thought to occur at the precipitation and transfer 
to the column step of the procedure. 
3.4 Cell-free assays. 
It must be noted at the outset that the in vitro assay used 
was developed by Birch and Shaw at Lonza AG. Throughout the 
course of my work the workers at Lonza suggested various 
additives to test in in vitro assays having carried out many more 
assays than I could have possibly achieved in the time available. It 
was necessary however to repeat their work because I used 
different cell-lines and expression plasmids compared with the 
types used at Lonza AG. 
3.4.1 Spheroplast activity. 
Permeabilised cells (or spheroplasts) were obtained by a 
modification of the method of Kaback, 1971. This involved the 
treatment of bacterial cells with lysozyme and EDTA. Spheroplast 
suspensions of IPTG induced pIMSB Dlii and pIMSB pCOi were 
prepared and assayed for biotin synthetase activity using the 
[14C]-DTB Sep-Pak assay. No activity could be detected using this 
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method. One reason could be that the enzyme is inhibited by either 
lysozyme or EDTA. 
3.4.2 Cell-free extract activity. 
Bacterial cell-free extracts were prepared using sonication to 
lyse the cells. A cell-free extract of cells induced to overexpress 
biotin synthetase was prepared as outlined in the Materials and 
Methods section. 
3.4.3 Biotin production in pCOi and DH11 
cell-free extracts. 
We had to confirm that pCOi (bio-) cells contained no 
detectable biotin synthetase activity and if the one chromosomal 
copy present in DH1i cells could be detected using the cell-free 
assay. Cell-free extracts of both cell lines were prepared and 
assayed for biotin synthetase activity. No biotin could be detected 
using this assay in the pCOi cell-free extract and in the DH1 
extract. We conclude from this result that the amount of biotin 
produced by pCOi and DH1i cell-free extracts was not detectable by 
our assay. 
3.4.4 Biotin production in pIMSB DH1i. 
The biotin synthetase activity of cell-free extracts of pIMSB 
DH1i without IPTG induction was compared to that of IPTG 
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induced cells. Uninduced cells were prepared in the same manner 
as induced, however IPTG was not added to the growth media. 
Using the cell-free assay it was not possible to detect biotin 
production in the induced cells whereas the induced cells produced 
biotin, indicating that biotin synthetase was expressed in pIMSB 
DH1i cells under the conditions used. 
3.4.5 Comparison of pIMSB DH1i and pIMSB pCOi. 
Cell-free extracts were prepared from pIMSB pCOi (bio -) 
cells induced with IPTG to express biotin synthetase. The activity 
of this extract was assayed and was found to be similar to that 
found for pIMSB DH11 cell-free extract activity. 
3.4.6 Effects of cofactors, substrates and inhibitors 
on biotin synthetase activity. 
With a assay for biotin synthetase and an active cell-free 
extract we set about trying to identify the unknown parameters in 
the conversion of DTB to biotin. We tested the effect of various 
putative sulfur donors, cofactors and inhibitors of the reaction by 
adding these to a standard cell-free assay of pIMSB DH1i cell-free 
extract and determining whether the presence of these additives 
produced more or less biotin in comparison with a standard assay. 
For these assays aliquots of a cell-free extract prepared from 
a 51 pIMSB DH1i culture ( CFII) were used throughout. The 
standard reaction mixture contained lOOjil cell-free extract, in 
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50mM HEPES buffer, pH 7.5, 0.75p.g [14C]-DTB (specific activity 
57.2mCiJmmol4) and the various cofactors in a final volume of 
650pl. The reaction was incubated at 37°C for ihour and stopped 
by the addition of TCA to 1%. The amount of biotin was calculated 
by isolating the biotin using the SEP-PAK procedure and counting 
of the baseline, DTB and biotin spots on t.l.c. plates by scintillation 
counting. 
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3.4.7 Conversion of DTB to biotin in cell-free extracts. 
Activity of cell-free extract. 
We carried out the standard assay procedure without any 
additives and calculated that the extract produced 0.02jig biotin or 
alternatively 3% of the 0.75 jig DTB added was converted to biotin. 
3.4.8 Effect of MgATP. 
To determine whether the reaction might require an energy 
requirement we incubated the cell-free extract in the presence of 
1mM MgATP. The amount of biotin produced increased from 3% to 
14% as shown in Table 3.1. 
Table 3.1 Effect of MgATP. 
MgATP added to the reaction mixture at the given final 
concentration. The amount of biotin formed is shown in jig and as 
a percentage of the 0.75 jig DTB added. 
Addition 	Concentration 	Biotin formed 




MgATP 	 1 	 0.11 14 
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3.4.9 Effect of sulfur compounds. 
We assumed the possibility that the sulfur donor is the rate-
limiting factor in biotin formation, therefore the effects of various 
sulfur compounds on biotin-forming activity was tested. We tested 
these in the presence of 1mM MgATP. Table 3.2 shows the results 
of these experiments. Of the sulfur compounds added cysteine and 
methionine did not have a large effect although they were both 
inhibitory at 10mM concentration. 13-Mercaptopyruvate was 
inhibitory at 6.5 mM concentration. 
Table 3.2 Sulfur compound was added to the reaction mixture at 
the given final concentrations. All incubations were carried out in 
the presence of 1mM M2ATP. 
Addition 	Concentration 	Biotin formed 
(MM) 	(.tg / %) 
None 	 0.11 14.0 
Cysteine 6.5 0.12 15.3 
Cysteine 10.0 0.08 10.2 
Methionine 6.5 0.11 14.0 
Methionine 10.0 0.12 15.3 
f3-MP 6.5 0.02 2.9 
f3-MP 10.0 0.02 2.2 
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3.4.10 Effect of pyruvate. 
The inhibitory effect of -mercapto-pyruvate prompted us to 
test the effect of pyruvate in our assay. It can be seen from Table 
3.3 that pyruvate increases the amount of biotin formed at 10mM 
concentration. We are unsure as to the nature of this stimulation 
of biotin production. 
Table 3.3 Effect of pyruvate on biotin synthesis at the given 
concentrations in the presence of 1mM MgATP. 
Addition 	Concentration 	Biotin formed 
(MM) 	 (pg/%) 
Pyruvate 	 5 	 0.12 16.4 
Pyruvate 	 10 	 0.21 27.5 
3.4.11 Effect of Fe 2 . 
The presence of the CXXXCXXC (CYS-BOX) motif (see 
chapter 4) suggested to us that a metal cofactor could be involved in 
the conversion of DTB to biotin. Iron has been shown to be 
required in the synthesis of isopenicillin by IPNS (Baldwin et al., 
1991) and several workers (Parry, 1983) have suggested that a 
similar mechanism and cofactors might be involved in the biotin 
synthetase reaction. Fe2+  was added to the reaction and its effect 
assayed both in the absence and presence of MgATP. 
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Table 3.4 Effect of Fe2 . 
The effect of Fe 2 at 1mM concentration on biotin synthesis with 
and without MgATP (1mM). 
Adthton 	Concentration 	Biotin formed 
(MM) 	 (p.g / %) 
None 	 0.02 3 
Fe2 	 1 	 0.11 15 
Fe2 fMgATP 	1 / 1 	0.21 28 
After the initial set of cell-free assays listed above we carried 
out all further assays in the presence of MgATP and Fe 2 . 
3.4.12 Effect of Iron-binding reagents. 
To test for the absolute requirement for Fe2+  we carried out 
incubations in the presence of the Fe2+  binding reagent ferrozine. 
Ferricyamde is known to inhibit the Fe 2 binding enzyme aconitase 
and cyanide ions are known to complex with Fe2+  so these were 
also assayed for their effect on DTB to biotin conversion as shown 
in Table 3.5. 
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Table 3.5 Effect of iron-binding and complexing reagents on 
biotin synthesis. Incubations were carried out in the presence of 
Fe2 (1mM) and MgATP (1mM) including the listed reagents at the 
given concentrations. 
Additon 	Concentration 	Biotin formed 
(MM) 	 (pg / %) 
Ferrozine 0.1 0.14 18.5 
Ferrozine 1.0 0.17 22.5 
Ferrozine 5.0 0.01 1.8 
K3Fe(CN)6 1.0 0.19 25.0 
K3Fe(CN)6 10.0 0.03 3.6 
K3Fe(CN)6 20.0 0.02 2.6 
The results from the table show that iron-binding agents 
inhibit the conversion of DTB to biotin. Although it is possible that 
these compounds inhibit the reaction in some other way it is more 
than likely that they do so by binding iron which is obviously an 
essential cofactor of the reaction. 
3.4.13 Effect of primary thiol (1.mercapto-DTB). 
It has been proposed that the primary thiol 1-mercapto 
dethiobiotin is an intermediate in the conversion of DTB to biotin. 
This metabolite has not been isolated from cells and is thought to 
have a short half-life, tightly bound to the enzyme. If the thiol is 
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an intermediate and thus a substrate for the ring closure then it 
would compete for the DTB binding site on biotin synthetase. We 
tested whether the primary thiol 1-mercapto-DTB could act as a 
competitor for the DTB site by adding the thiol in a dimeric form in 
the presence of DTT (the reducing conditions would monomerise 
the dithiol species) at high concentrations. We had previously 
shown that DTT has no effect on biotin synthesis.(see Table 3.6). 
See also Publication section. 
Table 3.6 Effect of 1-mercapto-DTB. 
Biotin production was measured in the presence of 1mM 
MgATP, 1mM Fe2 , (0.75ig/0.2j.tCi) [ 14C]-DTB and various 
concentrations of the thiol prepared in DTT (1mM). 
Addition 	Concentration 	Biotin formed 
	
(MM) 	 (pg / %) 
1-mercapto-DTB 	0.43 	0.21 28.0 
1-mercapto-DTB 	0.86 	0.21 28.0 
The results from the above table show that 1-mercapto-DTB 
does not reduce the turnover of DTB to biotin. We conclude from 
this that either 1-mercapto-DTB is not a competitive inhibitor of 
DTB to biotin conversion or that its k1 value is high and that there 
was not a sufficiently high enough concentration of the compound 
present to effect inhibition. 
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3.4.14 Effect of sulfur-thiol blocking agents. 
The cysteine residues of biotin synthetase from E. coli, B. 
sphaericus and S. cerevisiae exhibit a high degree of conservation 
(see Figure 4.2). We wished to test the significance of these 
conserved thiol residues using thiol blocking agents. Enzymic thiol 
groups accessable to solvent can be blocked with various reactive 
thiol-blocking agents such as iodoacetate (IAA), iodoacetamide, 
dithionitrobenzene (DTNB), dithionitropyridine (DTNP), 
methylmethane thiosuiphonate (MMTS) (see Table 3.7). 
Table 3.7 Each of the above reagents were incubated in a 
standard biotin synthetase assay containing MgATP and Fe 2 
(1mM each), (0.75p.tg10.2p.Ci) [14C]-DTB and various concentrations 
of the thiol reagents. 
Additon 	Concentration 	Biotin formed 
(MM) 	 (j.tg / %) 
MMTS 1 0.05/6 
DTNB 1 0.05/6 
DTNP 5 0.05/6 
IAA 5 0/0 
Iodoäcetamide 10 0/0 
The results shown in table 3.7 indicate that the sulfur-
blocking agents used inhibit the conversion of DTB to biotin. The 
precise nature of this inhibition is unclear. It is not possible to 
determine whether the above compounds react with the enzyme or 
with the substrate or whether they are simply subtrate inhibitors. 
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3.5 [35S]-Cystine incorporation. 
Although the exact nature of the sulfur donor in the biotin 
synthetase reaction is unclear there is growing evidence that 
cysteine is, if not the actual sulfur source, very close on the 
metabolic pathway to the sulfur donor (Eisenberg 1987). The 
addition of unlabelled cystine had little effect on the turnover of 
DTB to biotin in the above experiments. We did however test 
whether cystine is a substrate for the reaction by incubating the 
active pIMSB Dlii cell-free extract with radiolabelled cystine 
rather than DTB in the presence of Fe 2 , MgATP, DTB. Reactions 
using amino-acid substrates quite commonly use pyridoxal 
phosphate as a coenzyme and so this was also added to incubations. 
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Table 3.8 Cystine incorporation into biotin. lOOml Cell free 
extract was incubated in the presence of 50mM HEPES buffer 
pH7.5, 1mM MgATP, 1mM Fe2 , 1mM DTB and [35S]-cystine lOpCi 
(200p.Cilml) in a final volume of 650p.l for lhr at 37°C. Pyridoxal 
phosphate (PyrPh) was added at the given concentration. The 
amount of biotin formed is given as a percentage of the 
radioactivity added. 
Additon 	Concentration 	Biotin formed 
(MM) 	 (%) 
none 	 0.2 
PyrPh 	 5 	 0.2 
The amount of biotin formed was barely detectable using the 
cell-free assay but there was however definite incorporation of [35S} 
from cystine into biotin. The addition of pyridoxal phosphate did 
not increase the amount of incorporation. The very small amount 
of incorporation of cystine sulfur suggests that it is indeed not the 
immediate sulfur source and that it must be metabolised to some 
other sulfur containing species. Other explanations could be that 
the cystine added is diluted in the large cystine pool and that 
cystine is the sulfur source but another unidentified cofactor is 
required. 
3.6 Activity of AORF1 and AbioC mutants. 
The genes ORF1 and bioC lying within the bio locus of E.coli 
are thought to be involved in biotin biosynthesis, however their 
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exact biochemical function is unclear. We wished to determine if 
they were involved in the biotin synthetase reaction. Due to the 
fact that pIMSB pCOi (bioC, ORF-) can convert DTB to biotin both 
in in vivo and cell-free assays, these genes are obviously not 
required for synthesis. We wanted to test if overexpression of these 
genes in the presence of biotin synthetase would increase the turn-
over of DTB to biotin. We used the iORF1 and iThioC pB030 
derived plasmids transformed into pCOi to prepare cell-free 
extracts. These plasmids contain all of the other genes in the bio 
locus overexpressed apart where noted. Cell-free extracts were 
assayed using the [14C]-DTB SEP-PAK assay in the presence of 
1mM MgATP and 1mM Fe2 . The cell-free extracts of both cell 
lines were able to convert DTB to biotin but notably did not give 
higher yields of biotin than pIMSB DH1i. So we can be absolutely 
sure that bioC and ORF1 have no direct role in DTB to biotin 
conversion and overexpression of these genes neither enhances nor 
decreases the DTB to biotin converting activity of these cells. We 
did note however that pB030 EORF1 when transformed in DH1i 
was slower to grow than pB030 ibioC. We note that the difference 
between these two cell lines was the overexpression of bioC. This 
phenomenon has also been noted by Brown et al., (1993). They 
found that overexpression of the bioC gene decreased the growth 
rate of the cells. 
3.7.1 Activity of late log phase cells. 
pIMSB DH1i extract CFIII was assayed for its ability to 
convert DTB to biotin. Cells in vivo cease to produce biotin in late 
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log phase and we determined if this was the case with a cell-free 
extract. Aliquots of cells were assayed for DTB to biotin conversion 
in the absence and presence of 1mM Fe 2 and 1mM MgATP, 0.2p.Ci 
14C-DTB. It was seen from developed autoradiograms that the cell-
extract could convert DTB to biotin in both cases. This means that 
the substrates are still present in cell-free extracts prepared from 
late log phase cells. The conversion of DTB to biotin in whole cells 
must involve a more complicated energy and substrate coupling 
with cell metabolism. 
3.7.2 Activity of pCOi (bio -)cells. 
A cell-free pCOi extract (CF1V) was prepared and assayed for 
its ability to convert DTB to biotin in the absence and presence of 
1mM Fe2 , 1mM MgATP and 0.2j.tCi 4C-DTB. No biotin was 
detected in either assay. 
3.8 Protein purification. 
After demonstrating biotin synthetase activity in cell-free 
extracts of pIMSB DH1i and with the knowledge of some if not all 
of the cofactors involved in the reaction we hoped to proceed by 
purifying biotin synthetase to homogeneity. Addition of the various 
cofactors boosted cell-free activity to a level that we hoped would be 
detectable even if we recovered small amounts of biotin synthetase 
from the various chromatographic purification procedures. 
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3.8.1 Ammonium sulphate fractionation. 
Ammonium sulphate fractionation of cell-free extracts was 
carried out according to the procedure described in Materials and 
methods. We initially divided the extract into three fractions. :-a 0-
40% fraction (AS 0-40), a 40-60% fraction (AS 40-60), and the 
supernatant obtained from the 60% fractionation (AS 60). We 
analysed each of the fractions by SDS-PAGE and found that a band 
corresponding in size to biotin synthetase was present in the AS40-
60 fraction (see figure 3.7). Each of the fractions were assayed for 
biotin synthetase activity in the presence of Fe 2 and MgATP but 
were found to be inactive. 
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Figure 3.7 Ammonium sulphate fractionation of pIMSB DH1i 
extracts. Ammonium sulphate fractionation was carried out on 
cell-free extracts (CFI) as described in Materials and methods. 
Aliquots of the fractions were analysed by SDS-PAGE. The arrow 
indicates the position of biotin synthetase. 
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Ammonium Sulphate precipitation 









We carried out ammonium sulphate fractionation of pIMSB 
DH1i extracts to produce a 0-50% fraction (ASO-50) and the 
supernatant from the 50% fractionation (AS50). The bioB protein 
was present in the ASO-50 fraction. Both these fractions were 
assayed for biotin forming activity but were found to be inactive. 
When the ASO-50 and AS50 fractions (without desalting) 
were combined and assayed they were found to be active. We also 
prepared a cell-free extract of pCOi cells. This extract could not 
convert DTB to biotin. However when the AS40-60 and the ASO-50 
fractions were supplemented with pCOi extract they were both 
active. We concluded from these results that a low molecular 
weight fraction and at least one other protein were required for 
DTB to biotin conversion. 
3.8.2 G-25 Gel filtration of cell-free extracts. 
At the same time as we were fractionating the cell-free 
extracts with ammonium sulphate we also produced a total protein 
fraction using a G-25 Fast-Desalt column on FPLC (as described in 
Materials and methods) the elution profile of which is shown in 
figure 3.8. This column separated the cell-free extract into what 
we called protein and low molecular weight components (LMWt). 
The total protein and the LMWt extacts were assayed in the 
presence of MgATP and Fe 2 separately and found to be inactive. 
However the activity of the total protein extract was recovered by 
supplementation with LMWt. We concluded that the LMWt extract 
contains various unidentified cofactors and substrates. 
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Figure 3.8 Gel filtration of pIMSB DH1i extract on F.P.L.C. Fast Desalt G-25 
column. inil cell-free extract (CFI) loaded on column and eluted with 50mM 
HEPES buffer, pH7.5 at 3mllmin. 2inl Fractions collected. Vertical scale 
0D280 (0-2 OD units). 
pH Stability of the LMWt extract. 
The stability of the LMWt extract was determined by raising 
and lowering the pH of the sample with formic acid and ammonium 
hydroxide. The samples were freeze-dried and neutralised and 
then assayed for the ability to reconstitute the activity of a protein 
fraction as described above. It was found that both extracts 
reconstituted the activity of the protein extract. 
3.8.3 Sephacryl-S200IIR Gel-filtration 
of cell-free extracts. 
Our initial step in trying to purify biotin synthetase involved 
separation according to molecular weight on a high resolution gel 
filtration column. The cell-free extract was loaded onto the column 
and eluted as described in Materials and methods yielding the 
elution profile in figure 3.9. The fractions were analysed by SDS-
PAGE to identify fractions containing the synthetase. See figure 
3.10. These fractions were assayed for biotin forming activity in 
the presence of MgATP, Fe 2 and LMWt extract. No active 
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Figure 3.9 Sephacryl S-200 HR Gel-filtration column. lOmi 
pIMSB DH1i cell free extract (CFI) loaded on column and eluted 
with 50mM HEPES buffer, pH 7.5. Fractions (7ml) were collected 
and aliquots (500j.d) containing biotin synthetase (by SDS-PAGE 
analysis, see figure 3.10) were assayed for activity using the SEP -
PAK technique in the presence of 1mM Fe 2 , MgATP, 0.75pg 14C.. 
DTB (0.2pCi) and lOOp.! of LMWt extract for lhr at 37°C. 
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Figure 3.10 SDS-PAGE analysis of fractions from Sephacryl S-
200HR Gel-filtration column. Fractions numbers are from those 
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3.8.4 Q-Sepharose ion exchange chromatography. 
We attempted to purify the synthetase protein by anion 
exchange chromatography on Q-Sepharose anion exchange resin. 
The column was prepared and the cell-free extract loaded and 
eluted according to the procedure detailed in the Materials and 
Methods to give the profile shown in figure 3.11. Proteins eluted 
in lOmi fractions were analysed by SDS-PAGE (see figure 3.12). 
Fractions were assayed for biotin synthetase activity in the 
presence of MgATP, Fe2 and LMWt extract. No activity was 
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Figure 3.11 Elution profile of Q-Sepharose ion exchange. 5ml CFI 
extract loaded onto column in 50mM HEPES buffer, pH7.5 and a 
salt gradient developed over 600m1, in buffer + 0-1M NaCl. 
Fractions were collected, analysed by SDS-PAGE and biotin 
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synthetase containing fractions (imi) assayed for activity in the 
presence of 1mM Fe2 , 1mM MgATP, lOOp.! LMWt and 14C-DTB. 
3.8.5 MonoQ anion exchange chromatography. 
The cell-free extract CFI was subjected to ion exchange 
chromatography on MonoQ resin as described in Materials and 
methods yielding the chromatogram in figure 3.13. The fractions 
from the cobimn were analysed by SDS-PAGE (see figure 3.14). 
Fractions containing bands of the size of biotin synthetase were 
assayed in the presence of MgATP, Fe 2 and LMWt extract. No 
activity was detected in any of the fractions assayed. The MonoQ 
resin had achieved a modest separation of biotin synthetase from 
unwanted proteins. 
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Figure 3.12 SDS-PAGE analysis of fractions from pIMSB DH1i 
cel-free extract CFI extract separated on Q-Sepharose column. 
Fraction numbers from figure 3.11. The arrows indicate the 
position of biotin synthetase. 
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Sepharose-Q ion exchange column 
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Figure 3.13 Attempted purification of biotin synthetase by MonoQ 
ion exchange column. Fraction pIMSB DH1i CFI 2m1 was filtered 
through a 0.21.Lm filter and loaded onto the Mono Q column. The 
sample was eluted with 50mM HEPES buffer, pH7.5 at a flow rate 
of 0.75ml. Fractions (2m1) were collected and analysed for protein 
content by SDS-PAGE. Biotin synthetase containing fractions 
(lml) were assayed in the presence of 1mM Fe2 , MgATP, lOOp.l 
LMWt, and 14C-DTB. 
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Figure 3.14 SDS-PAGE analysis of pIMSB DH1i CFI fraction 
separated by F.P.L.C. MonoQ ion exchange. Fraction numbers 
from figure 3.13. 	The arrows indicate the position of biotin 
synthetase. 
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chromatography on bioB cells (pCOi) and using a biotin synthetase 
containing extract as an add-back to recover activity. 
3.9 Conclusions of cell-free extract biotin assays. 
In this study we have demonstrated the conversion of DTB to 
biotin in cell-free extracts of cells overproducing biotin synthetase. 
Initial attempts to prepare a cell-free system using spheroplasts 
failed to yield an active extract. Possible explanations for this 
could be that a component of the synthetase reaction is inactivated 
by the lysozymelEDTA procedure. A cell-free extract was prepared 
by sonication then removal of the cell debris by centrifugation. 
A number of cell-free extracts were prepared from various 
cell lines and their activity was assayed using the [14C]-DTB SEP-
PAK assay. 
We tested the effect that various cofactors, putative 
substrates and inhibitors had on DTB to biotin conversion. Two 
additions which had the most effect on the reaction were MgATP 
and Fe2 . We are unsure what part MgATP plays in the conversion 
of DTB to biotin. After the completion of this work Ifuku et al., 
(1992) produced an active cell-free extract and carried out a similar 
investigation of putative cofactors and substrates. However, Ifuku 
et al. tested ATP in their cell-free system and found that it had no 
influence on the conversion of DTB to biotin. 
Ifuku et al., also tested various glucose metabolites and 
found that fructose-1,6-bisphosphate (FBP) caused the greatest 
increase in DTB to biotin conversion. They are unsure as to the 
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role that FBP plays in the reaction but they postulate that it could 
act directly as a coenzyme in the reaction although there is no 
report about FBP's role as a coenzyme in the literature. FBP may 
also act upon another enzyme which is involved in a hitherto 
unknown part of the reaction. 
The exact nature of the sulfur source of biotin is still unclear. 
DeMoll and Shive (1983) provided evidence that L-cystine is the 
sulfur source in E.coli cells. We tested the effect of various sulfur 
compounds on the conversion of DTB to biotin. We were surprised 
to find that L-cysteine and methionine had little effect on the 
amount of biotin formed. Ifuku et al. also found that cystine and 
cysteine had little effect on biotin production but found that 
methionine caused a significant increase in biotin production in 
their investigation. In our work, the addition of -mercatopyruvate 
substantially reduced the amount of biotin formed. We are unsure 
as to the nature of this inhibition. Ifuku et al. found that S-
adenosyl methionine was the best sulfur source in their cell-free 
system but there was not enough evidence to suggest that SAM is 
the actual sulfur donor of biotin. 
Using the fact that MgATP increased biotin production we 
incubated all further assays in MgATP and analysed the effect of 
Fe2  and pyruvate on DTB to biotin conversion. a-Ketoglutarate 
and Fe2  are cofactors used by isopenicillin N-synthetase (IPNS), 
the enzyme that effects the ring closure by carbon-sulfur bond 
formation of the tripeptide to form isopenicillin. By analogy it has 
been proposed that biotin synthetase might follow a similar 
mechanistic pathway to IPNS. Biotin synthetase contains a CYS-
BOX peptide sequence which has been implicated as a metal 
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binding site. We assayed the effects of these two substrates and 
found they both increased DTB to biotin conversion. Previously 
Shaw and Birch (private communication, Feb, 1990) incubated 
biotin synthetase overexpressing cells with 55Fe2 and analysed the 
products by native-PAGE and autoradiography. The biotin 
synthetase band bound the radioactive 55Fe2 and the 55Fe2 could 
not be removed from the enzyme even after prolonged incubation 
with 5mM EDTA. 
The fact that addition of Fe 2 to the assay stimulated biotin 
production led us to incubate all further assays in the presence of 
MgATP and Fe2 . Although pyruvate increased the turnover of 
DTB to biotin we are unsure of the exact role that pyruvate plays in 
the reaction and we did not include it in future incubations. 
After establishing conditions for detectable DTB to biotin 
conversion we tested whether the sulfur atom of [35S]-L-cystine was 
incorporated into biotin. In the presence of DTB, MgATP and Fe 2 
we detected [35S]-labelled biotin. We were disappointed at the very 
small amount of incorporation detected. If cystine sulfur is the 
direct sulfur source for biotin then we would have expected higher 
incorporation. Possible explanations for this include the dilution of 
the sulfur label into the background cellular sulfur pool. Also if the 
synthesis of the actual sulfur donor from cystine is a slow multi-
enzymatic process, then of the labelled cystine added only a small 
amount was converted to the sulfur donor and incorporated during 
the time course of the reaction. However, this provides evidence 
that the sulfur atom of L-cystine is incorporated into biotin. 
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3.10 Cell-free extract rhodanese assay. 
Having established that another unidentified protein was 
required for DTB to biotin conversion in cell-free extracts we 
assayed for the presence of the enzyme rhodanese in our extracts. 
The rhodaneses are a group of enzyme proteins which share the 
ability to catalyze the transfer of the sulfane sulfur of thiosuiphate 
to cyanide to form thiocyanate and sulfite (Westley, 1977). 
SS032- + CN 	 SCN- + S032- 
Current knowledge of rhodanese structure and function 
derives mainly from studies on bovine liver mitochondrial 
rhodanese. Also, Alexander and Volini in 1987 purified an enzyme 
with rhodanese activity, from E.coli with a molecular weight of 14 
kDa.. The enzyme undergoes autoxidation to a polymeric form 
which is reactivated by millimolar concentrations of cysteine. 
Steady-state initial velocity measurements indicated that the 
enzyme catalyzes the transfer of sulfane sulfur by way of a double 
displacement mechanism with the formation of an enzyme-sulfur 
intermediate. 
The exact role of rhodanese in the bacterial cell is unclear. 
One possible role for the enzyme is as a detoxification protein to 
remove cyanide. However the high Km  value for cyanide rules this 
out, as bacterial cell cyanide concentrations are known to be low. 
Alexander and Volini showed that the enzyme is capable of 
catalysing the formation of iron-sulfur centres and the sulfur 
transferred to rhodanese is also incorporated into ferrodoxin. The 
130 
enzyme is also able to utilize reduced lipoic acid as a sulfur 
acceptor molecule. It is also inhibited by the sulfhydryl blocking 
reagents iodoacetic acid (IAA) and dinitroflurobenzene (DNFB). 
The wide range of activities exhibited by rhodanese led 
Alexander and Volini to postulate that the enzyme is involved in 
aerobic energy metabolism, possibly as sulfur donor to enzymes of 
the aerobic respiratory chain. The bovine enzyme when incubated 
with ferrous iron ions and a reducing agent can activate several 
enzymes of oxidative metabolism, including succinate 
dehydrogenase and NADH dehydrogensase. 
Cell-free extracts of pIMSB Dlii were assayed for the 
presence of rhodanese. Steady-state initial velocity measurements 
were carried out according to the procedure given in Materials and 
methods (2.16) the results of which are shown in figures 3.15 and 
3.16. The intercepts of the primary plots, which are reciprocals of 
the apparent maximum velocities at saturation of substrate, were a 
linear function of the reciprocal substrate. concentration. The 
values obtained for Km are in good agreement with the values of 
Alexander and Volini, 1987 (see Table 3.10). 
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Figure 3.15 Plot of kinetics of thiosulfate-cyanide reaction 
catalysed by rhodanese. Secondary plot of (Vapp CN)-1 against 













-1 -0.5 0 	0.5 	1 	1.5 	2 	2.5 	3 
[CN]-1 x 10-2, M-1 
Figure 3.16 Plot of kinetics of thiosulfate-cyanide reaction 
catalysed by rhodanese. Secondary plot of (Vapp S203) -1 against 





pIMSB DH1i cell-free extract Purified rhodanese 
Km S203 (MM) 
	
6.9 	 5 
Km ON (mM) 
15.0 	 24 
Table 3.9 Kinetic constants for thiosulfate production by pIMSB 
DH1i cell-free extracts compared with values obtained for pure 
rhodanese (Alexander and Volini, 1987). 
The results from the protein fractionation experiments 
indicates that another protein is required for biotin formation in 
cell-free extracts. We do not know if rhodanese has a role to play in 
biotin formation. The results of cell-free biotin assays does point to 
the involvement of a rhodanese-like enzyme. For example the 
biotin synthesising activity of cell-free extracts is increased by the 
addition of ferrous ions so rhodanese could be involved in 
generating an iron-sulfur active site on biotin synthetase. Both 
biotin synthesis and rhodanese are inhibited by suithydryl-blocking 
reagents. 
Rhodanese participation in DTB to biotin conversion could be 
tested by the addition of the purified enzyme to fractionated cell-
free extracts of biotin synthetase-containing fractions and 
determining if rhodanese could recover biotin synthetase activity. 
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BIOTIN SYNTRETASE MUTANTS 
4.1 Introduction 
In our study the bioB gene was cloned in the pKK223-3 
expression vector which contained a synthetic, consensus ribosome 
binding site and a strong ptac promoter under control by the lac 
repressor laci. The vector was named pIMSB (S. Little, Ceiltech, 
personal comm.). 
Using the cloned bioB gene we hoped to construct mutant 
enzymes which would enable us to work out the enzyme's 
mechanism and reveal which amino acids have important catalytic 
and/or structural importance. At the initiation of this study we 
knew nothing of the protein apart from its amino acid sequence 
(figure 4.1). With this in mind it is very difficult to start to mutate 
single, specific residues and test for their effect on activity with 346 
a.a. to choose from and with no good assay for activity. 
To focus on appropriate areas we carried out a best-fit 
sequence comparison between the two known bioB enzyme 
sequences, the E. coli and Bacillus sequences (figure 4.2). This 
exercise had previously been carried out by Ohsawa et al. (1989) 
who found the overall amino acid sequence homology between the 
two enzymes to be 32.5%. Our analysis gave a value of 34.7% 
rising to 59.6% when conservative replacements are considered. 
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Figure 4.1 Escherichia coli 	Biotin 	synthetase amino acid 
sequence and nucleotide sequence of the bioB gene. Amino acid 
usage data. 
810 8 DNA -. 1-phase Translation 
DNA sequence 	1041 b.p. ATGGCTCACCGC ... GC?.GCATrATCA linear 
1 	/ 	1 	 31 	/ 	11 
ATC CCT CAC ccc CC?. CCC 7CC ACA TTC TCG CM G7C AG?. GA?. TTA rrr GM AAA ccc TTC 
set ala his arp pro erg trp thr let ser gin val thr pit let phe pit lye pro let 
61 I 21 91 I 31 
crc CAT crc crc rTT CM ccc GAG GAG GTG CAT CCC GAG CAT rrc CAT ccT ccr GAG CM 
ieu asp let ieu phe pit ala pin gin val his erg pin his phe asp pro erg gin val 
121 / 41 151 I 51 
CAG crc AGC ACC rrG CTO 7CC ATT MC ACC CGA ccr TCT CCC GM CAT 7CC A?.?. TAG TGC 
gin vat 5cr thr let let 3cr lie lye thr ply ala cys pro pit asp cys lys cyr cys 
181 / 61 211 I 71 
CCC CA?. AGC 7CC CCC TAC MA ACC GGG CTG CA?. CCC GAG CCC TTG ATC CM GMT GM GAG 
pro gin ser 8cr arp tyr lye thr ply let pit ala pit arg let set pit val pit pin 
241 / 81 271 I 91 
CTG crc GAG TCC CCC CCC A?.?. CCC A?.?. GCC CC?. CC?. TCC ACG CCC ?7C TCT ATC CCC CCC 
val let pit ser ala erg lys ala Lys ala ala ply oar thr erg phe cys set ply ala 
301 I 101 331 I iii 
CCC 7CC MG MT CCC CAC GAA CCC CAT ATG CCC TAG CTG CA?. CM ATO crc GAG CCC GTh 
ala rrp lys asn pro his pit erg asp set pro tyr let plu pin set vat pin ply val 
361 / 121 391 / 131 
A?.?. CCC AM CCC C7G GAG CCC TGT ArC ACG CTG CCC ACC TTG ACT CA?. TCT CAG CCC GAG 
lys ala set ply let pit ala cys set thr let ply thr let ser pit oar pin ala pin 
421 I 141 451 I 151 
ccc crc ccc MC CCC CCC crc CAT TAG TAG MC CAC MC CTC GAG ACC 7CC CCC GAG rDT 
erg let ala can ala ply let asp tyr tyr aso his asn leu asp thr 3cr pro pit phe 
481 / 161 511 I 171 
TAG CCC MT ATC ATC ACC AC?. CCC ACT TAT CAG GM CCC crc CAT ACG crc CA?. A?.?. CTG 
tyr ply aso lIe Ile thr thr erg thr cyr pin pit erg let asp thr let pit iys val 
541 I 181 571 1 191 
CCC CAT CCC CCC ?.TC A?.?. GTC 7GT TCT CCC CCC ADr CTG CCC TTA CCC CA?. 3CC GTA A?.A, 
arg asp ala ply ile iys val cys ser ply ply ile val ply let ply pit thr vai lys 
601 I 201 631 / 211 
CAT CCC CCC CC?. TV. TTC CTC CM CrC CC?. MC C1'G CCC ACC CCC CCC CA?. AGC C7G CC?. 
asp erg ala ply let ieu let pin let ala asn let pro thr pro pro pit 5cr val pro 
661 / 221 691 / 231 
ATC MC ATG crc CTC MG CTG A?.?. CCC 3CC CCC CT CCC CAT MC CAT CAT CC CAT CCC 
ile asn met let val lys val lys ply thr pro let ala asp can asp asp val asp ala 
721 / 241 751 I 251 
Drr CAT rrr ArT CCC ACC ArT CCC CTC CCC CCC ATC ATG ATG CCA ACC TCT TAG GTG CCC 
phe asp phe ile arg thr Lie ala val ale arp Lie met met pro thr ser tyr val erg 
781 / 261 811 / 271 
CTT TCr CCC CC?. CCC GAG CAG ATC MC GA?. CAG ACT CAG CCC ATG 7CC Drr ?.TC CC?. CCC 
let ser ala ply erg pit girt set asn pit gin th.r pin ala set cys phe met ala ply 
841 / 281 871 / 291 
CC?. MC 7CC ATT TTC TAG GCT 7CC A?.?. crc C7G ACC ACG CCC MT CCC CM CA?. CAT AM 
ala asn ser Lie phe tyr ply cys lys let let thr th.r pro asn pro pit plu asp lys 
901 / 301 931 / 311 
GAG CrC CM crc irc CCC A?.?. crc CCC CTA MT CCC GAG CM ACT CCC CTG crc CCA CCC 
asp leu pin let phe erg lye let ply let asa pro pin pin chr ala val let ala ply 
961 I 321 991 ,' 331 
CAT MC CA?. CA?. GAG CA?. CCT crr GA?. GAG CCC CTC ATG ACC CCC GAG ACC GAG GA?. V.7 
asp asn pit pin pin pin erg let pit pin ala let set thr pro asp thr asp plu cyr 
1021 / 341 
TAG MC CCC CC?. CC?. TA TGA 
tyr asn ala ala ala let OPA 	- 
346 Amino Acids MW 38623 Dalton 
n n(%) MW MW(%) 
A ala alanine 32 9.2 2273 5.9 
C cys cysteine 8 2.3 824 2.1 
0 asp aspartic acid 19 5.5 2185 5.7 
K pit plutamiC acid 25 7.2 3226 8.4 
F phe phelaianine 10 2.9 1470 3.8 
C ply plycine 21 6.1 1197 3.1 
H his histidine 5 1.4 685 1.8 
K ile isoleucine 10 2.9 1130 2.9 
K lys lysine 16 4.6 2049 5.3 
L let letcine 39 11.3 4410 11.4 
N met mechionine 14 4.0 1834 4.7 
U asn asparapine 14 4.0 1596 4.1 
P pro protine 18 5.2 1746 4.5 
Q gin glutamine 24 6.9 3073 8.0 
R erg arginine 20 5.8 3122 8.1 
S ser sertne is 4.3 1305 3.4 
7 th.r th.reonine 24 6.9 2425 6.3 
V val valine 19 5.5 1882 4.9 
U trp ccypcophan 2 0.6 372 1.0 
X--- unknown - - 
Y tyr tyrosine ii 3.2 1793 4.6 
K--- STOP - - 
Gap Weight: 3.000 	Average Match: 0.540 
Length Weight: 0.100 Average Mismatch: -0.396 
Quality: 209.9 	Length:335 
Ratio: 0.656 Gaps: 7 
Percent Similarity: 59.621 	Percent Identity: 34.700 
1 MAHRPRWTLSQVTELF. .EKPLLDLLFEAQQVHRQHFDpR 38 
.......... 1 MNWLQLADEVIAGKVISDDEALAILNSDDDDILKLMDGAFAI . RKHYYGK 49 
39 QVQVSTLLSIKTGACPEDCKYCPQSSRYKTGLEAERLMEVEQVLESARKA 88 
50 KVKLNMIMNAKSGYCPEDCGYCSQSSKSTAPIEKYPFITKEEILAGAKRA 99 
89 KAAGSTRFCMGAAWKNPHERDMPYLEQMVQGVKAM. GLEACMTLGTLSES 137 
100 FENKIGTYCIVASGRGPTRKDVNVVSEAVEEIKAKYGLKVCACLGLrJKEE 149 
138 QAQRLANAGLDYYNHNLDTSPEFYGNIITTRTYQERLDTLEKVRDAGIKV 187 
150 QAQQLKEAGVDRYNHNLNTSERHHSYITTTHTYEDRVNTVEVVKKHGISp 199 
188 CSGGIVGLGETVKDRAGLLLQLANLPTPPESVPINMLVKVKGTPLADNDD 237 
200 CSGAI IGMKETKMDVVEIARALHQL. . DADSI PVNFLHAIDGTKLEGTQD 247 
238 VDAFDFIRTIAVARIMNPTSYVRLSAGREQMNEQTQANCFMAGANSIFYG 287 
I::.: 	1111111 
248 LNPRYCLKVLALFRYMNPSKEIRISGGREVNLGFLQPFGLYA . ANSIFVG 296 
288 CKLLTTPNPEEDKDLQLFRKLGLNPQQTAVLAGDNEQQQRLEQALMTPDT 337 
297 .DYLTTEGQEANSDYRNLEDLGFEIELT ....... ..QKQEEAFCS 332 
338 DEYYNAAAL 346 
Fig. 4.2 Best-fit alignment of the biotin synthetases from (a) E. coli and (b) 
B. sphaericus. Vertical bars, colons, and dots between the aligned protein 
sequences represent identical, conserved and similar a.a. respectively. The 
a.a. are numbered from the first Met residue. 
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E.coli bioB gene 
1041 b. p. 
RESTRICTION SITES 
Tth3I Alul RsaI Bgll 
21 153 333 946 
1 Jr Jr Jr 
I p 
I I I 
Xholl Alul NruI SspI 
63 187 425 1016 
Fig. 4.3 Restriction map of E.coli bioB showing sites used in 
deletion mutagenesis constructs. Numbers in b.p. refer to 
nucleotide sequence with A of Met start codon taken as nt#1. 
Boxed, hatched region shows position of CYS-BOX. 
We decided to begin mutagenesis experiments by deleting 
small portions of the gene and analysing the effect this had on the 
subsequent expression and activity of the mutant protein produced. 
Using restriction enzymes to cut the bioB gene at specific sites and 
ligating fragments together we hoped to produce deletion mutants. 
We analysed the DNA sequence of the bioB gene for restriction 
sites as shown in figure 4.3. 
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Six target deletions were identified:- 
2 X N-terminal or 5' deletions 
	
7 a.a.- using Tth31 
21 a.a.- using XhoII 
CYS-BOX deletion 
	
34 a.a.- using 2 X Alul 
Internal deletion 	 31 a.a.- using NruJJRsaI 
2 X Carboxy terminal or 3' deletions 	7 a.a.- using SspI 
30 a.a.-using BglI 
4.2 Synthesis of deletion mutants 
4.2.1 Amino-terminal deletions. 
4.2.1.1 	Tth3l -7 a.a. amino-terminal deletion. 
Best-fit data of the two bioB gene sequences from E.coli and 
Bacillus sphaericus shows that at the N-terminal end of the two 
proteins there is little sequence homology. To test for the 
importance of this region the unique Tth31 restriction site was used 
to create a 7 a.a. deletion the synthetic strategy of which is shown 
in figure 4.4. The vector pIMSB was digested with Tth31 and then 
treated with Kienow fragment to give a blunt end. This fragment 
was then further digested with XbaI to give a 5'-blunt, 3'-sticky-end 
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fragment. pIMSB was digested with NcoI, blunt ended with 
Kienow fragment to give the ATG start codon and then digested 
with XbaI to give the pIMS vector with compatible ends to the bioB-
gene fragment. Ligation of the bioB-gene to the pIMS vector gave a 
recombinant vector pIMSB/Tth3l. The deletion mutant was 
analysed according to its restriction digest map with Tth31 and 
NcoI. 
4.2.1.2 	XhoII -21 a.a. amino-terminal deletion. 
An earlier investigation by Nath (1988) had shown that 
transcription from the bioBFCD segment of the bio operon was 
terminated in certain conditions. Nath isolated the prematurely 
terminated RNA and showed it to be 96 nucleotides long. The 
mRNA was shown to be bioB specific. The synthesis of this RNA is 
markedly stimulated in the presence of biotin indicating that 
termination of bioB transcription is biotin dependent. Nath 
analysed the secondary structure of the RNA at the site of 
termination and predicted it would have a weak stem-loop 
structure. The formation of this structure could cause attenuation 
of transcription. He implicated this to the fine tuning of regulation 
of expression, suggesting the bio repressor controlled the gross 
transcription of the complete bio operon whereas early bioB mRNA 
termination controlled the transcription of the gene at the final step 
in the biotin biosynthetic pathway. 
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We wanted to create a 21 a.a. deletion of biotin synthetase to 
test whether the protein was active, but also to test whether the 
deletion of 63 nucleotides of the 96-mer mRNA removed the fine 
tuning element from bioB transcription. Also at this time we 
realised that the reduction of termination of bioB message would 
lead to more biotin synthetase expression. If the N-terminal 
mutant was as catalytically active and stable as the wild-type 
enzyme, it could be used as the source of biotin synthetase in an 
overproducing strain. 
The unique Xholl site in the bioB gene was used to create 
the desired deletion as detailed in figure 4.5. The bioB gene was 
recovered from the pIMSB vector by digestion with XhoII. The bioB 
gene fragment was separated by gel electrophoresis and purified. 
The fragment was blunt ended with Kienow enzyme then digested 
with XbaI to give a 5'-blunt end and a 3-XbaI overhang. The pIMS 
vector was prepared by digesting with NcoI, blunt ending with 
Kienow enzyme and then digesting with XbaI. The two fragments 
were incubated with T4 ligase and the ligation mixture used to 
transform JM83. Suspect recombinant plasmids were analysed by 
their restriction digest pattern with XhoH and Tth3I. Plasmid 
DNA from sixty-four suspect colonies was analysed, however no 
recombinants were isolated. The reason could be the inefficient 
digestion of the XbaI enzyme as this site is close to the XhoII site. 
It is known that some restriction enzymes are unable to cut at sites 
close to 5' or 3' ends. 
A recent investigation by M. Fuhrmann at Lonza (private 
commun.) has shown that there is no attenuation of the bioB 
transcript, contradicting Nath's earlier results. 
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Figure 4.4 Construction of a 5' 21 h.p. deletion (7 a.a., amino 
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Figure 4.5 Constuction of a 5', 63 h.p. bioB deletion mutant (21 
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4.2.2 Carboxy terminal deletions. 
Comparison of the biotin synthetase sequences shows that 
there is no significant homology at the carboxy terminus. To test 
the functional importance of this region the synthesis of two 
mutants was attempted. A 7 a.a. deletion using the unique bioB 
site SspI was constructed. However the attempted synthesis of a 31 
a.a. deletion using the unique BglI site was unsuccessful. 
4.2.2.1 	SspI-7 a.a.-carboxy-deletion. 
pIMSB was digested with SspI and the bioB containing 
fragment isolated and purified by gel electrophoresis as shown in 
figure 4.6. This fragment was then digested with EcoRI to provide 
a 5'-sticky end and a blunt 3'-end. The pIMS vector was prepared 
by digestion of pIMSB with Hindlil and then blunt ending with 
Kienow enzyme. This was then digested with EcoRI to give pIMS 
and bioB fragments. These were separated by electrophoresis and 
the pIMS fragment purified. The 5'-sticky, 3'-blunt bioB fragment 
was then ligated to the pIMS fragment. Ligation of these two 
fragments in this way provided the bioB gene with a stop codon at 
the 3'-end which had been lost by digestion with SspI. The 
pIMSB/SspI recombinant vector was analysed by its restriction 
fragment map. The isolated vector was sequenced to confirm the 
presence of the stop codon at the carboxy terminus. 
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Figure 4.6 Construction of 3' 21 b.p. bioB deletion mutant (7 a.a. 
carboxy terminal) using the SspI sit. 
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4.2.2.2 	Bgll-31a.a.-carboxy-terminal deletion. 
Plasmid pIMSB was digested with BglI and the bioB gene 
containing fragment was isolated as detailed in figure 4.7. 
Utilising the 3-5' exonuclease activity of T4 DNA polymerase, the 3' 
BglI overhang was digested to give a blunt end. This fragment was 
then ligated to the double-stranded XbaI linker TCTAGA to provide 
the bioB gene with a TAG stop codon which had been removed by 
digestion with BglI. The bioB fragment was then digested with 
EcoRI and XbaI. This fragment was ligated to the pIMS vector 
which had been digested with EcoRI and XbaI. Suspect 
recombinant vectors were isolated and analysed by their restriction 
digest map with BglI, and SspI. However, of 40 isolated suspects 
no BglI mutant vector was recovered. One possible reason for the 
failure of the synthesis could be that often the exonuclease activity 
of T4 DNA polymerase does not produce blunt-ended double-
stranded fragments. If this had occurred then the bioB gene 
fragment would not have the blunt end required for ligation to the 
XbaI linker. 
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Figure 4.7 Construction of 3', 93 b.p. (31 a.a., carboxy terminus) 
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4.2.3 Internal deletion mutants. 
There are two areas where the sequence identity between the 
enzymes from E. coli and Bacillus rises to more than 50%. There is 
a region near the N-terminal end of the proteins where there are 
three conserved cysteine residues (residues 54, 58 and 61). We 
have designated this area the CYS-BOX region. This CYS-BOX is 
flanked by two Alul restriction sites. The other region of high 
homology occurs within the middle of the primary sequence. This 
region is bounded by two unique enzymes NruI and RsaI. We used 
the above enzymes to delete these regions to test for their 
importance on structure and activity. 
4.2.3.1 	CYS-BOX AluI-Internal deletion. 
The two Alul sites within the bioB gene were used to create a 
34 b.p. deletion within the gene to remove the CYS-BOX region as 
detailed in figure 4.8. The constructed mutant produced a 
frameshift within the deletion disrupting the coding of the bioB 
gene so we could not analyse the consequences of this deletion in 
vivo. pIMSB was digested with EcoRI and PstI to remove the bioB 
gene. The bioB gene was then digested with Alul to produce three 
fragments. The reaction mixture was then used to ligate to the 
pIMS vector cut with EcoRI and PstI. Ligation of the two Alul sites 
together with the 34 b.p. missing produced a new, unique 
restriction site within the pIMSB construct. The recombinant Alul 
mutant was isolated by its digestion pattern with SstI. The 
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isolated pIMSB/AluI mutant was sequenced to the confirm the 
deletion. 
4.2.3.2 	RsaIINruI 31 a.a. Internal mutant 
A deletion mutant between residues 111-142 was constructed 
using two enzymes unique within the bioB gene as detailed in 
figure 4.9. pIMSB was digested with NruI to give two fragments 
of 1284 b.p. and 4349 b.p. The large fragment was isolated and 
then digested with PstI to give a 621 b.p. fragment containing the 
3'-end of the bioB gene. pIMSB was digested with PstI and Sail to 
give the bioB fragment. This fragment was then digested with RsaI 
to give a 867 h.p. fragment containing the 5'-end of the bioB gene. 
The bioB containing fragments were then ligated together with the 
pIMS vector digested with Sail and PstI. The recombinant deletion 
vector was selected by its digestion pattern with NruI, RsaI and 
PstI. 
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Figure 4.8 Construction of an internal 34 b.p. (CYS-BOX, 
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Figure 4.9 Construction of an in frame internal 93 b.p. (31 a.a.) 
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4.3 Analysis of bioB mutants. 
4.3.1 Protein product analysis by SDS-PAGE. 
The four mutant deletion constructs were analysed by SDS-
PAGE to ascertain whether the mutations introduced were 
expressed as soluble proteins. Each of the mutant plasmids were 
used to transform pCOi cells. This enabled us to study each of the 
mutant enzymes in a bioB background. Each of the cell lines was 
grown in minimal media and the mutant gene induced with IPTG 
and labelled with [35S]-methionine. The total cell extract was then 
analysed by SDS-PAGE and autoracliography (figure 4.10). 
It can be seen that both the Tth3I and the SspI deletions 
produce proteins with a faster mobility than wild-type biotin 
synthetase. The Tth3I mutant should code for an enzyme of 339 
a.a. (37718 Da). The SspI mutant should code for a protein of 339 
a.a. (37856Da). However no band could be seen for the RsaL'NruI 
(expected band 315 a.a., 35272Da) and Alul mutants. We expected 
the Alul deletion to produce no protein as the mutation introduced 
causes a frameshift causing early termination of the bioB gene 
product. However the RsaI/NruI mutant produced no protein 
either. It is not surprising because such a 31 a.a. deletion within 
the protein surely causes such disruption that the mutant protein 
produced is unstable and rapidly degraded. 
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Figure 4.10 35S-methionine labelling of mutant proteins. pCOi 
was transformed with mutant constructs. Mutant protein 
expression was induced with 0.1mM IPTG in the presence of 3 S-
methionine as described in Materials and Methods. 
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Mutant pIMSB pCOi constructs 
35S-Met Induction (0.1mM IPTG) 
WT Tth3l Rsal SspI 
- Ina . 
4- bioB 
4.3.2 In vitro activity. 
A cell-free extract of each of the mutant enzymes was 
prepared and analysed for its in vitro biotin synthetase activity 
using the [14C]-DTB assay. At the time the specific activity of the 
mutant proteins could not be determined compared with the wild-
type enzyme because we could not calculate the necessary kinetic 
data with this assay. 
Assay of the mutant proteins showed that the Tth3I and SspI 
mutants were able to convert [14C]-DTB to biotin. The RsaJiNruI 
and Alul mutants were not able to convert DTB to biotin. 
Summary. 
MUTANT Protein Activity 
Tth3I N-7a.a.  +  + 
Alu CYS-BOX  
RsaINruI 31a.a.  
SspI C-7a.a.  +  + 
4.4 Conclusions of biotin synthetase mutant 
experiments. 
A number of methodologies are available to identify key 
amino acids or structural motifs involved in enzymatic reactions 
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and to probe protein structure and function. One powerful method 
is to alter the primary stucture of proteins either by deleting 
regions of the protein or by introducing non wild type amino acid 
substitutions using site-directed mutagenesis. At the outset of this 
work such a study on biotin synthetase was not possible due to the 
lack of a sensitive assay, the lack of a method of purifying both 
wild-type and mutant proteins and with no knowledge of which of 
the 346 amino acids is involved in the catalytic reaction of the 
enzyme or which have an important structural role to play. By 
deleting small regions of the biotin synthetase bioB gene we altered 
the primary structure of the resultant protein with an aim to 
narrowing down regions of importance within the enzyme primary 
structure. 
By aligning the protein sequences of the two known biotin 
synthetase enzymes from Escherichia coli and Bacillus sphaericus 
we found that the biotin synthetases from the two species show 
32.7% identitity and 52.6% similarity over 335 a.a. We identified 
regions of homology between the primary structures of the two 
enzymes. We expected these conserved regions to be of significance 
to both protein structure and function. 
Six mutant gene syntheses were attempted to produce six 
protein deletion mutants. Four were successful. Two mutant 
enzymes were produced one lacking the seven N-terminal amino 
acids and another with a deletion of the seven a.a. at the carboxy 
end of the protein. Both these enzymes were found to convert DTB 
to biotin in a cell-free assay. This is not surprising as the N-
terminal and C-terminal ends of the two biotin synthetases showed 
no homology. An internal mutant was constructed but no protein 
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product was observed. This could be due to the resultant protein 
being unable to fold correctly or to be so unstable as to be degraded. 
Another mutant gene construct was synthesised but due to the 
introduction of a shift of reading frame no protein product was 
observed (CYS-BOX mutant). At first sight it seems that it was 
pointless to make such a deletion construct in the knowledge that it 
would not code for a protein product. However the creation of a 
unique restriction site in the bioB gene will enable insertion of 
double-stranded DNA oligomers coding for specific amino acids into 
this CYS-BOX region. This will enable studies to be carried out to 
analyse the exact role that the CYS-BOX region plays in biotin 
synthetase structure and function. 
At present we cannot conclude a great deal from the results 
of the mutant enzyme work with regard to biotin synthetase 
mechanism or structure. However future mechanistic studies with 
pure wild-type enzyme, aided with the cloning and sequencing of 
bioB genes from other bacterial species, should enable a more 
specific mutation of the enzyme primary structure (see Chapter 5). 
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CHAPTER FIVE 
BIOTIN SYNTIJETASE SEQUENCE HOMOLOGIES. 
5.1 Sequence alignment of Biotin synthetases. 
After the completion of the mutant enzyme synthesis the 
biotin synthetase gene from Saccharomyces cereuisiae was cloned 
and its DNA and protein sequence established (Zhang et al, 
unpublished, sequence obtained from database search, 1993). We 
carried out best-fit analysis with this protein sequence comparing it 
to the sequences from the E.coli and Bacillus proteins the results of 
which are shown in figures 5.1 and 5.2. The enzymes from E.coli 
and S.cereuisiae show 46.7% identity rising to 67.3% when 
conservative replacements are taken into account. Similarly the 
B.sphaericus and S.cerevisiae enzymes show 32.4% identity and 
54.5% overall similarity. 
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Gap Weight: 3.000 	Average Match: 0.540 
Length Weight: 0.100 Average Mismatch: -0.396 
Quality: 266.8 	Length: 344 
Ratio: 0.847 Gaps: 5 
Percent Similarity: 67.302 	Percent Identity: 46.667 
1 MAHRPRWTLSQVTEL ..... FEKPLLDLLFEAQQV ............... 30 
............ 
1 MPQLNRQLHPQKLVPGCSTICIVFRLTKSFVDKIAIKRNLSYPTARTYSCSHNCS 55 
31 HRQHFDPRQVQVSTLLSIKTGACPEDCKYCPQSSRYKTGLEAERLMEVEQ 80 
II. 	lI.Il::II:.II.I:I.IIIlII:IIl.III.II:::.I:: 
56 HRKWHDPTKVQLCTLMNIKSGGCSEDCKYCAQSSRNDTGLKAEKMVKVDE 105 
81 VLESARKA. KAAGSTRFCMGAAWKNPHER. . DMPYLEQMVQGVKANGLEA 127 
106 VIKRGRRGCKRNGSTRFCLGAAWRDMKGRI{SANKRIQEMVTKVNDMGLET 155 
128 CMTLGTLSESQAQRLANAGLDYYNHNLDTSPEFYGNIITTRTYQERLDTL 177 
156 CVTLGMVDQDQAKQLKDAGLTAYNHNIDTSREHYSKVITTRTYDDRLQT I 205 
178 EKVRDAGIKVCSGGIVGLGETVKDRAGLLLQLNLPTPPESVPINMLVKV 227 
206 KNVQESGIKACTGGILGLGESEDDHIGFIYTLSNMSPHPESLPINRLVAI 255 
228 KGTPLADN.. .... DDVDAFDFIRTIAVARIMMPTSYVRLSAGREQMNEQ 271 
256 KGTPMAEELADPKSKKLQFDEILRTIATARIVMPKAI IRLAAGRYTMKET 305 
272 TQANCFMAGANS IFYGCKLLTTPNPEEDKDLQLFRKLGLNPQQTAVLAGD 321 
306 EQFVCFMAGCNSIFTGKKNLTTIYNGWDEDKANLAKWGLQPMEAFKYDRS 355 
322 NEQQORLEQALMTPDTDEYYNAAAL 346 
Figure 5.1 Best-fit alignment of the biotin synthetases from (a) E.coli and (b) 
Saccharomyces cerevisiae. Vertical bars, colons, and dots between the aligned 
protein sequences represent identical, conserved and similar a.a. respectively. 
The a.a. are numbered from the first Met residue. 
159 
Gap Weight: 3.000 	Average Match: 0.540 
Length Weight: 0.100 Average Mismatch: -0.396 
Quality: 186.6 	Length: 357 
Ratio: 0.574 
Percent Similarity: 54.517 
aps: 9 
Percent Identity: 32.399 
(a)1 MNWLQLADEVIAGKVISDDEALAIL .... NSDDDDILKLMDGAFAI ........ 42 
(b) 1 MPQLNRQTHPQKLVPGCSTICIVFRLTKSFVDKIAIKRNLSYPTARTYSCSH 52 
43 .... RKHYYGKKVKLNNIMNAKSGYCPEDCGYCSQSSKSTAPIEKYPFIT 88 
................................ 53 NCSHRXWHDPTKVQLCTLMNIKSGGCSEDCKYCAQSSRNDTGLKAEKMVK 102 
89 KEEILAGAKRAFENKIGT . YCIVAS... . :GRGPTRKDVNVVSEAVEEIK 132 
103 VDEVIKRGRRGCKRNGSTRFCLGAAWRDMKGRKSANKRIQEMVTKVNDM. 151 
133 AKYGLKVCACLGLLKEEQAQQLKEAGVDRYNHNLNTSERHHSYITTTHTY 182 
152 ... GLETCVTLGMVDQDQAKQLKDAGLTAYNHNIDTSREHYSKVITTRTY 198 
183 EDRVNTVEVVKKHGISPCSGAIIGMKETKMDVVEIARALHQL. . DADSIP 230 
.1.: 
199 DDRLQTIKNVQESGIKACTGGILGLGESEDDHIGFIYTLSNMSPHPESLP 248 
231 VNFLHAIDGTKLEG ..... .TQDL.NPRYCLKVLALFRYMNPSKEIRISGG 274 
249 INRLVAIKGTPMAEELADPKSKKLQFDEILRTIATARIVMPKAI IRLAAG 298 
275 REVNLGFLQPFGLYAA.NSIFVG . DYLTTEGQEANSDYRNLEDLGFEIEL 322 
I. 	I..:I:IIII.I.III 
299 RYTMKETEQFVCFMAGCNS IFTGKKMLTTIYNGWDEDKANLAKWGLQPME 348 
323 TQKQEEAFCS 332 
349 AFKYDRS 355 
Figure 5.2 Best-fit alignment of the biotin synthetases from (a) B.sphaericus 
and (b) Saccharomyces cerevisiae. Vertical bars, colons, and dots between the 
aligned protein sequences represent identical, conserved and similar a.a. 
respectively. The a.a. are numbered from the first Met residue. 
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When the three biotin synthetase sequences are analysed by 
the multiple sequence alignment program of Pearson and Lipman 
the results show that the three enzymes can be aligned to give an 
overall identity of 21.1% covering 355 a.a. rising to 45.4% similarity 
using conservative replacements (figure 5.3). 
E .co MA--HRPRWTLSQ--------VTELF--EKPLLD-------LLFEAQQV--------HRQ 
B. sph MNWLQLADEVIAGKVI SDDEALAILNSDDDDILKLM- - - -DGAFAI------------RK 
S . c er MP- -QLNRQLHPQKLVPGC STICIVFRLTKSFVDKIAIKRNLSYPTARTYSCSHNCSHRJ( 
E . co HFDPRQVQVSTLLSIKTGACPEDCKYCPQSSRYKTGLEAERLMEVEQVLESARKA-KAAG 
B. sph HYYGKKVKLNNIMNAKSGYCPEDCGYCSQSSKSTAPIEKYPFITKEEILAGAKRAFENKI 
S . cer WHDPTKVQLCTLMNIKSGGCSEDCKYCAQSSRNDTGLKAEKMVKVDEVIKRGRRGCKRNG 
* 	* * * *** ** *** 
E . co STRFCMGAAWKNPHERD- -MPYLEQMVQGVKAM-GLEACMTLGTLSESQAQRLANAGLDY 
B. sph GT-YCIVASGRGPTRKDVNV--VSEAVEEIKAKYGLKVCACLGLLKEEQAQQLKEAGVDR 
S . cer STRFCLGAAWRDMKGRKSANKRIQEMVTKVNDM-GLETCVTLGMVDQDQAKQLKDAGLTA 
E . CO YNHNLDTSPEFYGNIITTRTYQERLDTLEKVRDAGIKVCSGGIVGLGETVKDRAGLLLQL 
B. sph YNHNLNTSERHHSYITTTHTYEDRVNTVEVVKKHGISPCSGAIIGMKETKMDVVEIARAL 
S . cer YNHNIDTSREHYSKVITTRTYDDRLQTIKNVQESGIKACTGGILGLGESEDDHIGFIYTL 
**** ** 	** ** * * 	* 	** * * * * * 	* 	* 
E. CO ANLPTPPESVPINMLVKVKGTPLAD --- NDDVDAFDF --- IRTIAVARIMNPTSYVRLSA 
B. sph HQLD- -ADSIPVNFLHAIDGTKLEG------TQDLNPRYCLKVLALFRYMNPSKEIRI SG 
S. cer SNNSPHPESLPINRLVAIKGTPMAEELADPKSKKLQFDEILRTIATARIVMPKAI IRLAA 
* 	• ** . 	 .. 	. • .* 	* • * 
E. CO GREQMNEQ'rQANCFMAGANS I FYGCKLLTTPNPEEDKDLQLFRKLGLNPQQTAVLAGDNE 
B. sph GREVNLGFLQPFGLYAA-NSIFVG-DYLTTEGQEANSDYRMLEDLGF ------------- 
S. cer GRYTMKETEQFVCFMAGCNS IFTGKKMLTTIYNGWDEDKANLAKWGLQPMEA-------- 
** 	* 	. *. **** * 	*** 	• * 	. . 	*• 
E. CO QQQRLEQALMTPDTDEYYNAAAL 346 
B.sph ----- EIELTQKQEEAFCS---- 332 
S.Cer -----------------FKYDRS 355 
Figure 5.3 Multiple sequence alignment of the biotin synthetases from 
Escherichia coli , Bacillus sphaericus and Saccharomyces cereuisiae. Dots and 
asterices represent conserved and identical residues respectively. 
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5.2 Swiss-Prot Database search. 
The complete biotin synthetase a.a. sequence was used as a 
probe in a FASTA alignment search of the Swissprot protein 
database. The full result is shown in the Appendix Al. Two 
proteins which show homology to biotin synthetase are the 
Acinetobacter 	calcoaceticus 	PQQIII gene product and the 
Azotobacter uinelandii ni/B gene product. 
5.3 Biotin synthetase, PQQIII homology. 
Pyrrolo-quinoline-quinone (PQQ) is used by a variety of 
organisms as cofactor in dehydrogenase reactions. In some 
bacterial species PQQ is synthesized constitutively, however the 
biosynthetic pathway has still to be elucidated. Goosen et al (1989) 
cloned a 5kb fragment from A.calcoaceticus which contains four 
genes required for PQQ synthesis. The third gene PQQIII coding 
for a 43,600 Da protein shows 19.3% identity in a 135 a.a overlap 
with biotin synthetase as shown in figure 5.4. The enzymatic 
function of the gene product has still to be elucidated. 
WZ 
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20 	30 	40 	50 	60 	70 
BioB LFEKPLLDLLFEAQQVHRQHFDPRQVQVSTLLSIKTGACPEDCKYCPQSSRYKTGLEAER 
II: 	I 	11:111::: 	I 
pqq3 	 MTEGVGLPLWLLAELTYRCPLQCPYCSNPLDYA - --QHKN 
10 	20 	30 
80 	90 	100 	110 	120 	130 
bioB LMEVEQVLESARKAKAAGSTRFCMGAAWKNPHERDMPYLEQMVQGVKAMGLEACMTLG- - 
pqq3 ELTTQEWFDVFDQARQMGAVQLGFSGG- -EPLVRQD- -LEQLVAHAHQQGFYTNLITSGM 
40 	50 	60 	 70 	 80 	90 
140 	150 	160 	 170 	180 	190 
bloB TLSESQAQRLANAGLDYYNHNLDTSPEFYGNII - -TTRTYQERLDTLEKVRDAGI}CVcsG 
pqq3 GLTEQRIADLKQAGLDHIQVSFQASDPVVNDALAGSKHAFEQKYEMCRLVKKYDYPMVLN 
100 	110 	120 	130 	140 	150 
Figure 5.4 Alignment from FASTA search of the E.coli biotin synthetase and 
the Acinetobacter calcoaceticus PQQIII gene product. 
5.4 Biotin synthetase, ni/B gene product homology. 
Joerger and Bishop (1988) cloned a 3.8 kb genomic fragment 
necessary for nitrogen fixation in Azotobacter vinelandii. The ni/B 
gene from A. vinelandii is thought to be involved in the synthesis of 
a Fe-Mo cofactor required for nitrogen fixation. The ni/B genes 
from K pneumoniae and B. japonicum are highly homolgous to the 
A. uinelandii gene product with the cysteine reisidues of the 
predicted proteins being absolutely conserved. The ni/B gene 
product shows 16.7% identity with biotin synthetase in an 138 a.a. 
overlap as shown in figure 5.5. 
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30 	40 	50 	60 	70 	80 
bioB DLLFEAQQVHRQHFDPRQVQVSTLLS I KTGAC PEDCKYCPQSSRYKTGLEAERLMEvEQv 
II 	:1:11:: 
ni fb ENIRAKVQNBPCYSEEAHHYFARMHVAVAPACNIQCHYCNRXYDCANESRPGVvsEvLTp 
	
40 	50 	60 	70 	80 	90 
90 	100 	110 	120 	130 	140 
bioB LESARKAKAAGSTRFCMGAAWKNPHERDMPYLEQMVQGVKANGLEAC-MTLGTLSESQAQ 
ni fb EQAVKKVKAVAAAI PQMSVLGIAGPGDPLANPKRTLDTFRNLSEQAPDMKLCVSTNGLAL 
100 	110 	120 	130 	140 	150 
150 	160 	170 	180 	190 
bioB RLANAGLDYYN-HNLDTSPEFYGNI ITTRTYQERLDTLEKVRDAGIKVCSGGIVGLGETV 
ni th PECVEELAKHNIDHVTITINCVDPEIGAKIYPDLLEQQAHPRRQGRKILIEQQQKGLEML 
160 	170 	180 	190 	200 	210 
Figure 5.5 Alignment from FASTA search of the E.coli biotin 
synthetase and the Azotobacter vinelandii nifB gene product. 
5.5 Biotin synthetase, Pyruvate-formate-lyase 
activating enzyme homology. 
One other protein which shows interesting homology to 
biotin synthetase is the pyruvate-formate-lyase activating enzyme 
from E.coli. Pyruvate formate lyase is the key enzyme of the 
glucose fermentation route in anaerobically growing E.coli. This 
enzyme converts pyruvate to acetyl-CoA. Pyruvate formate-lyase, a 
homodimer of 2x85kDa is post-translationally interconverted 
between active and inactive forms. The active form has been shown 
to carry an organic radical. The conversion is carried out by an Fe-
dependent converter enzyme (pyruvate-formate-lyase-activating 
enzyme, pfl act) which is a monomeric protein of 28kDa. The 
interconversion reaction requires S-adenosylmethionine and 
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reduced flavodoxin as cosubstrates to produce 5'-deoxy-adenosine. 
Rodel et al (1988) cloned and sequenced both the pyruvate-formate-
lyase and the activating enzyme. Best-fit analysis of biotin 
synthetase and the activiting enzyme found that the enzymes were 
16.2% identical as shown in figure 5.6. 
Gap Weight: 3.000 	Average Match: 0.540 
Length Weight: 0.100 Average Mismatch: -0.396 
Quality: 79.7 	Length: 318 
Ratio: 0.327 Gaps: 10 
Percent Similarity: 44.813 	Percent Identity: 16.183 
19 PLLDLLFEAQQVHRQHFDPRQVQVSTLLSIKTGACPEDCKYCPQSSRYKT 68 
................ I:: 	.: 	II.... 	:.j 
1 SVIGRIHSFESC. .GTVDGPGIRFITFF. . . .QGCLMRCLYCHNRDTWDT 44 
69 GLEAERLMEVEQVLESARKAKAAGSTRFCMGAAWKNPHERDMPYLEQMVQ 118 
......................
HFMNASGG 71 
119 GVKAMGLEACMTLGTLSESQAQRLANAGLDYYNHNLDTS PEFYGNI ITTR 168 
11.1111.: 	II::: 	.• 	..... I:: 	I: 
72 GVTASGGEAIL ........ QAEFVRDWFRACKKEGIHTCLDTNGFV... R 110 
169 TYQERLDTLEKVRDAGIKVCSGGIVGLGETVKDRAGLLLQLANLPTPPES 218 
111 RYDPVIDELLEVTD ........................ LVMLDLKQMNDE 136 
219 VPINMLVKVKGTPLADNDDVDAFDFIRTIAVARIMMPTSYVRLSAGREQM 268 
137 IHQNLV ......... GVSNHRTLEFAKYLANKNVKVWIRYV . VVPGWSDD 176 
269 NEQTQAMCFMAGANSIFYGCKLLTTPNPEEDKDLQL ... FRKLGLNPQQT 315 
............ 
177 DDSAHRLGEFTRDMGNVEKIELLPYHELGKHKWVANGEEYKLDGVKPPKK 226 
316 AVLAGDNEQQQRLEQALN 333 
227 ETMERVKGILEQYGHKVM 244 
Figure 5.6 Best-fit alignment of the (a) biotin synthetase and (b) 
pyruvate-formate-lyase activating protein (pfl act) from E.coli. 
Vertical bars, colons, and dots between the aligned protein 
sequences represent identical, conserved and similar a.a. 
respectively. The a.a. are numbered from the first Met residue. 
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The degree of homology between biotin synthetase and the 
PQQIII and nifB gene products and the pyruvate-formate-lyase 
activating enzyme is not enough to suppose an evolutionary 
relatedness, however it is worth noting that each enzyme is 
predicted to bind a metal ion. Work at Lonza has shown that biotin 
synthetase binds Fe 2 and DTB to biotin conversion is increased in 
a cell-free extract assay of biotin synthetase in the presence of 
Fe2 . Each of the protein products contain the CYS-BOX motif 
detailed below. It could that each of the proteins binds iron in a 
similar manner using the cysteine residues of this motif. 
5.6 Sulfur insertion enzyme homology. 
5.6.1 Biotin synthetase, lip protein homology. 
During our FASTA protein database search and best-fit 
analysis detailed above one of the most interesting amino acid 
motifs to become clear was near the amino terminus of the protein. 
Three cysteine residues are present within a sequence of eight a.a. 
with the following pattern:-CXXXCXXC. Ohsawa et al (1989) had 
previously highlighted the degree of conservation of cysteine 
residues between the E.coli and Bacilius proteins. Recently 
Hayden et al (1992) cloned and sequenced the lipA gene from 
E.coli. This gene codes for a protein of 281 a.a. (31,350 Da) which 
catalyses the insertion of one or more of the sulfur atoms into 
octanoic acid during the biosynthesis of lipoic acid. Hayden found 
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that the predicted lip protein and biotin synthetase from E.coli had 
significant sequence identity. We carried out a best-fit analysis 
between biotin synthetase and the lip gene product as shown in 
figure 5.6. The central region of the sequence (residues 141-201) 
makes up the largest stretch of similarity and is 36% identical with 
E.coli biotin synthetase. This region is also the site of highest 
identity between the biotin synthetase sequences of E.coli and 
Bacillus sphaericus. They also noted what they called the cysteine 
triad near the N-terminus, which is located at a constant distance 
from the central area of high identity. Hayden et al also point out 
that there are 92 amino acids separating Cys 61 and conserved 
His 153 in the lip protein, and the same spacing is observed for 
biotin synthetase sequences from both E.coli and Citrobacter 
freundii. The spacing between these two regions in the 
B.sphaericus biotin synthetase is 93 a.a. Hayden concluded that 
the overall degree of similarity between the lipA protein and biotin 
synthetase sequences (17% identity, 40% similarity, using 
conservative replacements according to FASTA alignment) is 
insufficient to support an hypothesis of evolutionary relatedness. 
Reed and Cronan (1993) have also recently cloned the lip gene 
predicting a larger protein (321 a.a., 36,061 Da) with a start codon 
40 codons upstream from Hayden's prediction. They also pick out 
the CYS-BOX motif and both groups note the motif may represent a 
metal-binding site. 
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Gap Weight: 3.000 	Average Match: 0.540 
Length Weight: 0.100 Average Mismatch: -0.396 
Quality: 103.5 	Length: 284 
Ratio: 0.378 Gaps: 	5 
Percent Similarity: 40.755 	Percent Identity: 15.849 
1 MAHRPRWTLSQVTELFEKPLLDLLFEAQQVHRQHFDPRQVQVSTLLSIKT 50 
5 LPADSTRIQGIKAANRKNGLHSV... CEEASC PNLAECFNHGTATFMILG 51 
51 GACPEDCKYCPQSSRYKTGLEAERLMEVEQVLESARKAKAAGSTRFCMGA 100 
52 AICTRRCPFCDVAHGRPVAPDANEPVKLAQTI ..... ADMALRYVVITSV 96 
101 AWKNPHERDMPYLEQMVQGVKANGLEACMTLGTLS ....... ESQAQRLA 143 
97 DRDDLRDGGAQHFADCITAIREKSPQ. . IKIETLVPDFRGRMDRALDILT 144 
144 NAGLDYYNHNLDTSPEFYGNIITTRTYQERLDTLEKVRDA. . GIKVCSGG 191 
................ 145 ATPPDVFNHNLENVPRIYRQVRPGADYNWSLKLLERFKEAHPEI PTKSGL 194 
192 IVGLGETVKDRAGLLLQLANLPTPPESVPINMLVKVKGTPLADNDDVDAF 241 
195 MVGLGETNEEIIEVMRDLRRHGVTMLTLGQYLQPSRHHLPVQRYVSPDEF 244 
242 DFIRTIAVARIMMPTSYVRLSAGREQMNEQTQAN 275 
245 DENKAEALAMGFTHAACGPFVRSSYHADLQAKGM 278 
Figure 5.7 Best-fit sequence alignment of the E.coli (a) biotin 
synthetase and (b) the lip gene product involved in lipoic acid 
biosynthesis. 
5.6.2 Biotin synthetase, thiH protein homology. 
One striking homology not detected by data-base searching 
was the homology between biotin synthetase and the thiH gene 
product from E.coli recently published by Vander Horn et al (1993). 
Vander Horn et al cloned and sequenced the thiCEFGH structural 
gene cluster for thiamine biosynthesis. Thiamine monophosphate 
is formed by the coupling of two precursors, 4-methyl-5-(b-
hydroxyethyl)thiazole monophosphate (THZ-P) and 4-amino-5- 
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hydroxymethyl-2-methylpyrimidine pyrophosphate (HMP-PP). 
THZ is synthesised from cysteine, tyrosine, and 1-deoxy-D-threo-2-
pentulose. The thiH gene is involved in the synthesis of THZ and 
encodes a protein of 377 a.a. containing a CYS-BOX motif. The 
CYS-BOX motif is 94 a.a. from a His residue which is consistent 
with the spacing found with the bioB and lip proteins. The overall 
identity is 21.2% and similarity is 40.9% as shown in figure 5.8. 
Gap Weight: 3.000 	Average Match: 0.540 
Length Weight: 0.100 Average Mismatch: -0.396 
Quality: 117.8 	Length: 368 
Ratio: 0.340 Gaps: 14 
Percent Similarity: 40.909 	Percent Identity: 21.212 
2 AHRPRWTLSQVTELFEKPLLDLLFEAQQVHRQHFDPRQVQVSTLLSIKTG 51 
I 	. 	:.I 	...:I 	..::.II 	.1 ........I. 	.:. 	.1. 
25 AADVERAL . NASQLTRDDMMALLS PAASGYLEQLAQRAQRLTRQRFGNTV 73 
52 A .......... CPEDCKYCPQSSRYKTGLEAERLMEVEQVLESARKAKAA 91 
74 SFYVPLYLSNLCANDCTYCGFSMSNR. . IKRKTLDEADIARESA. AIREM 120 
92 GSTRFCMGAAWKNPHERDMPYLEQMVQGVKAMGLEACMTLGTLSESQAQR 141 
121 GFEHLLLVTG . EHQAKVGMDYFRRHLPALREQFSSLQMEVQPLAETEYAE 169 
142 LANAGLDYYNHNLDTSPE . FYGNIITTRTYQE.. . RLDTLEKVRDAGI . K 186 
170 LKQLGLDGVMVYQETYHEATYARHHLKGKKQDFFWRLETPDRLGRAGIDK 219 
187 VCSGGIVGLGETVKDRA ..... GL.LLQLANLPTPPESVPINNLVKVKGTP 231 
II. 	..... 
220 IGLGALIGLSDNWRVDSYMVAEHLLWLQQHYWQSRYSVSFPRLRPCTGG. 268 
232 LADNDDVDAFDF IRTIAVARIMMP'PSYVRLSAGREQMNEQ'PQAMCFMAGA 281 
269 IEPASIMDERQLVQTICAFRLLAPEIELSLS .TRESPWFRDRVIPLAINN 317 
282 NSIFYGCKLLTTPNPEEDKDLQLFRKLGLNPQQ. . TAVLAGDNEQQQRLE 329 
318 VSAF. . SKTQPGGYADNHPELEQFSPHDDRRPEAVAAALTAQGLQPVW.. 363 
330 QALMTPDTDEYYNAAAL 346 
.1 	1.1.. 	I. 
364 ..... KDWDSYLGRASQR 376 
Figure 5.8 Best-fit analysis of the E.coli (a) biotin synthetase and 
(b) the thiH gene product involved in thiamine biosynthesis. 
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5.6.3 Sulfur insertion in biotin, 
lipoic acid and thiamine. 
No enzymatic activity has been associated with the thiH 
product as yet but it is interesting to hypothesise that a similar 
sulfur insertion mechanism could apply to biotin, lipoic acid and 
thiamine synthesis noting that cysteine can act as the sulfur donor 
for all of the products (White, 1982, DeMoll and Shive, 1985). It 
must also be noted that thiocystine is incorporated into biotin and 
thiamine (DeMoll and Shive, 1985). There will be differences in the 
sulfur insertion mechanism of each of the natural products due to 
the nature of the different substrates, cofactors and relative 
configuration of insertion of the sulfur atom(s) to give the above 
products but there now appears to be a link at the protein level of 
the sulfur insertion chemistry involved in the biosynthesis of biotin, 
lipoic acid and thiamine. 
5.7 CYS-BOX Sequence motif. 
By comparing the biotin synthetase sequence with known 
sequences it was possible to obtain proteins with similar motifs. 
One striking motif uncovered by this exercise was the identification 
of a so-called CYS-BOX motif. This motif has also been noted by 
Hayden et al., (1992) and Reed and Cronan, (1993). However our 
search has revealed a number of proteins containing the CYS-BOX 
motif found not only in the biotin synthetase and lip proteins but 
also found in proteins required for thiamine biosynthesis, nitrogen 
fixation, coenzyme PQQ biosynthesis and a protein which activates 
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pyruvate-formate lyase, an enzyme involved in acetyl-CoA 
biosynthesis. We have compared the CYS-BOX motifs at both the 
DNA and amino acid level as shown in figure 5.9. It is highly 
likely that this is a metal-binding site as the motif bears a high 
similarity to the metal-binding site of ferredoxin (Stubbe, 1991). 
Apart from the conserved cysteine residues the only other 
position highly conserved is before the third Cys. This position 
contains the aromatic residue Tyr or Phe. It is not possible at this 
stage to attach any structural or mechanistic importance to this 
residue. 
171 
E. coli 	bioB TGT CCG GAA GAT TGC AAA TAC TGC 
Rae bioB TGC CCA GAG GAT TGT GGC TAT TGC 
S.cerv 	bioB TGT TCT GAG GAC TGT AAG TAT TGT 
E. coli lip A TGT ACC CGC CGT TGT CCG 11C TGT 
E. coli 	thi H TGC GCT AAC GAC TGC ACG TAC TGT 
A. yin nif B TGC AAC ATC CAG TGC CAC TAC TGC 
A.cal 	PQQIH 	TGT CCG CTA CAA TGC CCA TAT TGC 
E.coli pfl act TGC CTG ATG CGC TGC CTG TAT TGT 
CONSENSUS TGT/ c XCX XXX G/4 TGC/ T XXX TAT/c TGC/ T 
E. coli 	bioB C 	P 	E 	D C K Y C 
Rae bioB C P E D C G Y C 
S.cerv 	bioB C 	S 	E 	D C K Y C 
E. coli lip A C T R R C P F C 
E.coli 	thiH C 	A 	N 	D C T Y C 
A.vin •nifB C N I Q C H Y C 
A.cal. 	PQQ III 	C 	P 	L 	Q C P Y C 
E.coli p17 act C L M R C L Y C 
CONSENSUS C 	-- 	 -- 	 -- C -- Y C 
E.colj - Escherichia coli 
Bac - Bacillus sphaericus 
A. yin - Azotobacter vinelandii 
A. cal - Acinetobacter calcoaceticus 
S.cerv - Saccharomyces cerevisiae 
bioB - Biotin synthetase B gene. 
lip A - Lipoic acid synthase A gene. 
thi H - Thiamine synthase H gene. 
nif B - Nitrogen fixation B gene. 
PQQIII - Pyrrolo-quinoline-quinone synthase gene M. 
p17 act - Pyruvate formate-lyase activating enzyme. 
Figure 5.9 CYS-BOX alignment. The DNA and a.a. sequences of 
proteins containing the CYS-BOX (CXXXCXXC) motif. 
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CHAPTER SIX 
CONCLUSIONS AND FUTURE WORK 
6.1.1 Initial in vivo experiments. 
The object of this study was to investigate the biosynthesis of biotin 
in Escherichia coli. The use of biotin as a biotechnological tool and as a 
food additive has led to an increase in demand and it is now desirable to 
produce the vitamin in large quantities by a fermentation process. 
However wild-type bacteria produce nanomolar amounts of biotin. A 
great deal of effort has been expended in trying to increase the amount of 
biotin produced mainly through genetic engineering of recombinant 
strains. 
In this thesis attention was focused on the final step in the 
biosynthetic pathway, namely the conversion of DTB to biotin. This 
conversion is catalysed by the enzyme biotin synthetase, the product of 
the bioB gene. The main aims of this study were to characterize this 
enzymatic reaction further both in vivo and in vitro, identify the 
substrates and cofactors involved and purify the protein components of the 
reaction. 
To facilitate this task the bioB gene was cloned and overexpressed 
in E.coli cells. The production of biotin in overproducing cells 
supplemented with DTB was evaluated. It was found that the rate and 
thus the amount of biotin produced in vivo is increased in such cells 
however this high rate of biotin synthesis decreases as cells grow from log 
to stationary phase. It was thought that this stalling of synthesis could be 
due to a depletion of substrates (in particular the intracellular sulfur 
donor). 
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Experiments were carried out which involved the addition of 
various suspect substrates and cofactors to analyse if they could reverse 
the stalling of biotin production. It was expected that the results of these 
experiments would aid in the identification of the substrates of the 
reaction in vitro. None of the possible sulfur substrates tested including 
cystine and methionine reversed or increased biotin production. The 
conclusions of these experiments coupled with results from other 
laboratories are that there is still a great deal not known about biotin 
biosynthesis not only at the final step i.e. DTB to biotin conversion but at 
previous steps in the pathway possibly involving biochemical steps not 
entirely devoted to biotin biosynthesis. 
6.1.2 In vitro / cell-free biotin biosynthesis. 
In conjunction with the in vivo experiments, work was undertaken 
to purify biotin synthetase from overproducing cells and identify the 
substrates required to reconstitute enzyme activity in vitro. This proved 
to be a difficult task. Following work carried out at Lonza AG, cell-free 
extracts of biotin synthetase overproducing cells were prepared which 
converted DTB to biotin. The rate of conversion was such that a 
radiometric assay using 14C-labelled DTB was used to assay biotin 
synthetase activity in cell-free extracts. With this assay in hand we 
determined various cofactors or inhibitors which increased or decreased 
the conversion of DTB to biotin. 
Various sulfur compounds were assayed in an attempt to identify 
the sulfur donor but no additive stood out. One result of note was that 
35S-Cystine was incorporated into DTB however we assume as with other 
workers that the sulfur donor of biotin is a cystine derivative (DeMoll and 
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Shive, 1983, White, 1982 and DeMoll et al., 1984). Two additives which 
stood out in their ability to increase DTB to biotin turnover were Fe 2 and 
MgATP. The exact role these play in the reaction is unclear but it is 
worth noting that biotin synthetase is known to bind iron (N. Shaw, 
private commun.) and that although the enzyme does not contain an ATP 
binding sequence, it does contain a CYS-BOX motif resembling an iron-
sulfur centre (see below). The boosting of DTB to biotin conversion by 
these cofactors will aid in the identification of further substrates. 
6.2 Attempts at purification of biotin synthetase. 
The preparation of a cell-free extract capable of converting DTB to 
biotin enabled us to proceed with attempts to purify the protein 
components of the reaction. Initial salt fractionation led to the loss of 
activity of biotin synthetase containing fractions. The activity could only 
be recovered by the addition of other protein-containing and low molecular 
weight-containing fractions. Any attempt to purify the enzyme from 
cellular wild-type proteins by standard chromatographic techniques led to 
the loss of activity even in the presence of MgATP, Fe 2 and DTB. An 
add-back system was developed where various protein and low molecular 
components had to be combined to recover the activity of biotin-containing 
protein fractions. 
The results from these experiments and from the work of others 
(Ifuku et al., 1992) have led to the conclusion that at least one other 
protein and possibly more apart from biotin synthetase are required for 
DTB to biotin conversion in vitro. 
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6.3 Mutagenesis of biotin synthetase and bioB homologies. 
To gain insight into the residues required for structure and/or 
function we deleted regions of the bioB gene. The protein sequences of 
two known biotin synthetases, E.coli and Bacillus sphaericus, were 
aligned and regions to be deleted were chosen between regions of high and 
low identity between the two enzymes. Of the four mutant genes 
synthesised, two were able to convert DTB to biotin in a cell-free assay. 
One of these active deletion mutants had the 7 a.a at the N-terminal 
removed whereas the other had the 7 a.a at the C-terminus removed. This 
was not surprising as these regions show no identity between the two 
enzymes. Two other gene deletion products were inactive. One gene 
which had its internal core (a region of high identity) removed produced 
no protein whereas another resulted in a frameshift mutation which was 
also produced no protein product. 
The recent addition of the predicted biotin synthetase sequence 
from S. cerevisiae to the protein sequence databases has enabled us to 
compare the three sequences with an overall sequence identity of 21.1% 
covering 355 a.a. This alignment will enable a rational strategy to mutate 
individual conserved residues and assay for their effect on DTB to biotin 
conversion. 
Stemming from this work we found other proteins in the protein 
sequence databases which showed homology to the biotin synthetase from 
E.coli. Proteins involved in the biosynthesis of lipoic acid, thiamine, 
coenzyme PQQ, acetyl-CoA and nitrogen fixation show similarity to biotin 
synthetase. I have picked out a new motif common to these proteins 
termed a CYS-BOX motif (CXXXCXXC) which resmbles an iron-sulfur 
cluster binding motif. This motif had previously been identified by 
177 
Ohsawa et al., (1989), Hayden et al., (1992) and Reed and Cronan, (1993) 
in the biotin synthetase and lip protein product but not in all of the above 
proteins. Work in the future could elucidate whether this motif does 
indeed bind iron and determine what role it plays in biotin synthetase 
with respect to structure and catalytic function. 
One of the most interesting findings was that the biotin synthetase 
enzyme shared homology with the lip gene product from E.coli. This 
result has also been found by Hayden et al., (1992). The lip gene product 
is involved in the incorporation of sulfur into octanoic acid to yield lipoic 
acid. The lip protein also has a CYS-BOX motif but both Hayden et al., 
(1992) and Reed and Cronan (1993) are still unsure as to the precise 
function of the lip protein. 
Another similarity which was not discovered as the result of a 
database search was the high sequence identity between biotin synthetase 
and the thiH gene product from E.coli (Vander Horn et al., 1993). Vander 
Horn found no proteins with a high degree of similarity to the thiH 
product in a search of the databases. The thiH gene product is involved in 
thiamine biosynthesis in a yet unspecified reaction (Begley, personal 
communication). However I have noted that the thiH protein contains a 
CYS-BOX motif and shows high identity to biotin synthetase. It is now 
tempting to postulate that the mechanism of sulfur insertion into biotin, 
lipoic acid and thiamine occurs through a similar, if not identical 
pathway. Evidence is accumulating from feeding studies which show that 
the above compounds are more than likely synthesised using a similar 
sulfur source and we now have results from protein studies which lend 
support to the idea that there are similarities between the sulfur 
incorporation enzymes of these stucturally and functionally diverse 
natural products. 
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6.4 Future work. 
Future investigations on biotin synthetase and biotin biosynthesis 
will continue to focus on the identification of the exact nature of the sulfur 
donor and other cofactors involved. These findings, in conjunction with 
the identification of the other protein(s) involved in DTB to biotin 
conversion will, in turn, lead to an in vitro biotin synthetase assay. Such 
an assay will then allow a complete kinetic and mechanistic study of the 
enzyme, aided by the synthesis and characterization of mutant enzymes. 
A similar analysis is also ongoing in research into the thiamine and lipoic 
acid sulfur insertion reactions, the results of which will enable us to 
ascertain whether a common pathway is involved in each of the reactions. 
It is interesting to speculate on the nature of the possible 
interaction of biotin synthetase with Fe 2 . It could be that the enzyme is 
a member of the class of non-heme iron proteins, or an enzyme in the 
ferredoxin class, as the CYS-BOX motif closely resembles that found in 
iron-sulfur. clusters (e.g. Stubbe, 1991). This thesis has not dwelt upon 
the possible mechanism of the reaction and whether the reaction can be 
included in the growing band of enzymes catalysing reactions by a radical 
process (e.g. Stubbe, 1988). Too many factors are still unknown at this 
stage and only when all the enzymes and substrates involved are 
identified can a thorough mechanistic analysis of the insertion of sulfur 
into DTB to form biotin begin. 
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M, UDINININ 
Al Fasta search. 
The complete biotin synthetase protein sequence was used to search 
the Swiss-Prot protein sequence databases according to Pearson and 
Lipman, 1988. 
FASTA SEARCH 
The best scores are: 
sw:biob_ecoli P12996 escherichia coli. biotin synthetase 
sw:biob_bacsh P19206 bacillus sphaericus. biotin synthet 
sw:nifb_azovi P11067 azotobacter vinelandii. nifb protei 
sw:fas_rat P12785 rattus norvegicus (rat). fatty acid sy 
sw:rafa_ecoli P16551 escherichia ccli. alpha-galactosida 
sw:asal_entfa P17953 enterococcus faecalis (streptococcu 
sw:pqq3_acica P07782 acinetobacter calcoaceticus. coenzy 
sw:71es_drome P13368 drosophila melanogaster (fruit fly) 
sw:b3a3_mouse P16283 mus musculus (mouse). neuronal band 
sw:b3a3_rat P23348 rattus norvegicus (rat). neuronal ban 
sw:mpri_human P11717 homo sapiens (human). cation-indepe 
sw:prts_serma P09489 serratia marcescens. extracellula 
sw:ha2d_pig P15981 sus scrofa (pig). sla class ii histoc 
sw:ccgl_human P21675 homo sapiens (human). cell cycle ge 
sw:rrpl_mease P12576 measles virus (strain edmonston). r 
sw:pt2l_lacca P24400 lactobacillus casei. phosphotransfe 
sw:pzp...human P20742 homo sapiens (human) . pregnancy zone 
sw:cins_rat P15390 rattus norvegicus (rat). sodium chann 
sw:evil_mouse P14404 mus musculus (mouse). ecotropic vir 
sw:pol_mlvak P03357 akr murine leukemia virus. p01 polyp 
sw:pol_mlvrd P11227 radiation murine leukemia virus. p01 
sw:pol_mlvav P03356 akv murine leukemia virus. p01 polyp 
sw:tcpl...yeast P12612 saccharomyces cerevisiae (bakers y 
sw:lain2_xenla P21910 xenopus laevis (african clawed frog 
sw:ntrb_klepn P06218 klebsiella pneumoniae. nitrogen reg 
sw:polg....yefv2 P19901 yellow fever virus (strain pasteur 
sw:mdr_leita P21441 leishxnania tarentolae. multidrug res 
sw:polg.yefvl P03314 yellow fever virus (strain 17d). ge 
sw:ntrb_ecoli P06712 escherichia ccli. nitrogen regulati 
sw:ulaS_hcmva P16736 human cytomegalovirus (strain ad169 
sw:nep_human P08473 homo sapiens (human). neutral endope 
sw:a2mgrat P06238 rattus norvegicus (rat). alpha-2-macr 
sw:polg_hrvlb P12916 human rhinovirus lb (hrv-lb). genom 
sw:polg_tvmv P09814 genome polyprotein (34 kd protein; h 
sw:yp23_staau P23217 staphylococcus aureus. hypothetical 
sw:rirl...human P23921 homo sapiens (human). ribonucleosid 
sw:a2mg_human P01023 homo sapiens (human). alpha-2-macro 
sw:gchl_rat P22288 rattus norvegicus (rat). gtp cyclohyd 
sw:rrppi3h4 P12577 human parainfluenza 3 virus (strain 
sw:teto_strmu P20174 streptococcus mutans. tetracycline 
A2 BLASTA SEARCH 
The complete biotin synthetase protein sequence was used to search 
the Bethesda protein sequence database in a Blasta sequence search of 
the Swiss-Prot and EMBL databases according to Pearson and Lipman, 
P 'ASi• 
Sequences producing High-scoring Segment Pairs: 
gb1J04423 IECOBIO E.coli 7, 8-diainino-pelargonic aci.. 
gbIX72701ISCBI02GNA S.cerevisiae gene for biotin synt.. 
gbIX63612ISCZU01 S.cerevisiae ZUOl gene for zuotin.. 
gbIM27867IM27867 Figure 2. Nucleotide sequence of 
gblM29292 I BACBIODAYB B. sphaericus b10DAYB operon genes. 
gb1M277311M27731 Figure 6. A part of the DNA seque.. 
gb1M23640 ISMAEXPH Serratia liquefaciens extracellul.. 
gbIM28800IHUMTCGDCF Human T-cell receptor trans-rearr.. 
gbIM94448IERWGAP Erwinia herbicola gluconic acid p.. 
gbIJ03955INEUVMA1A N.crassa vacuolar ATPase 67-kd su.. 
gbIX58778IKPPQQAF K.pneumoniae pqqABCDEF genes, inv.. 
gbIX61392IZMFERRI2 Maize mRNA for ferritin (clone FM.. 
gbIX62880ISSCRCRNA S.scrofa mRNA for calcium release.. 
gbIJ05200IHUMRYR Human ryanodine receptor ritRNA, co.. 
gbIM91451IPIGRYRN.H Sus scrofa ryanodine receptor CRY.. 
gbIM91452IPIGRYRN Sus scrofa ryanodine receptor (RY.. 
gbID10879IHS1ULR Herpes simplex virus type 1 long 
gbIX14112IHE1CG Herpes simplex virus (HSV) type 1 
gbIY00850IMMKR2 Murine mRNA for multifinger prote.. 
gb1M97217 IAFAACOSYN Alcaligenes eutrophus acetyl-coen.. 
gbIX53022IPFPPFK14 P.falciparum DNA for erythrocyte 
gblX07013 IFDCPCBA4 Fremyella diplosiphon constitutiv. 
gbIM33190IRATCYP2A3A Rat cytochrome P450 II A3 	(CYP2A3.. 
gblX53389 IMFIAHCC M. fascicularis germline imxnunogl.. 
emblS99993 1S99993 lip=lipoate biosynthesis [Escheri.. 
gbIM82805IECOLIP Escherichia coli lipoic acid synt.. 
gbl S5464l I S54641 HZF-16=Kruppel-related zinc finge.. 
gbIX53705IMFIGACR M. fascicularis immunoglobulin alp.. 
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Synthesis and Biological Activity of 9-Mercaptodethiobiotin--a Putative Biotin 
Precursor in Escherichia co/i 
Robert L. Baxter,' Dominic J. Camp,' Andrew Coutts 8 and Nicholas Sha w b 
Department of Chemistry, University of Edinburgh. West Mains Road, Edinburgh, EH9 3JJ, UK 
b Lonza A.G., CH-3930 Visp, Switzerland 
A total synthesis of (±)-9-mercaptodethiobiotin  3 via the aldehyde 9 is described. Compound (±)-
3 does not function as a biotin replacement factor for an E. coil mutant (SA291) lacking the entire 
biotin synthesis operon (b10ABFCD) but supports growth of an E. coil bioA mutant. Compound 
(±)-3 also supports growth of transformed cells of SA291 carrying a plasmid encoding the E. coil 
biotin synthase (bioB) gene indicating that the compound may be able to substitute for 
dethiobiotin 2 as a substrate for biotin synthase. 
The coenzyme biotin 1 is a commercially important vitamin 
which is produced only in minute amounts from biological 
sources. The mechanistic aspects of the role of biotin as the 
carrier of carbon dioxide in enzymatic carboxylation and 
transcarboxylation reactions continues to be the subject of 
investigation.' Perhaps the most interesting step in the pathway 
of biotin biosynthesis is the final step which involves the 
introduction of sulfur between C-6 and C-9 of the dethiobiotin 
skeleton 2. Parry' has shown that the substitution of sulfur at 
C-6 involves loss of the pro-S hydrogen, resulting in retention 
of configuration at this position. In contrast, insertion of sulfur 
at the C-9 position of 2 appears to involve racemisation of the 
ethyl group hydrogens.' In E. coli and Bacillus sphaericus the 
ulfur insertion reaction is apparently catalysed by a single 
nzyme, biotin synthase, which is encoded by the bioB gene of 
he biotin operon.45 While the identity of the cellular sulfur 
onor is at present unknown it can be envisaged that the 
eaction catalysed by biotin synthase proceeds by one of three 
utually exclusive pathways—involving either (a) the inter-
mediacy of the primary thiol 3; (b) the intermediacy of the 
secondary thio 4; or (c) a 'concerted' reaction in which no 
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Scheme I  
Marquet and her co-workers have reported a synthesis of the 
methyl ester of the primary thiol 3 from a chiral starting 
material and have cited preliminary evidence for the incor-
poration of 3 into biotin by cells of B. sphaericus. 6 In this 
paper we describe the synthesis of (±)-3 using a different 
approach and evidence from studies with bio mutants and 
transformed strains of E. coli which support a precursorial 
role for 3. 
Synthesis of the disulfide dimer of (± )-9-mercaptodethio-
biotin, 3a, was carried out as outlined in Scheme 2. Synthesis 
of the key intermediate aldehyde 9 was achieved in a 
straightforward manner by a refinement of the route used by 
Zavylov.' Thus condensation of (± )-tartaric acid and urea 
afforded the carboxylic acid 5 which was decarboxylated, by 
treatment with K 2CO 3 , to give imidazolin-2-one 6.8  Acylation 
of 6 with ethyl 5-chioroformylpentanoate in the presence of 
AId 3 afforded the ketone 7 which was reduced with NaBH 4 
to give an epimeric mixture of the corresponding allylic 
alcohols 8. Condensation of 8 with paraformaldehyde and 
piperidine gave a Mannich base adduct which was hydrolysed 
with aqueous acetic acid to afford 9. 
To render the double bond of the imidazolinone ring 
susceptible to catalytic hydrogenation, the aldehyde 9 was 
acetylated to give the IV,N'-diacetylated product 10. In an 
earlier study of the synthesis of(±)-9-hydroxydethiobiotin 11, 
Frappier et al.9 have shown that catalytic reduction of II over 
10% palladium on charcoal in dioxane affords a 60:40 mixture 
of the cis- and trans-9-oxo-NN'-diacetyl derivatives, 12 and 
13, presumably due to epimerisation of the C-8 centre after 
reduction. To circumvent the epimerisation at the C-8 centre, 
which was a major drawback in the earlier synthesis, we carried 
out the reduction under conditions where hydrogenolysis of 
the aldehyde function was slightly favoured over reduction of 
the imidazolinone double bond. Thus hydrogenation of 10 over 
pre-reduced Adam's catalyst in glacial acetic acid gave ethyl 
(±)- !V,:V' -diacetyl-9-hydroxydethiobiotin 12 as the major 
product accompanied by minor amounts of the easily separated 
N,N'-diacetyl derivatives 14 and 15. The observation of a 10.1 
Hz coupling between 7-I-f and 8-H in the 'H NMR of 12 
confirmed the cis configuration at the 7 and 8 positions. Under 
these conditions no significant amounts of products with trans-
configuration at the 7 and 8 position were detected. Our initial 
approach to the introduction of the C-9 thiol function involved 
tosylation of the alcohol 12 to give the ester 16, followed by 
substitution of the tosyl group with the anion of toluene-2-
thiol.' ° However, the latter reaction afforded a plethora of 
products. Displacement of the tosyl group could, however, be 
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Scheme 2 i, K 2CO 3 ; ii, a.co(cH 2 )4c02 Et, Aid 3, C6 H 5NO2 ; iii, 
NaBH 4. MeOH; iv, (HCHO),, piperidine, MeOH; v, HOAc; vi, Ac 20; 
vii, H, Pt0 2, HOAC; viii, Tosyl Cl, pyr, ix, KSCOCH 3, DMF; x, 
NaOH, MeOH 
achieved cleanly using sodium thioacetate to afford the 9-thio-
acetyl derivative 17 in 82% yield. Hydrolysis of 17 in aqueous 
alkali, followed by purification of the product by cation 
exchange chromatography afforded the dimer 3a. Confirmation 
of the identity of the product was evinced from mass 
spectrometry [m/z 491.1998; C20H35N406S 2 , (M + l)] and 
the appearance of a methylene resonance at 43.0 ppm in the ' 3C 
NMR spectrum indicative of a disulfide methylene carbon." 
Desulfurisation of 3a with Raney nickel afforded (±)-
dethiobiotin 2 confirming the relative stereochemistry at the 
C-7 and C-8 positions. 
Reduction of 3a to the primary thiol 3 could be achieved by 
treatment with dithiothreitol (DTT) in water. In the ' 3C NMR 
DEPT spectrum the methylene resonance at 43.0 ppm was 
replaced by a peak at 26.2 ppm indicative of a CH 2SH 
function." However, it was not possible to isolate the 
• In biological experiments 3a was administered to cells in 5 mmol 
dm- ' DTT. i.e. principally as the monomer 3. In the reducing 
environment of the cytosol (see, for example. B. Alberts, D. Bray. J. 
Lewis, M. RaIL K. Roberts and J. D. Watson in Molecular Biology of 
the Cell. 2nd edn., 1989, Garland, London, p. 445) we would expect 
the monomeric form to be predominant. 
t Details of the construction of plasmids containing the biotin synthase 
(bioB) gene and the bioABFCD gene cluster will be described elsewhere. 
monomeric thiol in a pure form; attempts to separate the 
monomeric and dimeric forms from the reducing agent, even 
in degassed solvents, gave mixtures of 3 and 3 a.* 
Evidence for the jossible role of ( ± )-9-mercaptodethiobiotin 
3 as an intermediate in biotin formation in E. coil is suggested 
by growth experiments on bio-mutants. Even at very high 
concentrations (>1 mmol drir 3) the thio does not support 
growth ofSA29l, a b1oABFCD deletion mutant which lacks all 
of the biotin synthesis genes and requires biotin for growth, 4° 
indicating that the compound itself does not substitute for 
biotin as a coenzyme. However, at concentrations above 4 imol 
dnr3 it supports normal growth of an E. co/i, bioA mutant 
(strain 6435), which lacks functional 7,8-diaminopelargonate 
synthase activity and thus requires 7,8-diaminopel argon ate, 
dethiobiotin or biotin for growth. At this concentration (±)-3 
also supported growth of cells of the b1oABFCD deletion 
strain SA291 transformed with a pKK223 derived plasmidt 
carrying a functional E. co/i biotin synthase gene under control 
of a tac promoter (pKbioB) and which is thus able to grow 
in dethiobiotin supplemented minimal medium. 
While this evidence suggests that the primary thiol 3 may 
act as a biosynthetic intermediate between dethiobiotin 2 and 
biotin I in E. co/lit should be noted that it is also consistent 
with an alternative hypothesis that 3 could merely act as an 
abnormal precursor of dethiobiotin in vivo. That is, that 3 
could be catabolised by an, as yet, uncharacterised desulfuris-
ation process to give sufficient dethiobiotin for growth of biotin 
synthase competent cells. 
Further studies on the mechanism of the conversion of 2 
into I are underway. 
Experimental 
NMR spectra were recorded on Bruker WP80, WP200 and 
WM360 spectrometers: J values in Hz. Mass spectra were 
measured using a Kratos ZAB spectrometer. IR spectra were 
recorded on a Perkin-Elmer X98 spectrophotometer. M.p.s 
were determined on a Reichert hot-stage apparatus and are 
uncorrected. 
4-(5-Elhoxvcarbon;1-l-oxora/er,I)irnida:o/in-2.one 	7.—A 
ground mixture of (±)-tartaric  acid (42 g) and urea (13 g) 
was slowly added to stirred conc. H 2 SO4 (100 cm') the rate 
being adjusted so that the temperature did not exceed 65 C 
without external cooling. The resultant mixture was heated at 
80 C for 1 h, cooled to 20 C  and poured on crushed ice (1 kg). 
The resulting precipitate was filtered off and washed with water 
(0.5 dm 3 ) and acetone (100 CM 3) to afford 4-carbox,in;ida:oiin-
2-one 5 (19 g, 53%). m.p. 226-230 C (lit.,' 232-235 C); 
6,(( 2 HJDMSO) 9.8 (3 H. br s) and 7.15 (I H. s): 
v,,(Nujol)/cnr' 3200. 1759, 1670 and 1600. A solution of 
compound 5 (27 g) in aq. K,CO 3 (0.7 mol dm-1; 300 cm') was 
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heated at reflux for 4 h, charcoal (I g) added, and the solution 
refluxed for a further 0.5 h. The hot solution was filtered, 
vaporated under reduced pressure to Ca. 80 cm 3 and the 
iLesultant precipitate washed with acetone (30 cm 3 ) and ether (20 
cm  x 2) to give in?ida:olin-2-one 6 (14 g, 75%), m.p. 238-
240 °C (lit., 8 240-241 SC); 6H[2Hb]DMSO)  9.71 (2 H, br s) and 
6.23 (2 H, br s); '.. 3 (Nujol)/cm 3120, 1604 and 1575. 
Powdered AId 3 (72 g) was added over I h to a stirred, cooled 
solution of compound 6 (13 g) in nitrobenzene (130 cm 3) at 
10 °C. The solution was stirred for a further 0.5 h and ethyl 5-
chloroformylpentanoate' (35 g) slowly added. The stirred 
solution was heated at 65 °C for 4 h, poured into ice-1 mol dm 3 
aq. Na 2CO 3 (1:1; 600 cm 3), mixed with ether (500 cm 3) and 
filtered. The precipitate was dissolved in hot water (20 cm 3 ), 
treated with charcoal (0.1 g), filtered and cooled to afford 7(15.2 
g, 43%) as colourless needles, m.p. 236-240'C (lit.,' 239-
242 °C); 6H([2H6)DMSO)  10.39 (2 H, br s, NH), 7.59 (1 H, s, 5-
H), 4.04(2 H, q, J 7.0, OCH2CH 3), 2.64 (2 H, br t, J 7, =CCH 2J, 
2.37 (2 H, br t, J 7, CH 2CO 2 Et), 1.53 (4 H, m, CH 2CH 2 ), and 
1.17 (3 H, t, J 7.0, CH 2 CH3 ). 
Ethyl 9-Oxo-7,8-didehydrodethiobiotin 9.—Powdered NaBH 4 
(2.7 g) was slowly added to a stirred methanolic solution of 
compound 7 (12 g, 250 cm 3 ) over 5 min and the solution was 
stirred at room temperature for 2.5 h, filtered, and evaporated 
to dryness. The residue was washed successively with water (20 
cm 3), acetone (20cm 3) and ether (20 cm') and crystallised from 
EtOAc-EtOH to afford a mixture of the 6R and 6S alcohols 8 
(7.5 g, 62%), m.p. 170-173 °C. The mixture of alcohols was 
dissolved in MeOH (120 cm -1 ) and paraformaldehyde (1.1 g) 
and piperidine (3.1 CM  3) were added; the mixture was then 
heated at reflux for 8 h. Removal of MeOH and piperidine 
under reduced pressure afforded the crude product as a brown 
solid (7.2 g) which was dissolved in glacial HOAc (80 cm') 
and heated at 60 °C for 10 h. Evaporation of the solvent gave 
an oil which was separated by flash column chromatography on 
Si02 using EtOAc followed by crystallisation from EtOAc to 
give 9 (2.5 g, 46%), m.p. 143-145 ec (lit., 145-146 °C); 
6H(CDCI 3 ) 11.57, 9.87 (2 H, br s, NH), 9.43 (1 H, s, CHO), 4.10 
(2 H, q, J 7.0, CH2 CH 3), 2.77 (2 H, t, J 7.0, 6-H), 2.28 (2 H, t, J 
7.0, 2-H), 1.49 (6 H, m, CH 2 CH 2CH 2), 1.22 (3 H, t, J 7.0, 
CH 2CH3 ); v 3 (Nujol)/cm•' 1730, 1710 and 1668. 
Ethyl (± )-N,N'-Diacetyl-9-hydroxydeihiobios'in 12.—.A sol-
ution of compound 9 (10 g) in Ac0 2 (100 CM 3) was heated at 
reflux for 1 h and evaporated under reduced pressure to afford 
an oil which was fractionated by flash column chromatography 
on Si0 2, using EtOAc-hexanes (2:3) as eluent, to give the 
N,N'-diacetyl derivative 10 (11.5 g, 86%) as a colourless oil; 
6H(CDCI 3 ) 10.13 (1 H, s, CHO), 4.22 (2 H, q, J 7.0, CH2CH 3 ), 
3.28 (2 H, t, J 7.0, 6-H), 2.65 (6 H, s, NCOCH3 ), 2.40 (2 H, t, J 
7.0, 2-H), 1.7 (6 H, m, CH,CH 2 CH 2 ) and 1.31 (3 H, t, J 7.0, 
CH2CH3 ); vmaz(film)/cm' 1825, 1735 and 1690. 
A stirred suspension of Pt0 2 (1.5 g) in glacial HOAc (10 cm 3) 
was pre-reduced with H 2 at ambient pressure for 1.5 h and a 
solution of 10 (2.3 g) in HOAc added. After 3 h the catalyst was 
filtered off and washed with HOAc (6cm 3) and the filtrate and 
washings were evaporated under reduced pressure to afford an 
oil. This was fractionated by flash column chromatography on 
Si02 , using 10-100% EtOAc-hexanes to afford the products 14 
(0.4 g, 17%) 9 15 (0.24 g, 11%) and 12 (0.9 g, 40%) as colourless 
oils. Ethyl NN'-diacetyldidehydrodethjobiotin 14; 6 H(CDCI 3 ) 
3.95 (2 H, q, J 7.0, CH2 CH 3 ), 2.55 (2 H, m, 6-H), 2.46 (6 H. s, 
NCOCH 3), 2.16 (2 H, br t, J 7, 2-H), 1.6-1.3 (6 H, br m, 
CH2CH 2CH 2) and 1.09 (3 H, t, J 7.0, CH 2CH3 ): öC(CDCI 3 , 
DEFT) 60.06, 42.35, 33.76, 26.17, 25.51, 24.42, 24.10, 23.60, 
14.01 and 11.99; vma (film)/cm' 1750, 1735 and 1705. 
Ethyl (± )-N,N'-diacetyldethiobiotin 15; 6 H(CDCI 3) 4.23 
(2 H, m, 7, 8-H), 3.95 (2 H, q, J 7.0, CH,CH 3 ), 2.37, 2.36 (6 H. 
2 s, NCOCH 3 ), 2.16(2 H, br I. J 7, 6-H) and 1.8-1.1 (11 H, m); 
6c(CDCI 3 , DEFT) 54.62, 51.16, 50.29, 33.58, 28.74, 26.71, 
25.09, 24.98, 24.77, 24.38 and 13.49; v ma (film)/cm 1755, 1735 
and 1695. 
Ethyl (±)-N,N'-diacetyl-9-hydroxdethiobiotin 12; 
(CDCI 3 ) 4.21 (I H, dt, J 10.0, 5.1, 8-H),'3.98  (5 H, m), 3.12(2 H, 
t, J 5.1, 9-H), 2.42 (2 H, m, 6-H), 2.36, 2.32 (6 H, 2 s, NCOCH 3 ), 
2.13(2 H, br t, J 7,2-H), 1.4-1.2(6 H, m) and 1.17(3 H, t, J 7.0, 
CH2 CH3 ); vm (film)/cm' 3440, 1750, 1735 and 1695. 
Ethyl (± )-N,N'-Diacet;'l-9-zhioacety/det/iiobioi'jn 17.—A 
solution of tosyl chloride (0.87 g) in dry pyridine (3 cm 3) was 
slowly added to a stirred solution of'compound 12 (0.4 g) in 
pyridine (5 cm 3) at -5 °C over S mm. Solid diaminopyridine (1 
mg) was added and the mixture allowed to come to room 
temperature; it was then stirred for a further 72 h. The mixture 
was poured on crushed ice (20 cm 3 ), I mol dm 3 aq. HC1 added 
(5 cm 3) and the whole extracted with ether (20 cm -' x 4). The 
ethereal extract was washed with water (20 cm'), dried 
(MgSO4) and evaporated to afford an oil (0.52 g) which was 
fractionated by flash column chromatography on SiO 2 , 
employing a 10-60% EtOAc-hexanes gradient, to give the 
tosylate 16 (0.32 g, 55%) as a colourless waxy solid: 6 H(CDCI 3 ) 
7.68, 7.32 (4 H, ABA'B', J 8.3, ArH), 4.26 (1 H, dd, J 10.0, 7.0.8- 
H), 4.07(4 H, m, 9-H, CH2CH 3 ), 4.00(1 H, dd, J 10.0, 6.0,7-H), 
2.52(2 H, m, 6-H), 2.42,2.41 (6 H, 2 s, NCOCH3 ), 2.24(2 H, m), 
1.5 (4 H, m) and 1.20 (3 H, t, J 7.0, CH2 CH3 ); v,,,(film)/cm 
1760, 1732, 1700, 1365 and 1185. To a stirred solution of 
compound 16 (0.31 g) in dry DMF (2 cm') at ambient 
temperature under N 2, a solution of KSCOCH 3 (0.11 g) in 
DMF (2 cm 3) was added over 0.5 h. The mixture was stirred for 
20 h, after which the DMF was removed under reduced pressure 
and the residue dissolved in ether (30 cm 3). The extract was 
sequentially washed with water (10 cm 3 x 2), saturated brine 
(10 cm 3) and water (10 cm 3), dried (MgSO 4) and evaporated to 
afford a residue which was subjected to flash column 
chromatography on Si0 2 , eluting with a 10% EtOAc-hexanes 
to EtOAc gradient, to afford 17 (0.2 g, 83%) as a colourless oil; 
H (CDCI 3 ) 4.15(1 H. m, 8-H), 3.88 (1 H, dd, J 9.0. 3.5. 7-H), 4.06 
(2 H, q, J 7.0. CH2 CH 3), 3.11(2 H. AB of ABX. JAB 10.01  JAX 8.0. 
9-H), 2.40, 2.39 (6 H, 2 s, NCOCH 3 ), 2.25 (3 H. s, SCOCH 3 ), 
2.19(2 H, br t.J7, 2-H), 1.5(8 H, m) and 1.22(3 H, t, CH 2CH3 ); 
6C(CDCI 3 ) 173.4, 170.1, 169.7, 151.3 (CO), 60.1 (OCH 2CH 3 ), 
54.8, 54.3 (C-7, 8), 33.5 (C-9), 32.2 (C-2), 30.7 (C-6). 30.2 
(SCOCH 3 ), 28.4,24.4,23.8 (C-3,4,5),24.1,24.0 (NCOCH 3 ) and 
14.0 (CH 2 CH 3 ); vmax(film)/cm 1755, 1750, 1735, and 1700: 
rn/: (El) 400.1515 (M, C 18 H 28 N,06 S requires 400.1516). 
(± )-9-Mercaprodezhiobiotin Dimer 3a.—A methanolic sol-
ution of compound 17 (100 mg, 0.5 cm 3 ) was slowly added to I 
mol dm-3 aq. NaOH (3cm 3 ) and the solution stirred for 1.5 h at 
room temperature. The pH was adjusted to 8 with I mol dm -3 
aq. HCI and the solution applied to a column of AG50 x 2 
cation exchange resin (1 x 20 cm, 200 mesh. H form). The 
column was washed with water (30 cm') and eluted with EtOH-
H 2 0-NH4OH (5:3:2). Fractions (I cm 3 ) giving a positive 
nitroprusside test were pooled and lyophylised to give the dimer 
3a (36 mg. 60%) as a colourless hygroscopic solid; 
6H([H 5)pyrldine) 4.63 (1 H, m, 8-H), 4.42 (1 H, m. 7-H), 3.6(2 
H, br m. 9-H). 2.95(2 H, br t, J 7,6-H). 2.25 (2 H, br t, J7. 2-H) 
and 1.8 (6 H. m): c5c(D20-H 2 0. pH 8.5) 183.9 (C-I). 164.5 
(NCON), 57.3. 57.1 (C-7, 8), 43.0 (C-9), 37.6 (C-2). 34.8. 28.6. 
25.8, 24.0 (C-3. 4. 5, 6); v(Nujol)/cm' 3330. 3300, 1710 and 
1580; ml: (FAB glycerol) 491.1998 [(M + l. C, O H 3S NOO S, 
requires 491.1998]. 
Growth of E. coIl Muzants.—E. co/i 6435 and SA29I strains 
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w+re maintained on minimal 	containing 10 1g/cm 3 
bi,tin. SA291 was transformed with pK bioB using standard 
C40 2 transformation techniques 12  and transformants selected 
and maintained by growth on M9 minimal medium containing 
50sg/cm 3 ampicillin. 
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